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Resistance exercise (RE) is purported to induce muscle protein accretion 
primarily by stimulating muscle protein synthesis (MPS), with its effect potentiated by 
providing a protein or amino acid (AA) supplement post exercise. Glutamine, a 
conditionally essential AA, is increasingly recommended to improve exercise 
performance, but it is poorly soluble and unstable in sports drinks. This limitation can be 
overcome by combining L-glutamine with L-alanine to form a dipeptide (AlaGln). The 
first study demonstrated that AlaGln supplementation post resistance exercise 
significantly reduced the phosphorylation of AMPK and NF-kB p65 without activating 
intracellular signals for MPS. This study also showed that whey protein (WP) activated 
the mTOR signaling pathways without affecting signaling proteins that controls muscle 
protein breakdown (MPB). The results provide indirect evidence that AlaGln blocks 
 vii 
MPB via suppressing the activation of AMPK-FOXO3A and NF-kB p65, while WP 
promotes MPS.     
Recent research suggests that adding carbohydrate (CHO) to a protein supplement 
post exercise can produce greater protein accretion and subsequently increase the 
magnitude of resistance training adaptation relative to protein supplementation alone. 
Early studies from our laboratory found that co-ingestion of CHO and protein, as 
compared with CHO or protein intake individually, had a greater effect on the activation 
of anabolic signaling proteins. However, the effect of CHO plus protein on MPS and 
muscle adaptation is controversial. The second study demonstrated that adding CHO to a 
protein supplement (CP) accelerated MPS via activating the mTOR-signaling pathway in 
comparison with placebo (PLA) and WP during early exercise recovery, but CP did not 
affect signaling proteins that regulate MPB. The third study found that CP enhanced 
muscle strength relative to PLA and WP. The greater strength development in CP 
appeared due to increased myofibrillar protein content. Increased muscle hypertrophy 
occurred without an increase in myonuclei suggesting satellite cell activation was not 
required for muscle fiber development. Taken together, the results of this series of studies 
suggest that 1) AlaGln inhibits MPB following acute RE; 2) Adding CHO to a protein 
supplement accelerates muscle recovery by stimulating MPS, and increases the 
magnitude of muscle strength by accumulating more myofibrillar protein in comparison 
with PLA and WP.   
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Chapter I: General Introduction 
OVERVIEW 
Skeletal muscle constitutes about 40% of body weight and contains 50-75% of all 
proteins in the body (10). An enhancement of muscle mass is positively correlated with 
increased muscle strength and power, so an increase in muscle mass is crucial for 
promoting mobility, quality of life, and prevention of life-style related diseases. 
Two major strategies are generally used to increase muscle mass: resistance 
exercise (RE) and nutritional supplementation. RE is a potent stimulator of muscle 
protein synthesis (MPS), and its repeated activity can bring about skeletal muscle 
hypertrophy (14, 23). Muscle protein breakdown (MPB), however, is also elevated 
following RE. It results in a negative muscle net protein balance during the early 
recovery phase following RE if no nutritional supplement is consumed. This then may 
delay muscle repair and development, and extend the period of muscle fatigue.  
It is well known that protein intake is essential for hastening muscle recovery by 
ensuring sufficient amino acid (AA) availability and activation of the mammalian target 
of rapamycin complex 1 (mTORC1, referred as mTOR below) signaling pathway. mTOR 
is a central kinase that integrates upstream signals from muscle contraction, AA, and 
growth factors to stimulate MPS via mediating mRNA translation initiation. Therefore, a 
single bout of RE is able to activate the mTOR signaling pathway, with its effects 
potentiated by providing a protein supplement following RE. However, not all AA 
equally contribute to the muscle protein accretion.  
Glutamine is the most abundant AA in plasma and in skeletal muscle (15). It was 
found that the intramuscular glutamine concentration was highly associated with the rate 
of MPS (30). Therefore, maintaining or increasing the glutamine concentration in skeletal 
muscle is important, in particular under a catabolic state. Glutamine is classified as a 
conditionally essential AA. Under certain conditions such as severe illness, trauma, 
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cancer, and overtraining, the demand for glutamine exceeds its de novo synthesis and 
thus exogenous glutamine intake is necessary. In the past two decades, glutamine 
supplementation has become increasingly popular with athletes due to its potential 
benefit on glycogen resynthesis (5), protein synthesis (26, 30), and prevention of muscle 
atrophy (43). It also has been proposed that glutamine can exert a direct stimulatory 
effect on MPS possibly via the activation on the mTOR signaling pathway (29, 30), and 
inhibiting muscle atrophy via reducing the expression of myostatin, Atrogin-1 and 
MuRF-1 (29, 43). However, due to its poor solubility and instability in solution, interest 
from industry is greatly leaning to glutamine-containing dipeptides. SustamineTM (SUS), 
one such dipeptide composed of alanine and glutamine, has been shown to have better 
solubility and stability in a solution compared with glutamine alone (19, 41). L-
alanylglutamine (AlaGln) administration has been suggested to attenuate muscle damage 
as indicated by lower inflammatory biomarkers following a prolonged endurance exercise 
(7). However, its role on signaling proteins that control MPS and MPB after an acute RE 
needs to be investigated.  
Recent research also suggests that the addition of carbohydrate (CHO) to a protein 
supplement after RE may better benefit muscle recovery than that of protein/AA intake 
alone (9, 13, 35). We propose this idea because a carbohydrate/protein supplement 
greatly increases insulin secretion, and insulin is a very strong anabolic hormone. 
Immediately after high intensity RE, the human body is under a catabolic state due to the 
elevation of catabolic hormones such as cortisol and epinephrine. Insulin can inhibit the 
secretion of these hormones and reverse the catabolic environment to an anabolic 
physiological state. Also, many studies have clearly shown a potential suppressive effect 
of insulin on MPB (2, 6, 42) due to its inhibition on forkhead box 3A (FOXO3A) (12). 
Insulin also activates the mTOR signaling pathway through activation of Akt, but its role 
on MPS remains controversial. Many studies have utilized an isocaloric CHO supplement 
as a control in comparison with a protein supplement to study MPS post exercise. The 
effectiveness of the CHO supplement is generally negative or only mildly successful. 
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This failure to stimulate MPS is most likely due to a lack of AA availability. However, 
co-ingestion of CHO with protein is expected to maximize muscle protein accretion by 
overcoming a deficient AA pool and promoting a hyperinsulinemic state. To date, the 
few studies that have investigated the combined effects of CHO and protein 
supplementation on MPS have provided inconsistent results (28, 32). Moreover, results 
from some studies have demonstrated a similar pattern of change between MPS after 
acute RE and muscle hypertrophic response during a prolonged resistance training 
program (20, 22, 45), while other research has failed to support this relationship (31, 33). 
Thus, conducting a long-term study is necessary to examine the role of CHO in 
conjunction with protein on muscle hypertrophy and strength. 
To address the incongruent information in the literature regarding nutritional 
supplementation and muscle protein synthesis and development, we aimed to investigate 
1) the effect of AlaGln on cell signaling proteins that control MPS and MPB in 
comparison with exercise plus protein or exercise alone; 2) the effect of co-ingestion of 
CHO with protein compared with protein supplementation alone on MPS during the 
immediate hours after acute RE; 3) and the effect of co-ingestion of CHO with protein on 
muscle hypertrophy during a resistance training program.  
OBJECTIVES 
Study 1: to compare the effect of acute resistance exercise (RE) and post exercise 
supplementation of whey (WP) and two different dosages of AlaGln on rat skeletal 
muscle cell signaling proteins that control protein synthesis and degradation.  
Study 2: to determine whether the addition of CHO to a WP supplement (CP) can 
increase MPS after acute RE compared with exercise plus WP or exercise alone 
(PLA=ddH2O). We also proposed to investigate the relationship of MPS with 
phosphorylation of proteins responsible for control of MPS in the insulin and mTOR 
signaling pathways. Additionally, we investigated the effect of these treatments on the 
FOXO3A pathway that controls MPB. 
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Study 3: to determine whether a post-exercise CHO plus whey hydrolysate (CP) 
supplement compared to WP or PLA can bring about a greater enhancement of muscle 
hypertrophy and percent of lean body mass during 8 weeks of resistance training. We 
also aimed to investigate whether activation of satellite cells (SCs) was involved in the 
change of muscle mass by different treatments. 
HYPOTHESES 
Study 1 
1. An acute RE will modulate phosphorylation of signaling proteins that increase 
MPS and reduce MPB compared with the non-exercise group (SED) at both 20 
and 40 min post exercise. 
2. AlaGln provided immediately post RE will modulate phosphorylation of signaling 
proteins in a manner that enhances muscle protein synthesis and reduces protein 
degradation compared with exercise alone (PLA) at both 20 and 40 min post 
exercise.  
3. AlaGln provided immediately post RE will have a better or comparable effect on 
phosphorylation of signaling proteins in a manner that enhances muscle protein 
synthesis and reduces protein degradation in comparison with WP at either 20 or 
40 min post exercise.  
4. The high dose AlaGln will have a better effectiveness than the low dose AlaGln in 
the regulation of signaling proteins that increase MPS and reduce MPB at both 20 
and 40 min post exercise. 
5. AlaGln will increase anabolic hormonal circulation (insulin, GH, and IGF-1). 
Study 2 
1. In comparison with a WP supplement or PLA, a CP supplement will (a) enhance 
MPS after acute RE, and (b) increase the phosphorylation of cell signaling 
proteins in the mTOR and insulin signaling pathways. 
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2. In comparison with a WP supplement or PLA, a CP supplement will enhance 
modulation on the phosphorylation status of cell signaling proteins in the 
FOXO3A pathway.  
3. In comparison with a WP supplement or PLA, a CP supplement will promote a 
higher anabolic hormonal circulation (insulin, GH, and IGF-1) and lower the 
corticosterone level in plasma of rats. 
Study 3:    
1. In comparison with PLA and WP, CP will demonstrate a greater improvement in 
the body composition (increasing lean body mass and/or decreasing fat mass) 
during 8 weeks of resistance training.  
2. In comparison with PLA and WP, CP will produce greater muscle hypertrophy 
and muscle strength during 8 weeks of resistance training. 
3. Additional nuclei as assessed by protein expression of Pax 7, MyoD, and 
myogenin will be recruited over 8 weeks of resistance training, and enhanced by 
CP supplementation. 
4. The order of effects will be CP > WP > PLA. 
 
SIGNIFICANCE 
Acute RE induced MPS can last for up to 48 h (38), but MPB is simultaneously 
elevated after RE. Previous studies have demonstrated that exercise-stimulated MPS may 
not occur until 6 h post RE in rodents (21) or 3 h post RE in humans (38), whereas MPB 
can be increased during RE and remain elevated for 24 h post exercise in the fasted state 
(1, 38). Acceleration of muscle recovery after high-intensity RE is essential for athletes to 
maintain optimal performance in an upcoming competition, especially when the recovery 
time is limited between the two activities. Muscle recovery is also important after each 
high-intensity RE session during a prolonged exercise training regimen in order to 
generate greater muscle hypertrophy. On the other hand, protein intake alone increases 
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MPS with a minor effect on MPB, and its effect on MPS is transient. When combining 
protein supplementation with RE, their additive effects on the activation of the mTOR 
signaling pathway can augment the amplitude and duration of MPS. It is well established 
that increased AA availability post exercise is positively associated with an increase in 
MPS. However, not all AA contained in a protein supplement participate in the activation 
of mTOR, which in turn stimulates MPS. Glutamine is a conditionally essential AA. In 
normal situations, its requirements can be met by de novo synthesis within most tissues 
(e.g. skeletal muscle and liver) (36, 37) and from dietary protein intake. A fall in 
glutamine level can be seen in severe diseases, trauma, and strenuous exercise, in which 
exogenous glutamine intake may be necessary to meet the body’s demands. Glutamine is 
the most abundant AA in plasma and occupies more than 60% of the intramuscular AA 
pool (11, 15). Therefore, maintenance of glutamine level is crucial for various metabolic 
reactions. Early research observed a positive correlation between intramuscular glutamine 
concentration and the rate of MPS (30, 39, 40). Several investigations indicated that 
exogenous glutamine stimulates MPS by means of increasing GH and activating the 
mTOR signaling pathway (18, 30), particularly under a catabolic state (29, 46).  In 
addition to its possible benefit on MPS, glutamine may inhibit MPB (16, 43). Despite its 
important influence on muscle protein accretion, glutamine is not readily dissolvable in a 
sports drink due to its instability and limited solubility in solution with a low pH. 
Nevertheless, this limitation can be overcome by combining glutamine with another 
amino acid such as alanine (SustamineTM, a dipeptide composed of AlaGln). 
Consumption of AlaGln facilitates glutamine absorption and increases plasma glutamine 
concentration to a higher level (19, 41). AlaGln was reported to decrease muscle damage 
post exercise training and attenuate the reduction of MPS in post-operative patients (7, 
17). However, it is not conclusive as to whether AlaGln has any impact on muscle protein 
metabolism after acute resistance exercise. Study 1 represented the first study to 
investigate the effect of AlaGln on cell signaling proteins controlling MPS and MPB. 
Demonstrating significant changes in the phosphorylation state of signaling proteins 
conducive with an increase in MPS and decrease in MPB with AlaGln supplementation 
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would support the use of AlaGln in sports recovery drinks and thus provide a practical 
means of improving muscle net protein balance after exercise.  
With regard to protein intake, 20 to 25 g high-quality protein supplementation is 
sufficient to maximize MPS post RE in young adults (34). However, it has little or no 
effect on MPB. Recent research suggests that adding CHO to a protein supplement may 
have potential benefits on muscle recovery after RE (24, 32, 35). It is widely accepted 
that CHO intake can inhibit MPB by an increase in the phosphorylation of FOXO3A. In 
addition, insulin activates mTOR (35) through a different pathway from exercise or AA, 
suggesting that the combination of CHO and protein supplementation may have an 
additive effect on muscle protein accretion. Some in vitro studies demonstrated that 
insulin increases myotube protein synthesis (25, 27), but only a few in vivo studies have 
confirmed this positive effect (13). The few studies that have investigated the combined 
effects of CHO and protein on MPS also provided inconsistent results (28, 32). 
Therefore, in studies 2 and 3 we investigated whether CHO plus protein results in a 
greater MPS and training adaptation than protein alone. In our studies, dextrose (L-
glucose) was chosen as the CHO source because dextrose is a simple CHO and promotes 
a high insulin response (3). With regard to the source of protein supplement, ingestion 
milk protein is superior to soy protein in stimulating protein synthesis after RE (20). 
Compared with casein, however, whey is considered the best option to provide 
immediately post exercise for rapid muscle recovery because it has a faster absorption 
rate than casein (4, 8). In studies 2 and 3, if dextrose combined with whey is able to 
enhance MPS and promote muscle hypertrophy, then this nutrient combination should be 
an effective supplement for athletes to hasten muscle recovery in order to perform 
optimally during competition and achieve a faster training adaptation.   
Collectively, one major goal of our studies was to develop more effective ways 
(i.e. AlaGln and CP) to regulate cell signaling pathways controlling muscle protein 
accretion following acute strenuous RE. The other major goal of our study was to 
investigate the feasibility of a CP supplement on muscle protein synthesis and muscle 
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adaptation to RE. If our hypotheses are correct, our studies will provide several non-
pharmacological strategies to accelerate muscle protein accretion and training adaptation. 
Ideally, these nutritional strategies will yield an enhancement of lean body mass and 
increase in strength, thereby improving physical function for athlete. The strategies will 
also improve the muscle development of young adults and reduce the rate of sarcopenia 
in middle-aged and older individuals and improve their quality of life.  
LIMITATIONS AND DELIMITATIONS 
Ladder climbing was used as a resistance exercise protocol in all three studies. 
Therefore, the first consideration was that rats refusing to climb would affect the 
experiment results. To minimize this limitation, we familiarized the rats with this task 
over the first two weeks. If the rats were unwilling to climb, we provided encouragement 
by tapping their tails lightly with a bottle brush. If they continued to refuse to climb, they 
were eliminated from the study. Second, the muscle development in the rat with ladder 
climbing is mainly in the small muscles that control the toes, which does not afford large 
changes in body composition.  
Studies 1 and 2 were to test MPS and signaling proteins that control MPS and 
MPB. As we know, the phosphorylation of proteins is varied and occurs transiently as a 
result of muscle contraction or nutritional supplementation. Therefore, a third limitation 
is the possibility of missing the phosphorylation of designated proteins. According to the 
study of Harris et. al., ingestion of AlaGln led to a faster and higher increase in the 
plasma glutamine concentration than that of either glutamine or wheat protein 15-60 min 
after administration. The peak concentration of plasma glutamine caused by AlaGln 
supplementation is 30 min (19). Therefore, to minimize time course limitations, we chose 
two different time points (20 and 40 min) to investigate in study 1 post exercise. Based 
on the study of Morrison et al (35) and our pilot studies, we also chose two different time 
points (1 and 2 h) to investigate in study 2. However, each protein likely has a different 
pattern of phosphorylation, and therefore it is possible that our results are limited by the 
times of muscle harvesting.   
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To better understand the roles of AlaGln and CP on muscle protein accretion, both 
MPS and MPB should have been examined in our acute studies. However, due to funding 
and specific equipment limitations, we were only able to measure the signaling proteins 
that control MPS and MPB in study 1. Additionally, we could have measured 3-
methylhistidine levels in urine, plasma and isolated muscle as a marker of MPB, but this 
method has been criticized as an inaccurate measure of MPB. Therefore, a realistic 
technique for measuring MPB was beyond the scope of our acute studies.    
If in study 2, CP does not further enhance MPS compared with protein alone, it is 
still essential to perform study 3, because the acute effect does not always reflect the 
effectiveness of the supplement over time. Based on previous results (23, 44), an 
improvement in body composition, muscle hypertrophy and strength in the FHL is 
expected to be observed after 8-12 weeks of high intensity resistance training. The effects 
of nutritional supplementation in combination with exercise training are to be determined. 
Finally, young adult male rats were used in our studies. Regardless of the 
findings, our results will have to be confirmed with human research if more effective 
nutritional supplementations are to be developed in the future. The mode of exercise in 
our studies was resistance exercise, and therefore the results may not be generalized to 
other types of exercise, such as aerobic exercise.   
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Chapter II: Review of Literature 
Contemporarily, the importance of muscle mass change on metabolic function, 
strength, and power has been well recognized. An increase in muscle mass is crucial for 
competitive athletic performance. The maintenance in muscle mass is essential for 
maintaining a healthy and productive lifestyle and reducing risk of injury. As such, the 
development of appropriate strategies that can accelerate muscle protein synthesis (MPS), 
reduce muscle breakdown and increase or maintain muscle mass is highly recommended 
and beneficial for multiple populations, including athletes, body builders, elderly humans 
with sarcopenia, and patients suffering from clinical diseases that have a high catabolic 
state. In order to exploit the right treatments, we must first understand the molecular 
mechanisms that regulate skeletal muscle protein turnover.  
MOLECULAR MECHANISMS OF MUSCLE PROTEIN TURNOVER 
Signaling pathways that control muscle protein synthesis 
The regulation of muscle protein turnover involves interactions of gene 
transcription, mRNA translation, and protein degradation. Translation contains three 
main steps: translation initiation, elongation and termination, in which initiation is the 
rate limiting step in the regulation of overall MPS (5, 59). It is widely acceptable that 
mammalian target of rapamycin (mTOR) complex is a major regulator on MPS and 
muscle mass changes (166). mTOR complexes consist of mTOR complex 1 (mTORC1) 
and 2 (mTORC2). mTORC1 is a central protein integrating AA, muscle contraction, and 
anabolic hormones (65) signaling, with activation of mTORC1-dependent signaling 
pathway sufficient to induce MPS and in turn muscle fiber growth and repair (72).  
The core components of mTORC1 consist of mTOR, G protein β-subunit-like 
protein (GβL), and regulatory associated protein of mTOR (Raptor) (42, 45, 82). The 
activation of mTORC1 is a complex process requiring its subunits interacting with 
mTOR by formation, localization, and phosphorylation. mTOR is a Ser/Thr kinase 
containing multiple domains such as kinase domain, HEAT repeated, FKBP12-
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Rapamycin Binding (FRB) domain, and regulatory domain (RD), etc (82, 193). GβL can 
bind to the kinase domain on mTOR to increase its kinase activity and stabilize mTOR-
raptor association (82). Raptor is an adaptor protein essential for substrate binding with 
mTOR and thus recruiting downstream substrates to the mTOR for phosphorylation by its 
kinase. In addition to the core components, other molecules also interact with mTOR 
such as homologously enriched in brain (Rheb), Proline-rich Akt substrate 40kDa 
(PRAS40), and phosphatidic acid (PA) (45, 95). Of these molecules, Rheb-GTP activates 
mTOR kinase domain and stimulates mTOR phosphorylation at the Ser2448 site. 
Likewise, PA has been shown to bind to the FRB domain on mTOR, which in turn 
directly activate mTOR kinase activity (87, 195). Moreover, Rheb-GTP and PA are 
considered the only two molecules that are capable of activating mTOR signaling directly 
(86, 166). Conversely, PRAS40 is a protein inhibiting the activity of mTOR by directly 
interacting with the mTOR kinase domain and downstream substrates. In both rodents 
and humans, mTORC1 plays an important role during the muscle hypertrophy process in 
the regulation of mRNA translation initiation and elongation (14, 185). mTORC1 will be 
referred to as mTOR below.  
Once mTOR is activated by the phosphorylation at the Ser2448 site, it further 
phosphorylates two other downstream factors, 70 kDa ribosomal protein S6 kinase 
(p70S6k) and eukaryotic initiation factor 4E binding protein 1 (4E-BP1) (54, 55). p70S6k 
can further activate ribosomal protein S6 (rpS6), which is a component of the eukaryotic 
40S ribosomal subunit (97). The activation of rpS6 results in translation of specific 
mRNA to increase capacity of protein synthesis. The specific mRNA contains ribosomal 
proteins (eIF4G), elongation factors (eEF1/2), and poly A binding proteins (156). On the 
other hand, 4E-BP1 mediates binding of mRNA to the 40S ribosomal subunit (56). Once 
dephosphorylated, active 4E-BP1 competes with eukaryotic initiation factor 4G (eIF4G) 
and binds to eukaryotic initiation factor 4E (eIF-4E), which causes a dissociation between 
eIF4E and eIF4G. In this condition, 4E-BP1-eIF-4E can still bind with mRNA but not 
with the 43S preinitiation complex. Conversely, hyperphosphorylation of 4E-BP1 at the 
Thr37/46 site dissociates itself from eIF-4E so that eIF-4E is able to bind to eIF4G and 
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eIF4A to start eIF4F complex formation (137, 185). This complex then becomes a bridge 
linking mRNA to the 43S preinitiation complex, which increases rates of mRNA 
translation. Both downstream pathways from mTOR ultimately increase the capability for 
protein synthesis.  
Akt/PKB is an upstream substrate of mTOR. The phosphorylation of Akt at the 
Ser473 site activates mTOR predominantly via inhibiting the activity of PRAS40 and 
tuberous sclerosis complex 1/2 (TSC1/2) (92). TSC1/2 acts as a GTPase activating 
protein (GAP) converting Rheb-GTP into Rheb-GDP. Rheb-GDP is incapable of 
activating mTOR signals. However, the phosphorylation of TSC2 by the Akt dissociates 
itself from TSC1, and loses its GAP activity. Then, Rheb-GTP can activate mTOR 
signals. Some anabolic hormones, for instance, insulin and insulin-like growth factor 
(IGF)-1, can activate Akt through the phosphatidylinositol 3–kinase (PI3k) pathway (111, 
112). Conversely, AMP-activated protein kinase (AMPK) α is an energy-sensing protein. 
During and immediately after RE, an increase in the AMP-to-ATP ratio as a result of 
myosin ATPase activity stimulates the phosphorylation of AMPKα at the Thr172 site 
(43). The activation of AMPKα reduces MPS via inhibiting mTOR and decreasing 4E-
BP1 phosphorylation (16, 44).  
Another step of translation initiation is the formation of the 43S preinitiation 
complex. This is determined by the binding of met-tRNA to the 40s ribosomal subunit 
with eukaryotic initiation factor 2 (eIF2)-GTP which form a ternary complex. The GTP 
on the complex is hydrolyzed to GDP, which releases eIF2-GDP from the 40S ribosomal 
subunit. eIF2ɑ then exchanges GDP for GTP in order to participate in another round of 
initiation (17). This exchange process is mediated by another important initiation factor 
eIF2Bɛ. The activity of eIF2Bɛ is regulated by glycogen synthase kinase 3 (GSK3). 
GSK3 phosphorylates eIF2Bɛ at the Ser539 site to reduce its activity (98). Either 
phosphorylation of Akt or p70S6k is able to inhibit GSK-3ɑ/β by the phosphorylation at 
the Ser21/9 site, leading to an activation of eIF2B (98, 102).  
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Regulatory systems that control muscle protein degradation 
Because muscle protein gain is a sum of synthesis and breakdown, merely 
measuring MPS is not sufficient to interpret net protein balance. The principal proteolytic 
systems in skeletal muscle are classified into the ubiquitin-proteasome system, lysosomal 
proteolysis, and Ca2+-activated proteases (i.e. calpain) (96, 143). Lysosomes are 
membrane-bound vesicles primarily degrading membrane proteins such as certain 
ligands, receptors, channels, and transporters (8). Calpain mediated proteolysis does not 
directly degrade the contractile proteins (i.e. actin and myosin), but it participates in the 
cleavage of cytoskeletal proteins such as titin, nebulin, and C-protein (145). Caspase 3 
was also shown to interact with the calpain systems and be involved in actomyosin 
disassociation (46). Among these proteolytic systems, however, the ubiquitin-proteasome 
system is the primary signaling pathway that mediates myofibrillar protein degradation 
(96). Of this system, the proteasome complex (26S) is composed of a core subunit (20S) 
and two regulatory complexes (19S). The 26S subunit can only recognize and degrade 
ubiquitinated proteins. Three types of ligases are required for protein substrate binding 
with ubiqutin: the ubiquitin-activating enzyme (E1), conjugation enzymes (E2s), and 
specialized ligases (E3s). During the entire process of protein degradation, E3 enzyme 
mediated ubiquitin ligation is considered as a rate limiting step (13, 174). Two crucial 
ubiquitin E3 ligases in the skeletal muscle, muscle atrophy F-box (MAFbx or atrogin1) 
and muscle ring-finger protein 1 (MuRF1), have been shown to stimulate muscle 
proteolysis (4). The activation of both E3 ligases is under the regulation of transcription 
factors such as forkhead box O (FOXO) 3A in the nucleus (197). The phosphorylation of 
FOXO3A causes it to be trapped in the cytoplasm and inactive. As mentioned above, 
both Akt and AMPK mediate the phosphorylation of mTOR, but with opposing control 
over MPS. Akt is also a key factor in the phosphorylation of FOXO3A (23), whereas 
AMPK stimulates FOXO3A translocated into the nucleus (128). Moreover, other 
investigations reported an important role of NF-kB p65 induced muscle loss due to the 
activation of MuRF1 expression (28). Taken together, the inactivity of FOXO3A and NF-
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kB p65 trapped in the cytoplasm turns off the expression of E3 ligases in the nucleus, 
thereby leading to a reduction of MPB.  
MUSCLE ADAPTATION TO ACUTE RESISTANCE EXERCISE  
Muscle protein turnover induced by an acute resistance exercise 
It is commonly accepted that RE induces muscle protein accretion primarily by 
stimulating MPS. Fluckey et al. demonstrated in a rodent study that 16 h after 4 sessions 
of full extension of the lower extremity by performing squat movements, both 
gastrocnemius and soleus muscles showed a higher rate of protein synthesis than the 
muscles in non-exercised rats (59). In another research study, Hernandez et al. 
investigated the time course of change in MPS following RE and observed that an 
increase in the rate of protein synthesis in the gastrocnemius did not occur until 12 h post 
exercise (83), and remained elevated 24 h after exercise (83). This result is in agreement 
with human studies. In research by Chesley and coworkers, MPS in the biceps after 
performing a high-intensity elbow flexion exercise was significantly increased by about 
two-fold compared to the non-exercise biceps for up to 24 h (32). In another research 
study, this same group found that MPS induced by RE returned to baseline 36 h after 
exercise (117). However, Phillips et al. showed that acceleration of mixed muscle protein 
fractional synthesis rate (FSR) lasted up to 48 h post RE with the highest rate at 3 h, 
which then resulted in a significant increase in net protein balance over 48 h post exercise 
(141). The conflicting results about the peak period of elevated MPS are probably due to 
the different methodologies adopted in the MPS measurement. Chesley (32) and 
Macdougall (117) et al. infused L-[13C]-leucine for 6 h constantly to detect MPS. In order 
to insure a consistent rate of appearance of endogenous energy and protein, energy intake 
has to be supplied 2 h before the leucine infusion. In other words, MPS was measured by 
L-[13C]-leucine infusion when subjects were in the fed state. In contrast, MPS was 
determined in the Phillip et al. study (141) using a primed constant infusion of [2H]-
phenylalanine after an overnight fast. Moreover, Tang et al. has reported that trained 
individuals had a smaller change of FSR relative to that of untrained (176). Thus, having 
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subjects in various training statuses might be another reason for this discrepancy. Taken 
together, MPS can remain elevated for at least 24 h after a single bout of RE. 
Furthermore, skeletal muscle is composed of various proteins, including myofibrillar 
protein, sarcoplasmic protein, and mitochondria. These proteins may have different 
responses to RE; in other words, one type of protein may increase, whereas another type 
of protein could decrease in response to exercise. Myofibrillar protein, primarily 
consisting of myosin and actin, makes up more than 50% of skeletal muscle protein 
(139). The more myofibril packed in the muscle fibers, the greater the muscle 
hypertrophy, and the stronger the muscle. Therefore, the observation of changes in 
myofibrillar protein would be more representative to determine the muscle response to 
RE. Cuthbertson et al. measured rate of myofibrillar and sarcoplasmic protein synthesis 
over 24 h post exercise in the fed state, and found that the synthesis of both myofibrillar 
and sarcoplasmic proteins were increased at 6 h and 24 h after RE. These changes were 
proportional to the activation of Akt and p70S6k (37), which are important anabolic 
signaling proteins that control MPS. Overall, a single bout of RE is able to stimulate 
MPS, especially myofibrillar proteins.  
Early research reported that acute RE did not only increase MPS, but also induced 
MPB, and there was a tight correlation between the changes of MPS and MPB (141). 
Consequently, in spite of an improvement of muscle protein accretion post exercise, net 
protein balance remains negative in the postabsorptive state (10, 141). MPB is commonly 
estimated using 3-methylhistidine (3-MH), which is found in some myofibrillar proteins 
like myosin and actin. Once 3-MH is excreted from those proteins, it cannot be reused. 
Thus, 3-MH in urine is used as an indirect marker of myofibrillar protein degradation 
(147, 148). To date, however, there is no direct and more reliable measuring method for 
MPB, because 3-MH can also be released from intestine and skin. Collectively, RE can 
increase both MPS and MPB. Although it stimulates muscle protein accretion, the net 
protein balance remains negative.  
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Molecular mechanisms of muscle protein turnover induced by RE 
RE induced changes of muscle mass are related to changes in the rate of MPS (69, 
71, 95). Numerous lines of evidence have shown that the enhancement in MPS after acute 
RE is largely due to translational rather than transcriptional regulation (32). For example, 
Chesley et al. found that an increase in MPS was positively correlated with an increase in 
RNA activity both at 4 h and 24 h post RE (32), whereas the change of RNA capacity 
was not observed. In this study, RNA activity was expressed as amount of protein 
synthesis per unit time and per unit RNA. RNA capacity was expressed as total RNA 
concentration. The data suggests that MPS elevated post exercise is related to the change 
in posttranscriptional events rather than transcription. 
Regarding the effect of RE on signaling proteins controlling MPS, Bolster et al. 
(18) studied time course changes on the mTOR signaling pathway over 1 h post RE in 
rats. The results showed that the phosphorylation of Akt, 4E-BP1, and p70S6k peaked at 
10 min after RE, and the peak phosphorylation in rpS6 occurred at 15 min after exercise. 
The association of eIF4E to eIF4G was also increased significantly at 10 min after 
exercise. The rapid response of activation of these anabolic signals during the period 
immediately post exercise implies a high sensitivity of muscle in response to exercise 
stimuli. Additionally, mTORC1 is a rapamycin-sensitive protein. Rapmycin is a bacterial 
product that is capable of inhibiting mTOR by associating with its intracellular receptor 
FKBP12. The rapamycin-FKBP12 complex can directly inhibit mTOR activity by 
binding the FRB domain on mTOR. Therefore, a finding that RE induced MPS was 
suppressed by rapamycin administration (107) further suggests that the activation of 
mTOR-dependent signaling pathways is necessary to promote MPS by RE. Interestingly, 
the study conducted by Bolster et al. did not observe changes of eIF2Bɛ activity and the 
phosphorylation of eIF2α within 1 h after RE. However, other researchers reported an 
important role for the activation of eIF2Bɛ by exercise relative to formation of the eIF4F 
complex for MPS during a longer period post exercise. Glover et al. found a substantial 
change of eIF2Bɛ dephosphorylation 6 h after exercise in humans (67). Earlier animal 
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studies also revealed that MPS was enhanced 16 h after RE due to an elevation of eIF2Bɛ 
activity (48), and not the dissociation of eIF4E from 4E-BP1 (49). Furthermore, 
considering the upstream regulation of the mTOR signaling pathway, it was hypothesized 
that the autocrine/endocrine release of IGF-1 promoted the activation of mTOR and 
subsequently p70S6k via the PI3k-Akt signaling pathway (70). However, the exercise-
induced activation of p70S6k still occurred despite pharmacological inhibition of IGF-1 
(90). Thus, the release of IGF-1 may be able to, but not be required to, activate the 
mTOR signaling pathway in response to an acute bout of RE. Moreover, as discussed 
previously, PA is an important molecule activating mTOR directly. It was recently 
demonstrated that mechanical loading-induced PA accumulation was necessary to 
stimulate mTOR activity and the elevation of PA concentration was independent of IGF-
1/PI3K signaling pathway (134). Following a series of in vitro and in vivo experiments, 
Hornberger’s laboratory found that phospholipase D (PLD) was localized at the z-line of 
the sarcomere, a central site for contractile force transmission (87). PLD is an enzyme 
synthesizing PA from phosphotidylcholine. Mechanical stimuli are capable of activating 
PLD, PA accumulation, and the subsequent mTOR signals. Conversely, a 
pharmacological inhibitor (1-butanol) of PLD blocked mechanical loading-induced PA 
accumulation and mTOR activation (87). The results indicate that mTOR activation in 
response to exercise is PLD/PA dependent. Taken together, acute RE can stimulate MPS 
via activating mTOR-signaling pathways. However, dissociation between the 
phosphorylation of signaling proteins and the change of MPS was also reported by some 
studies (68, 74, 125), thereby suggesting the necessity of detecting MPS directly.  
During exercise, however, protein turnover is favorable for catabolic processes. 
As mentioned previously, AMPK is an energy sensing protein responsible for inhibiting 
anabolic processes that require ATP (e.g. muscle protein synthesis) and stimulating 
catabolic processes that generates ATP (e.g. muscle protein breakdown). During and 
immediately after RE, AMPK activation inhibits mTOR signals by the activation of 
TSC2 (93). AMPK can also directly phosphorylate mTOR at Thr2446, which inhibits the 
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phosphorylation at Ser2448 (31). Later, researchers suggested that AMPK activation may 
contribute to the inhibition of MPS during exercise and to the delayed activation of MPS 
during early post exercise recovery (44, 104). Nevertheless, this elevated AMPK rapidly 
returns to basal level after exercise, in particularly when nutrients are provided (146, 
189). Beyond the changes in signaling proteins, release of catabolic hormones by RE also 
contributes to a negative net protein balance. Cortisol (in human)/Corticosterone (in 
rodent), released from the adrenal cortex, accounts for up to 95% of glucocorticoid 
activity (106). As we know, glucocorticoids result in rapid muscle atrophy (165), 
possibly by dampening MPS (122, 167) and increasing MPB (123). High intensity 
exercise increases plasma cortisol, which can remain elevated for at least 30 min post 
exercise (178, 196). Thus, this catabolic hormone causes a transient negative nitrogen 
balance during exercise and the period of early recovery.  
In summary, both MPS and MPB are stimulated following RE, with an increase in 
MPS for up to 24-48 h. However, within a short period after exercise, MPS may only 
have a minor or no increased effect in the fasted state even though the mTOR signaling 
pathways may be activated. When the interval between exercise sessions is very short, 
athletes desire an effective muscle recovery process in order to prepare for upcoming 
competition. In this case, in order to shift net protein balance in favor of protein synthesis 
during early recovery after RE, proper nutritional supplementation post exercise may be 
essential for muscle protein accretion and tissue repair.   
NUTRITIONAL INTERVENTION ON ACUTE RESISTANCE EXERCISE 
Effect of protein ingestion on MPS  
Types, amount, and timing of protein ingestion on MPS 
A synergistic effect of RE and feeding on MPS during the early phase of post 
exercise recovery (i.e. <5 h) has been well described (11, 126, 182), and the sensitivity of 
MPS to nutritional stimuli can last up to 24 hours after RE (25). When it comes to 
nutritional supplementation post exercise, previous research provides strong evidence that 
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protein ingestion promotes MPS relative to exercise alone (21, 124, 175). With regards to 
the interaction of protein supplementation on MPS, many considerations need to be 
discussed, including supplement timing, the quality, and quantity of protein supplements. 
Recently, Burd et al. reported that the sensitizing effect of RE to protein intake could be 
sustained for at least 24 h (25). In this study, participants performed either low (30% of 
maximal strength) or high (90% of maximal strength) intensity RE to voluntary fatigue 
and were fed 15 g whey isolate 24 h after exercise. The results showed that the synthesis 
of the myofibrillar fraction was still augmented with protein feeding 24 h post RE at both 
exercise intensities compared to that of protein feeding at rest. Despite the synergistic 
effect of RE and protein supplementation on MPS anytime within 24 h after exercise, the 
greatest enhancement on MPS appears to be achieved when protein is provided 
immediately after exercise (34). This importance in protein consumption timing is 
illuminated by Levenhagen et al. Protein plus CHO was given either immediately (early) 
or 3 h (late) after a 60-min moderate intensity of cycling (114). Compared with late 
supplement, early protein/CHO intake elevated leg protein synthesis almost threefold 
after exercise, which in turn contributed to a higher net protein balance. Therefore, 
protein provision immediately after exercise is recommended to drive a better muscle 
recovery.  
Our daily protein intake should be at least 0.8 g/kg for a young adult sedentary 
human according to the recommended daily allowance (RDA). An additional amount of 
protein consumption may be required depending on the quality of protein ingestion, 
physiological condition, and physical activity level. In order to increase MPS and/or 
muscle hypertrophy, the level of protein intake with exercise should maintain a positive 
nitrogen balance. The level of AA in the blood is a critical initiator of protein synthesis, 
so AA appears to stimulate MPS in a dose-dependent manner. To elucidate the response 
of MPS to the amount of protein intake clearly, Moore et al. examined different amounts 
of protein ingestion (0, 5, 10, 20, and 40 g) post RE. They observed a dose-dependent 
stimulation on MPS to increasing amounts of dietary protein until 20 g (equal to 8.6 g 
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essential AA), with MPS leveling off from 20 to 40 g protein provided post exercise 
(125). Simultaneously, leucine oxidation was elevated when 40 g protein was supplied 
compared with 20 g (125). These results indicate that 20 g high-quality protein 
supplementation is sufficient to maximize MPS post RE in young adults. Excessive 
protein consumption leads to oxidation of amino acids. 
With respect to the quality of protein supplementation, whey, casein, and soy 
proteins are all natural proteins found in daily food. It is believed that milk ingestion 
(whey or casein as sources) is superior in stimulating MPS compared to a same amount 
of soy protein after RE (81, 190), because whey and casein contain great portions of 
essential amino acids (EAAs), particularly branched chain amino acids (BCAAs). 
Therefore, whey and casein are considered high-quality protein sources. The metabolic 
response of these two proteins is primarily determined by their digestive characteristics. 
Whey protein (WP) is acid soluble in the stomach and thus allows a rapid absorption of 
AA, whereas casein is converted to a solid clot in the gastric acid environment and thus 
digested slowly (15, 38). Therefore, WP promotes a high but short increase in whole 
body protein synthesis (26). Conversely, casein stimulates a low but sustained increase in 
protein synthesis (169). Tang et al. compared whey isolate, casein, and soy supplements 
on MPS after RE in young men. Whey isolate stimulated MPS 3 h post exercise to a 
greater extent than that given by either casein or soy protein (175). Leucine, a BCAA, is a 
very strong stimulator in the mTOR signaling pathway. A faster digestion and a higher 
portion of leucine in whey isolate appeared to account for its greater stimulation on MPS 
compared with the other two types of proteins. Similar results were confirmed in elderly 
men in a study of Burd and coworkers (26). Participants performed unilateral leg RE and 
then were given either 20 g casein or WP. Both rest and exercise legs showed a higher 
MPS during 4 h exercise recovery with WP ingestion than casein. The increased MPS 
was associated with a greater hyperaminoacidaemia or leucinaemia with whey 
supplements in this study. However, investigations comparing WP and casein do not 
always show consistent results. Some studies reported that both whey and casein led to a 
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similar myofibrillar MPS during 6 h of recovery after a high-intensity resistance exercise 
in young and elderly (41, 149, 181). Others even demonstrated a better effect of casein on 
MPS than WP (169). These conflicting results among studies are possibly due to the 
timing of the synthetic measurements (i.e. 1-3 h or 4-6 h). Generally, WP exerts a higher 
stimulatory effect on MPS during the first 3 h post exercise, but casein might have a 
similar effect on MPS to WP when measured over 6 h after exercise. Nevertheless, in 
order to pursue a faster recovery and MPS after acute RE, WP is considered best for 
athletes.  
Possible cellular mechanisms of protein ingestion on MPS 
Apparently, AA digested from protein act as precursors for muscle protein 
building. More importantly, proteins play an essential role in the regulation of mRNA 
translation initiation via augmenting the activation of mTOR signaling pathways, in 
particularly of leucine. Our laboratory has completed several studies in recent years 
addressing the effect of protein on the mTOR signaling pathway following endurance or 
resistance exercise. In a study by Morrison and coworkers, the phosphorylation of mTOR 
and p70S6k was significantly increased by a protein supplement (whey isolate = 300 
mg/kg) compared to exercise alone 30 min after 3 h swimming of rats (127). In another 
unpublished study from our lab, rats ran on a treadmill for 50 min using a high-low 
interval intensity exercise protocol, and were provided a whey protein supplement (375 
mg/kg) immediately after exercise. The results showed that the phosphorylation of 
mTOR, p70S6k, and 4E-BP1 was enhanced 45 min post endurance exercise with protein 
supplementation compared with exercise alone. This study also found an increased 
phosphorylation of FOXO3A by protein supplementation, suggesting a possible 
inhibitory effect of protein on MPB. Furthermore, another animal study in our lab utilized 
a ladder climbing protocol to simulate a resistance-type exercise, and observed an 
increase in the phosphorylation of mTOR, p70S6k, and rpS6 at times of 20 and 40 min 
post RE when whey was provided immediately after exercise compared with exercise 
alone (unpublished data). In contrast, AA (10g) stimulated MPS can be completely 
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blocked by rapamycin (40), which further indicates a central role of mTOR signal on the 
enhancement of MPS.  
It is notable that AA/protein stimulates mTOR activation through some potential 
signaling pathway that is distinguished from the one stimulated by mechanical loading. 
High-quality of protein contains a large amount of leucine. Leucine supplementation can 
cause a transient increase (15-45 min after administration) in insulin secretion that could 
partly contribute to the activation of mTOR (3). Other evidence suggests that other 
upstream components through insulin-independent pathways play central roles in the 
regulation of AA-induced mTOR activation (161). Rag GTPases are a family of Ras 
small GTPase proteins, consisting of RagA, RagB, RagC, and RagD. The heterodimer 
RagA/B can be functional when AA stimulates GTP binding to them (161). The active 
heterodimer RagA/B then binds to Raptor directly and localizes mTOR to the surface of 
the lysosome membrane where Rheb-GTP is situated. As mentioned previously, the 
activation of mTOR includes formation, phosphorylation, and translocation. The 
translocation of mTOR to the lysosome membrane by the Rag complex facilitates its 
interaction with Rheb-GTP for activation (136). Moreover, vacuolar protein sorting 34 
(Vps34) is considered another AA sensor. It is a novel class III PI3-kinase that can bind 
with Vps15 and phosphorylate phosphoinositide (PPI) to PI3P on endosomal membranes. 
PI3P is capable of recruiting various proteins (e.g. mTOR) to the endosome for later 
activation (27, 132). Byfield et al. also demonstrated that Vps34 was not stimulated by 
insulin, but inhibited by amino acid starvation, further suggesting that it lies on the AA-
regulated pathway (27). Knock-down of Vps34, on the contrary, reduced p70S6k and 
activated 4E-BP1, the two downstream proteins of mTOR (27). MAP4K3 is another 
insulin-independent regulator of mTOR in response to AA (53). In a research study 
conducted by Findlay et al., overexpression of MAP4K3 increased phosphorylation of 
p70S6k and 4E-BP1, which actions were not affected by a PI3k inhibitor wortmannin 
(53). MAP4K3 may activate mTOR via the Rag complex, but further research on the link 
between MAP4K3 and mTOR needs to be conducted.  
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Taken together, exercise and AA/protein stimulate mTOR signals via divergent 
pathways. This could explain why combining protein supplementation with RE results in 
a more pronounced anabolic response than either strategy provided alone.    
Effect of L-Alanylglutamine (AlaGln) ingestion on muscle protein turnover 
Protein supplementation is widely used in athletes to build muscle mass. 
However, not all AA contribute to an anabolic response and promote muscle hypertrophy 
equally. It is well known that essential amino acids (EAA), especially leucine, are strong 
stimulators on MPS. In addition to the EAA, glutamine supplementation has been 
increasingly recommended for athletes in recent decades because glutamine is the most 
abundant free amino acid in plasma (550-750µM) and skeletal muscle (20mmol/kg wet 
weight muscle) (50, 66). This large concentration difference between plasma and skeletal 
muscle is maintained by active transporters, particularly the sodium/potassium ATPase-
driven ion pump and the system A transporters (42, 151, 152, 168). Moreover, glutamine 
has been clearly shown to have potential benefits on glycogen resynthesis (22), protein 
synthesis (99, 118), prevention of muscle atrophy (159), and immune system protection 
(29). Glutamine also serves as a precursor in many other metabolic reactions, such as 
biosynthesis of nucleotides and gluconeogenesis. The source of glutamine comes from 
exogenous ingestion and de novo synthesis (130) by the body and thus it is classified as a 
conditionally EAA (108). Under normal conditions, the demand for glutamine can be met 
by synthesis within the skeletal muscle and from dietary proteins (129, 130). Under 
catabolic conditions such as severe illness, trauma, and overtraining, glutamine 
concentrations in plasma and skeletal muscle may fall below normal levels (109, 133). 
When the requirement for glutamine exceeds its de novo synthesis (76, 157), exogenous 
glutamine intake becomes necessary. 
The effect of glutamine on muscle protein turnover 
When it comes to its effect on muscle protein turnover, early research observed a 
positive correlation between the intramuscular concentration of glutamine and the rate of 
MPS (99, 118, 150). MacLennan and colleagues showed that increasing perfusate 
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glutamine concentration led to an increased intracellular uptake of glutamine, which in 
turn enhanced isolated muscle protein synthesis both in the presence and absence of 
insulin (118). In a human study, enteral infusion of glutamine exerted a protein anabolic 
effect by a detect increase in nonoxidative leucine disposal, an index of whole body 
protein synthesis (79). However, some other investigations failed to show a beneficial 
effect of glutamine on MPS (73, 188, 198). In an in vitro study conducted by Zhou and 
colleagues, it was observed that the rate of protein synthesis by glutamine administration 
was only seen in stressed myotubes (administered by a heat shock treatment) but not in 
normal-cultured myotubes (198). This is the first study indicating that the effect of 
glutamine on protein synthesis may be conditionally dependent. A recent study also 
demonstrated that the modulation of glutamine supplementation on expressions of mRNA 
and proteins controlling MPS and MPB was seen in diabetic rats, but not in normal non-
diabetic rats (109). Moreover, Wilkinson et al. found that the addition of glutamine 
(0.3g/kg) to EAA plus CHO did not further enhance protein synthesis following 1.5 h of 
cycling (188). One possible explanation on this result is that this endurance exercise 
protocol was not sufficient to reduce plasma and intramuscular glutamine concentration, 
so exogenous glutamine was not able to affect muscle protein balance. Another 
possibility is that sufficient EAA were provided to maximize MPS so that the addition of 
glutamine would be of little benefit. This possibility was supported by an increase in 
leucine oxidation during exercise recovery when given EAA+CHO, suggesting a 
sufficient EAAs provision.  
The results from the above research studies reveal that glutamine supplementation 
would be more essential for the maintenance of net protein balance under catabolic states 
such as stressful exercise and injury when the glutamine level falls. Low level of 
glutamine is also seen in patients with cancer, trauma, burn, surgery and those who are in 
intensive care (187). In these conditions, glutamine supplementation is supplied to 
maintain muscle glutamine content, which in turn counteracts the fall of MPS and/or 
inhibit MPB (77, 78).  
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With respect to MPB, glutamine plays an important role in the prevention of 
muscle atrophy. Glucocorticoid treatment results in rapid muscle atrophy both in animals 
and humans because of its catabolic and anti-anabolic effects on the contractile muscle 
proteins (165). In a study of Salehian et al., rats were administrated dexamethasone, a 
potent synthetic glucocorticoid (159). After 5 days of administration, rats showed 
significant muscle atrophy with an increase in myostatin expression in muscle. 
Myostatin, a member of the transforming growth factor-β superfamily, plays a role in the 
down-regulation of muscle mass hypertrophy. It can activate ubiquitination via increasing 
expression of Smad 3, Atrogin-1, and MuRF-1 (116). Myostatin also inhibits 
proliferation and differentiation of satellite cells to reduce the myogenic process (179, 
180). Once glutamine was administered in this study, dexamethasone-induced expression 
of myostatin was dampened, and thereby muscle atrophy was attenuated (159). Although 
this study did not measure plasma or intramuscular glutamine concentration, results from 
previous research together with this study revealed that glucocorticoids can cause an 
increase in the expression of glutamine synthetase to facilitate glutamine release from the 
skeletal muscle for liver gluconeogenesis (76, 84, 159). The reduction of intramuscular 
glutamine concentration would eventually impact net protein balance in skeletal muscle. 
Therefore, maintenance of intramuscular glutamine concentration is not only crucial for 
enhancement of MPS, but also to inhibit MPB, which then prevents muscle atrophy.   
Possible mechanisms of glutamine on regulations of muscle protein turnover 
It was recently reported that oral administration of glutamine resulted in 
significant increases in plasma and muscle glutamine concentration in diabetic rats, 
compensating for a decreased glutamine level in such a catabolic disease (109). 
Nevertheless, glutamine supplementation did not further increase plasma or muscle 
glutamine concentration in the normal non-diabetic rats. Lambertucci et al. also reported 
that the modulation of glutamine supplementation on expressions of mRNA and protein 
controlling MPS and MPB was only seen in diabetic rats but not in normal rats. For 
example, glutamine supplementation increased both mRNA expression and protein 
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phosphorylation of Akt in diabetic rats, which triggered total protein expression of 
mTOR and dampened total protein expression of 4E-BP1. Furthermore, early 
investigations demonstrated that plasma concentration of GH can be elevated by the 
administration of glutamine (186), and that plasma GH was associated with skeletal MPS 
(60, 61). Accordingly, glutamine appears to have a potential effect on mTOR signals via 
increasing the GH-IGF-1 axis in catabolic states. On the other hand, research has 
demonstrated that activation of AMPK can increase myofibrillar protein degradation by 
increasing the expression of atrogin-1 and MuRF-1 in C2C12 myotubes secondary to 
increasing the expression of FOXO3A (128). Starving cells of glutamine was reported to 
cause an increase in the phosphorylated to total AMPK cellular content (199). 
Conversely, glutamine supplementation was found to attenuate MPB and muscle atrophy 
by blunting atrogin-1 and MuRF-1 expression (19, 109), indicating that glutamine may 
inhibit MPB via AMPK-FOXO3A pathway.  
However, some other studies proposed that glutamine may promote an increase in 
intramuscular leucine concentration and thus indirectly activate the mTOR signaling 
pathway. As mentioned above, glutamine influx into skeletal muscle relies on the 
sodium/potassium ATPase-driven ion pump and the system A transporters (SLC1A5 and 
SNAT2). Once taken up into the muscle fiber (cell), glutamine becomes an efflux AA. 
Leucine and glutamine share the same heterodimeric solute carrier family 7 member 5 
(SLC7A5)/ solute carrier family 3 member 2 (SLC3A2) bidirectional transporters. 
SLC7A5/SLC3A2 then exchanges intracellular glutamine for extracellular leucine for 
activation of the mTOR signaling pathway (109, 131). In a study by Nicklin et al., 
preloading cells with glutamine hastened EAA stimulated p70S6k activation as solute 
carrier family 1 member 5 (SLC1A5) located on the plasma membrane was able to 
transport glutamine into the cell initially and then allowed more EAA influx into the cell 
by out-flowing glutamine (131). Collectively, glutamine may activate the mTOR 
signaling pathway and enhance MPS, but more experiments are warranted to confirm its 
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direct or indirect mechanisms on muscle protein turnover. It also remains unclear whether 
glutamine mediates these signaling pathways following resistance exercise.  
Putative benefits of L-Alanylglutamine (AlaGln) 
The daily supplemental dose of glutamine recommended is approximately 20-40 g 
based on a 70 kg body weight in human, and no toxic side effects have been reported 
when large amount of glutamine was taken (168). Accordingly, exogenous glutamine 
supplementation is thought to be safe and well tolerated by most populations. As a 
nutritional supplement, however, glutamine is usually provided in the form of a capsule 
or as a powder. Although it can also be supplied in liquid form having a low pH that 
enhances palatability and reduces microbial growth (80), glutamine is also poorly soluble 
and unstable in such solutions (63). This limitation can be overcome by using a dipeptide 
form containing glutamine. SustamineTM (SUS) is such a dipeptide composed of L-
glutamine and L-alanine (AlaGln). Alanine, as the second most abundant AA in plasma, 
is essential for liver gluconeogenesis (33, 76). However, alanine is not thought to be a 
key factor contributing to the regulation of muscle protein turnover (73, 159). Thus, the 
influence of SUS on muscle net protein balance is predominantly controlled by the 
portion of glutamine administration. Apparently, SUS supplementation is more stable and 
soluble in aqueous solution than glutamine (80). Compared with provision of glutamine 
alone or intact protein (wheat protein), AlaGln facilitates glutamine absorption and 
increases plasma glutamine concentration to a higher level (80, 153). The positive 
correlation between glutamine level and protein balance was also seen in some studies 
when glutamine-containing dipeptide was given to clinical patients (36, 154, 172). A 
research study found that the administration of AlaGln (containing 0.235g/kg glutamine) 
to post-operative patients for 3 days significantly improved whole body nitrogen balance 
(78). The drop of intramuscular glutamine level and MPS were also attenuated by AlaGln 
(78). In a study conducted by Cruzat and colleagues, AlaGln administration has also been 
found to attenuate muscle damage as suggested by lower inflammation biomarkers 
following prolonged endurance exercise (36). Taken together, AlaGln appears to have 
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similar or better benefits, relative to glutamine alone, on muscle net protein balance and 
muscle damage prevention. However, whether AlaGln stimulates MPS via mTOR 
signaling pathway and inhibits MPB via FOXO regulation following a RE remain to be 
investigated.   
Effect of CHO ingestion on MPS 
In order to shift muscle net protein balance in favor of accumulation, another key 
point is to change the catabolic hormonal environment induced by the elevation of 
cortisol and the suppression of insulin during and immediately after high intensity RE. As 
discussed before, cortisol/corticosterone can enhance MPB as well as inhibit MPS. The 
generation of cortisol during high intensity RE also causes muscle damage and release of 
glutamine from working muscles, which can further lead to a negative net protein balance 
(76, 84). As such, the elevation of circulating cortisol level may compensate for the 
anabolic effect caused by exercise and protein/AA supplementation. Lines of evidence 
have demonstrated that nutritional supplementation containing CHO significantly 
reduced circulating cortisol level during and after exercise (7, 115, 163). For example, 
subjects receiving CHO plus protein before and during RE showed lower muscle damage 
assessed by detections of myoglobin and CK compared with subjects receiving placebo 
(7). The attenuation of muscle damage was reported to result from a suppression of 
cortisol level (7, 105).  
As oppose to cortisol, insulin is a strong anabolic hormone. Ingestion of certain 
proteins or AA can stimulate insulin release, but its secretion is highly responsive to 
ingestion of CHO (39, 58, 183). Insulin can act on mTOR primarily through the PI3k/Akt 
signaling pathway (160). Insulin first binds to the α-subunit of the insulin receptor (IR) 
on the extracellular side of plasma membrane, which causes auto-phosphorylation of the 
β-subunit of the receptor. Pleckstrin homology (PH) domain on insulin receptor substrate 
(IRS)-1 binds to the activated IR to trigger Src homology 2 (SH2) domains on other 
downstream targets such as PI3k. PI3k has two subunits and the conformational change at 
p85 subunit activates the catalytic subunit p110 domain. This in turn converts 
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phosphatidylinositol 4,5-biphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate 
(PIP3) on the inner side of plasma membrane. PIP3 recruits the PH domain containing 
protein, such as PDK1, Akt, and aPKC. Akt, which then can affect the mTOR signaling 
pathway and thus MPS as discussed previously. Therefore, insulin may promote protein 
synthesis through the mTOR-signaling pathway. Due to the potential dissociation 
between the phosphorylation of signaling proteins and the change of MPS (68, 74, 125), 
direct measurement of insulin’s effect on MPS was addressed.  
An in vitro study conducted by Airhart and colleagues showed an impact of 
insulin on promoting MPS via increasing mRNA translation initiation (1). Also, Fluckey 
et al. utilized hindlimb perfusion in situ and demonstrated that adding insulin to the 
medium (containing isolated muscle) can further elevate protein synthesis in rats 16 h 
post RE compared to exercise alone, but non-exercised muscle is not affected by insulin 
(59). However, other studies reported no effect on protein synthesis by insulin after RE 
(20, 158). Roy et al. only observed an increased trend in fractional synthetic rate over 10 
h when CHO (1g/kg) was given 0 and 1h after RE (158). In a human study conducted by 
Borsheim et al., CHO (100 g) provided 1 h post RE improved muscle net protein balance 
due to reduced MPB without affecting MPS, but the net protein balance did not reach a 
physiological positive value (20). This inconsistency is possibly due to the differences in 
insulin concentrations in those studies. For the in vitro study, researchers used a 
significantly higher insulin concentration than normal physiological level to uncover the 
effect of insulin on MPS. Additionally, an in vivo study raised local forearm insulin 
concentration by around 1000 fold higher than the normal physiological level and 
observed an elevated protein synthesis even when AA concentration was not increased 
(85). It indicates that increased insulin level in plasma may affect MPS when it is used in 
a pharmacological dose, rather than physiological dose. Yet such a high dose of insulin 
provision is not practical for those who desire a better response to acute or chronic 
exercise. Conversely, it is widely known that insulin can inhibit MPB assessed by 
observing a decrease in urinary 3-MH (20, 158) and this effect on MPB can be explained 
by an increase in the phosphorylation of FOXO3A, which then reduces the expression of 
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atrogin-1 (52, 74). Due to its inhibitory effect on MPB, less AA is released in both 
plasma and intracellular spaces. Thus, an increase in insulin concentration without AA 
supplementation may not stimulate protein synthesis and trigger a positive protein 
accretion even though anabolic signaling pathways are activated (39).   
Although CHO supplementation alone fails to promote MPS after exercise, it may 
potentially stimulate protein synthesis in the presence of AA availability. In other words, 
AA stimulated protein synthesis may be amplified by the elevation of insulin level (124), 
and vice versa. Fujita and coworkers infused three physiological doses of insulin in one 
leg and demonstrated that physiological hyperinsulinemia (i.e. the postprandial dose) 
increased muscle blood flow which resulted in more AA delivery to the muscle (62). This 
increased delivery of AA, particularly leucine, is very important because both AA and 
insulin are able to activate mTOR signaling pathway to stimulate mRNA translation 
initiation, thereby contribute to an additive effect on MPS. A later research study from 
the same laboratory then explored the effect of EAA+CHO consumption on MPS in 
relation to the mTOR signaling pathway 2 h after RE (43), and found that the elevated 
activation of the mTOR signaling pathway by EAA+CHO is a crucial regulator in the 
greater MPS post RE. Miller and colleagues evaluated the independent or combined 
effects of an AA mixture (6 g x 2) and CHO (35 g x 2) supplement administered 
immediately and 1 h post RE on muscle protein metabolism (124). The results showed 
that the coordinated effect of AA and CHO on MPS was roughly equal to the sum of their 
independent effect (124). It is worth noting an issue regarding the timing response to the 
nutrient co-ingestion. The maximal insulin effect may not be in accordance with its peak 
plasma concentration, because both rate of appearance of phenylalanine from muscle into 
blood (reflecting MPB) and urea production were only reduced during the third hour after 
CHO ingestion, whereas the insulin concentration peaked ~30 min after the drink, 
suggesting a delayed response of insulin action. Therefore, a slowed absorbed form of 
AA (i.e. intact WP instead of AAs) combined with CHO ingestion may elicit a greater 
interactive effect on MPS.  
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In recent years, our laboratory has investigated the impact of the combination of 
protein and CHO on signaling proteins that control MPS and MPB post exercise. In a 
study by Morrison et al., rats swam for 3 h and were then provided a placebo (exercise 
alone), protein, CHO, or protein+CHO (CP) supplement (127). The phosphorylation 
status of mTOR related signaling proteins were measured 0, 30, and 90 min post exercise. 
The results showed that all the supplements increased the phosphorylation of mTOR and 
p70S6k after exercise, but only CP enhanced the phosphorylation of rpS6 at 30 min and 
4E-BP1 both at 30 and 90 min above all other treatments. Additionally, the 
phosphorylation of rpS6 and 4E-BP1 was in conjunction with an increase in insulin level 
(127). The findings from this study suggest that CP supplement is most effective in 
activating the mTOR signaling pathway post exercise in comparison with CHO or protein 
supplement alone. Furthermore, in a human study, Ivy et al. did not only demonstrate a 
higher level of phosphorylation of mTOR and rpS6 by CP 45 min post exercise relative 
to exercise alone, but also showed that CP enhanced the phosphorylation of Akt and 
GSK3α/β (94). Taken together, CP, compared with CHO or protein intake individually, 
may drive a greater effect on MPS via promoting the activation of anabolic signaling 
proteins.  
However, not all studies support this beneficial effect of CHO supplement on 
MPS. For example, Koopman and colleagues compared casein plus different doses of 
CHO (0, 0.15, 0.6 g/kg) on whole body protein synthesis and breakdown 6 h after RE 
(103). They did not observe any differences in the rate of protein synthesis, breakdown, 
as well as whole body protein balance among the treatments. Staples et al. then reported 
neither MPS nor MPB could be further affected by CHO plus WP relative to WP 
supplement alone during 3 h after RE (170). Also, there was no difference in leg blood 
flow and intramuscular signaling proteins between treatments. The discrepancy of 
insulin/CHO effect on MPS might be partly due to the types of protein/AA consumed, 
measuring timing, and doses of supplements. A maximal dose of WP (25 g) or casein (30 
g) was provided in studies of Staple and Koopman, whereas Miller only provided 12 g of 
AA. As mentioned above, insulin could mediate an increase in MPS via increasing blood 
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flow. When sufficient protein is supplied (>20-25 g), however, insulin becomes 
permissive, but not required regardless whether it addresses more delivery of AA to the 
working muscle or not. In addition, in the study of Miller et al., the demonstration of a 
higher net phenylalanine uptake (reflecting MPS) by CHO+EAA was primarily observed 
during the 1st and 2nd hours post exercise compared to EAA intake alone, but the change 
of MPS was not observed in studies of Staple and Koopman during 3-6 h after exercise. It 
is still uncertain whether MPS will be augmented by adding CHO to a protein supplement 
within 2 h after exercise compared to protein intake alone. Also, an anabolic response is 
not only determined by MPS, but also by MPB. Much more work remains to be done on 
characterizing the role of combining CHO with protein intake on muscle protein 
accretion and its signaling pathways after acute RE. According to our earlier discussion, 
it is hypothesized that co-ingestion of CHO and protein will maximize muscle protein 
anabolism by increasing MPS and reducing MPB. 
PROTEIN AND CHO INTERACTION WITH CHRONIC RESISTANCE EXERCISE TRAINING 
Muscle adaptation in chronic resistance training 
Although nutritional supplements provided immediately after acute RE plays a 
crucial role in MPS, the final goal is to promote muscle development over long-term 
resistance training. An increase in muscle mass has a strong correlation with a high 
muscle strength and power, which then promotes a higher quality of life and lower 
morbidity. Therefore, the attention to muscle hypertrophy is of great interest 
contemporarily. Chronic resistance training programs can primarily lead to muscle 
hypertrophy and secondarily stimulate myogenesis (hyperplasia). The major 
morphological adaptation of hypertrophy is an increase in muscle cross-sectional area 
(CSA), which results from both MPS and new nuclei infusion into the muscle fiber. 
Hornberger and Farrar showed, in a rodent study, that 8 weeks of progressive resistance 
training induced an increase in flexor hallucis longus (FHL) muscle mass by ~23% (89). 
This degree of FHL hypertrophy represented 0.3%/day accretion of muscle mass, which 
rate was proportional to an increase of CSA. In this study, both total and myofibrillar 
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proteins were increased by ~24% in exercise rats compared with non-exercise rats, 
suggesting that the FHL hypertrophy is mainly due to an accumulation of myofibrillar 
protein. In addition, skeletal muscle is composed of distinct types of fibers that differ in 
their capillary density, enzymes, and metabolism. The major forms of muscle fiber types 
are classified as type I muscle fibers (slow-twitch motor units, i.e. soleus) and type II 
muscle fiber (fast-twitch motor units) based on their myosin heavy chain expression. 
Type II fibers are further subclassified into type lla and type llb (in rodent) or IIx (in 
human) fibers. Gastrocnemius and plantaris contain both type II fibers, whereas FHL and 
extensor digitorium longus (EDL) contain mostly type IIb(x) fibers. Type II fibers can 
display a larger hypertrophy than type I fibers in response to RE training (120, 171). For 
example, a human study showed that muscle hypertrophy only occurred in type IIa and 
IIx fibers and not in type I fibers following 8 weeks of knee extension and leg press 
training (101). This phenomenon can partly be explained by the activation of p70S6k, 
p38 mitogen-activated protein kinase (MAPK) specifically in type II fibers post exercise 
(177).    
Muscle protein synthesis in response to resistance training 
Muscle hypertrophy is normally characterized by increasing protein accumulation 
in the active muscle fibers. This accumulation is due to MPS exceeding MPB over an 
extended period of resistance training (88). Although it is clearly understood that acute 
RE stimulates MPS, it may not be appropriate to explain muscle growth adaptation to 
chronic training only using the data obtained following acute RE. Conflicting results 
upon changes of MPS in response to exercise training have been reported in numerous 
studies. Some investigators found that chronic training attenuated acute exercise induced 
MPS by detecting less change of mixed MPS in trained legs than untrained legs both in 
human and rodent studies (47, 101, 140, 142). One possible reason for this observation 
could be due to the diversity of exercise intensity. For example, Phillips and coworkers 
observed less elevation of MPS in trained relative to untrained participants at the same 
absolute workload (140). This result could be expected since the adaptive muscle over the 
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chronic resistance training was not stressed efficiently by the same absolute workload. 
Another possible reason for the observation is that training may alter the extent and 
duration of post exercise stimulated MPS (24). This view was demonstrated by Tang and 
colleagues (176). Changes in fractional synthetic rate were determined 4 h and 28 h after 
a bout of the same relative RE intensity in untrained and trained subjects. Combining 
their results with previous data from the same lab (101), Tang et al. reported greater 
amplitude of fractional synthetic rate in the trained state at 4 h post exercise, but its rate 
was reduced at 16 and 28 h post exercise compared to the untrained state. Based on the 
results, it was speculated that training alters the window of response to acute exercise and 
that an increase in MPS might be missed if measurements of protein synthesis are 
performed at the wrong time. This view was further supported by a study conducted by 
Gasier et al (64), in which rats underwent a 5-week resistance training program and then 
MPS post exercise was measured by two different methodologies. Interestingly, the 
change in FSR was not observed post-exercise in trained rats compared with sedentary 
controls when it was measured 16 h after exercise by a traditional short-term 
measurement of protein synthesis (a flooding dose of 3H-phenylalanine over 10-15 s at a 
time point of 16 h post exercise). Nevertheless, using a new methodological approach, 
which was capable of detecting a cumulative response of FSR over many hours (assessed 
over a 36-h period from 20 h before exercise till 16 h after exercise), demonstrated a 
significant elevation in FSR post exercise compared with sedentary controls. 
Collectively, these findings suggest that resistance trained individuals may have a more 
rapid and stronger increase in protein synthesis, but shorter duration after an acute 
exercise bout relative to untrained individuals.   
With respect to the underlying mechanisms, it is worth noting that p70S6k has 
been suggested as a marker for the phenotypic changes of muscle hypertrophy. The first 
evidence was report by Baar and Esser, who demonstrated a tight positive correlation 
between p70S6k activity and the change in muscle mass after 6 weeks of training (5). The 
activation of p70S6k, induced by mTOR, then drives mRNA translation to increase MPS. 
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Conversely, Bodine et al. found that resistance training induced muscle mass change in 
plantaris was blocked up to ~95% when rapamycin was administered (14). This study 
also showed that the increase in muscle CSA was accompanied by an elevation in total 
amount and the phosphorylation of Akt (14). Similar results were reported in a study of 
Leger and coworkers that 8 weeks of training caused muscle hypertrophy relevant to a 
higher resting phosphorylation of Akt, mTOR, and GSK3 (113). Taken together, the 
elevation of MPS induced muscle hypertrophy is possibly due to the elevation of both 
total and phosphorylation of mTOR signaling proteins.  
Activation of satellite cell on muscle adaptation 
During resistance training-induced muscle hypertrophic adaptation, the control of 
protein translation and subsequent synthesis brings about protein accretion, while satellite 
cells (SCs) sometimes are required to facilitate an infusion of new myonuclei to the 
active muscle, thereby maintaining the myonuclear domain (quantity of 
cytoplasm/number of nuclei within that cytoplam) for muscle hypertrophy. SCs, 
underneath the basal lamina, are normally quiescent. Once activated by muscle 
contraction, SCs migrate into the existing muscle cell and differentiate into 
multinucleated myofibers for muscle hypertrophy. This crucial role of SCs was first 
found in a study utilizing gamma-irradiation to kill SCs (155). Thereafter, muscle size 
was not further increased by overload in the irradiated rats (155). Later research by 
Patrella et al. reported that a greater hypertrophy was driven by a greater SCs activation 
(138). They also indicated a ceiling size on the myonuclear domain (~2000µm2). In other 
words, the myonuclei fusion by SCs is required to provide sufficient cytoplasmic space 
for muscle protein expansion to occur when the myonuclear domain reaches a ceiling 
size, below which the stimulation of MPS is probably the sole factor to induce 
hypertrophy. Nevertheless, McCarthy’s laboratory recently pointed out that SCs were not 
always required for skeletal muscle hypertrophy, but were necessary for fiber 
regeneration (121). The results above indicate that the stimulation of MPS plays a major 
role during the entire process of muscle hypertrophy, while the activation of SCs is 
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important for a greater muscle hypertrophy as the myonuclear domain reaches critical 
size.  
Some myogenic regulatory factors (MRF) are expressed during the proliferation 
and differentiation phases of myogenic cells. For example, MyoD and Myf5 expression 
occur during proliferation stage and determine the myogenic cell fate and formation of 
myoblast, while Myogenin and MRF4 function in the activation of muscle differentiation 
(9). These MRFs are usually considered markers for the recruitment of new nuclei, 
especially MyoD and Myogenin (144). The activation of SCs is also controlled by growth 
regulators, IGF-1 and myostatin. Typically, IGF-1s are classified into three distinct 
isoforms: IGF-1Ea, IGF-1Eb, and IGF-1Ec in human. IGF-1Ea and IGF-1Eb are 
produced primarily from the liver in response to GH secretion and then release into the 
circulating blood. Acute RE can increase IGF-1 in plasma and within muscle fibers (192). 
The increased expression of blood IGF-1 does not only activate the mTOR signaling 
pathway, but also mediate MRFs expression (2, 57). However, blood levels of IGF-1 do 
not always correlate with muscle protein accretion post exercise (119, 200). Also, due to 
their delayed production by liver and transportation into the muscle fibers, IGF-1Ea and 
IGF-1Eb may only participate in SCs differentiation and fusion rather than activation and 
proliferation (138). In contrast, IGF-1Ec was suggested to play a more important role 
than IGF-1Ea/Eb in an enhancement of muscle protein accretion and SCs activation 
induced by mechanical loading. So, it is considered as a Mechano Growth Factor (MGF) 
(70). IGF-1Ec is exclusively produced in skeletal muscle and exerts its impact by means 
of autocrin/paracrine action in the muscle (164). As such, IGF-1Ec can be rapidly 
upregulated after exercise, and subsequently stimulate MPS and the proliferation of SCs 
(6, 138, 194). Additionally, there is evidence showing that local IGF-1 production (IGF-
1Ec) restrains FOXO nuclear localization and transcriptional activity, which then blocks 
its downstream proteolytic actions (162, 173). Therefore, IGF-1, especially IGF-1Ec, 
stimulate MPS, suppress MPB, and trigger SCs activation. On the other hand, myostatin, 
as discussed previously, plays a role in the down-regulation of muscle mass change. 
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Contrary to IGF-1, myostatin impairs muscle growth via inhibiting proliferation (179) 
and differentiation (110) of the SCs, which then dampen the increase in muscle mass. 
However, resistance loading was shown to reduce mRNA expression of myostatin with a 
concomitant up-regulation in MGF mRNA (100). Overall, SCs can provide a source for 
new myonuclei and promote greater protein accretion during resistance training.  
Protein and CHO supplementations on RE training 
High intensity resistance training can bring about a prolonged muscle recovery 
and ultimately a weaker training response if there is lack of the right nutrient intervention 
provided. Adequate protein ingestion combined with each exercise session is critical for 
muscle protein accretion. Recently, a meta-analysis performed by Cermak et al. provided 
evidence on the proposed effect of high quality protein supplement on the gain of muscle 
mass, changes of fiber-type specific CSA, and muscle strength (30). The data 
summarized that dietary protein supplementation (mostly whey protein) in young adults 
augmented the gain in fat-free mass and muscle strength after a prolonged resistance-type 
exercise training (30). Interestingly, a consistent result from the research included in this 
meta-analysis showed that milk/WP supplement can stimulate muscle hypertrophy to a 
greater extent than soy or CHO supplement (10, 12, 81, 184, 191). Furthermore, some 
other studies investigated the improvement of muscle mass change by the combination of 
protein and CHO intake during exercise training. For example, our laboratory recently 
demonstrated that a greater improvement in the body composition (calculated by the 
difference between the lean and fat mass) was achieved after 4.5 weeks endurance 
training when administering chocolate milk (protein plus CHO) relative to an isocaloric 
CHO supplement (51). Bird and colleagues demonstrated that CHO+EAA 
supplementation during and immediately following resistance training sessions increased 
lean body mass and muscle fiber CSA to a greater extent than CHO, EAA, or PLA over 
12 weeks of training (12). With regard to the supplementation timing, Cribb and Hayes 
showed that a protein plus CHO and creatine supplement provided before and 
immediately after each workout, compared with providing the supplement in the morning 
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and late evening, resulted in a greater increase in type II fiber-specific CSA, lean body 
mass, and strength (35). This enhancement of the muscle mass appears more associated 
with the protein part of the supplement. Willoughby and coworkers compared the effect 
of protein ingestion with that of CHO intake alone on muscle development during a 10-
week resistance training program. In this study, 20 g high quality protein or 20 g CHO 
(i.e. dextrose) were ingested 1 h before and after each daily exercise. After 10 weeks, 
protein supplement, relative to CHO supplement, led to a greater increase in muscle mass 
and strength along with a higher myofibrillar protein concentration and the mRNA 
expression of IGF-1 in the active muscle (191). Other researchers also found that protein 
ingestion could promote the activation of SCs by detecting the change in myogenin 
mRNA expression (75, 91, 135). Hence, it is speculated that protein ingestion provided 
during the period of resistance training may result in a synergistic effect on the activation 
of SCs, thereby a greater muscle hypertrophy would be observed than that of provided by 
either strategy alone.  
From another point of view, elevated cortisol levels during and post exercise have 
enormous implications for strength athletes. The harder the resistance training is, the 
greater the cortisol released, and the greater protein degradation occurs in particular in 
type II muscle fibers (106). Thus, the anabolic benefits of exercise can actually be 
attenuated or negated by the elevation of cortisol and reduction of insulin levels. 
However, CHO supplementation can acutely and chronically reverse the changes of these 
two hormones and alter muscle protein turnover. A study by Tarpenning and coworkers 
demonstrated that CHO consumption during the 12 weeks of weight lifting exerted 
significant increases in both type I and type II muscle CSA, indicative of muscle 
hypertrophy, relative to exercise training alone (178). This study also clearly showed a 
high correlation between the enhancement of muscle CSA and the reduction of cortisol 
levels caused by CHO, suggesting that the modification of the cortisol response 
positively impacted muscle hypertrophic adaptation to resistance exercise training (178). 
Moreover, as discussed above in the study conducted by Bird et al., CHO+EAA 
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displayed a better muscle hypertrophy compared with CHO or EAA provided 
individually. This study also indicated that protein degradation assessed by measurement 
of 3-MH was significantly reduced by CHO+EAA relative to the PLA group and 
suppressed exercise-induced cortisol release (12). Therefore, co-ingestion of CHO and 
protein/AA may promote a greater muscle hypertrophic response via an anti-catabolic 
effect.  
Taken together, the results from various studies suggest that CHO 
supplementation alone may not be able to affect muscle hypertrophy to the same extent as 
protein supplementation, but it may induce an anabolic hormonal environment by 
increasing plasma insulin and reducing plasma cortisol, thus optimize the influence of 
protein on muscle hypertrophy. It is clear, however, that there is a big gap in our 
understanding as to whether the addition of CHO to a protein supplement can enhance the 
effect of protein supplementation on muscle protein accretion, muscle recovery, and 
training adaptation during long-term resistance training.  
SUMMARY 
Skeletal muscle protein accretion and hypertrophy are highly complex processes 
regulated by various aspects, such as altered mechanical activity, hormonal control, and 
nutritional supplementations. Resistance exercise is a powerful stimulus for muscle 
protein synthesis, with long-term resistance training contributing to muscle hypertrophy. 
In order to speed up muscle recovery after exercise, protein supplementation post 
exercise takes advantage of an increase in MPS and greater activation of SCs, which 
allows more addition of myonuclei into myofibers. Glutamine, a conditionally EAA, 
potentially impacts muscle protein accretion post exercise by the activation of the mTOR 
signaling pathway, particularly under a catabolic state. Due to its instability and 
insolubility in solution, however, a dipeptide containing glutamine (e.g. AlaGln) is more 
favorable to ingest. Beyond that of protein or AA supplementation, the addition of CHO 
to a protein supplement is considered another strategy to optimize an increase in muscle 
mass following strenuous RE. This is possibly due to the fact that CHO ingestion might 
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speed the conversion of a catabolic state to an anabolic state immediately after exercise. 
Furthermore, CHO is capable of activating the mTOR signaling pathway as well as 
inhibiting protein degradation in order to assist protein supplementation in maximizing 
muscle mass gain. In conclusion, AlaGln supplementation or CHO co-ingestion with 
protein supplementation may provide means of accelerating muscle recovery and/or 
muscle hypertrophy following resistance exercise.  
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Table 2.1. The impact of an acute resistance exercise on muscle protein turnover 
Subjects  Exercise protocol supplements Measuring time period MPS MPB Net change comments Ref. Young men 4 x 8 reps @ 10RM 5 x 10 reps @ 12 RM 
N/A 4 h post ↑ ↑ ↑, but still negative ↑ AAs transport Biolo 1995 
Trained Human 4 x 6-12 reps @ 80% 1RM N/A 4 and 24 h post ↑ N/A N/A ↑ RNA activity without changing RNA capacity 
Chesley 1992 
Rats 50 times touching illuminated bar w/ 0.6g/g weight 
N/A 16 h ↑ N/A N/A  Farrell 2000 
Rats 2 x 25 reps in lifting N/A 16 h post ↑  N/A N/A  Fluckey 1996 Rats 50 times touching illuminated bar w/ 0.6g/g weight 
N/A 3, 6, 12, & 24 h post ex. ↑ @ 12 & 24 h post ex. in gas. ↑ @ 24 in soleus 
N/A N/A ↑ p70S6k activity between 6-24 h post ex. in gas. 
Hernandez 2000 
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Table 2.1. (continued) The impact of an acute resistance exercise on muscle protein turnover  Subjects  Exercise protocol supplements Measuring time period MPS MPB Net change comments Ref. Rats 50 times touching illuminated bar w/ 0.6g/g weight 
N/A 16 h ↑ N/A N/A Rapamycin inhibits MPS Kubica 2005 
Trained Human 4 x 6-12 reps @ 80% 1RM N/A 36 h <--> N/A N/A  MacDougall 1995 Young men 8 x 8 reps @ 80% 1RM N/A 3, 24, and 48 h post ↑ ↑ @ 3 & 24 h  %MPS>MPB Phillips 1997 
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Table 2.2. The impact of glutamine on muscle protein turnover 
 Subjects Special conditions supplements Measuring time period 
MPS MPB Intramuscular glutamine comments Ref. 
C2C12 myotube TNFɑ for last  24 h GLN 8mM for 5 days  N/A ↓ myostatin N/A  Bonetto 2011 Human RT for 6 weeks 0.65g/kg     Muscle adaptation not affected 
Candow 2001 
Human  Infuse GLN 0.08mmol/kg.h  ↑ in gut mucosa N/A  ↓ ubiquitin mRNA Coeffier 2003 Rats  Swim for 6 weeks 1.5g/kg.d AlaGln 21 days  N/A N/A ↑ ↓ CK, TNFɑ, PGE2, LDH Cruzat 2010 Human  Postsurgical patients 24g/3h 3 h <--> N/A ↓ in ill <--> by GLN A possible restriction in GLN transport in ill 
Gore  2003 
Patients  After abdominal surgery 
GLN 0.285g/kg for 3 days 
 A less decrease N/A ↑  Hammarqvist  1988 
Patients  Post-operation 0.354g/kg ALA-GLN (0.235g GLN) 
3 days ↑ N/A ↑  Hammarqvist 1990 
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Table 2.2. (continued) The impact of glutamine on muscle protein turnover 
 Subjects Special conditions supplements Measuring time period 
MPS MPB Intramuscular glutamine comments Ref. 
Rats  Endotoxin, pro-deficient, low-pro+endotoxin, or 3 days starve 
N/A 24-30 h after endotoxin 
↓ with decreasing intramuscular GLN 
N/A ↓ No relationship btwn Gly or Ala and MPS 
Jepson 1988 
Normal and diabetic Rats 
N/A 1g/kg GLN for 15 days    ↑ in diabetic rats ↑ akt, mTOR,  ↓4E-BP1, atrogin 1, MuRF1 
Lambertucci  2012 
Isolated perfused rat hindquarter 
N/A Perfusate glutamine (0.67-5mM) 
45 min of perfusion ↑ w/ or w/o insulin N/A ↑ Positive relationship btwn intramuscular glutamine and MPS 
MacLennan  1987 
Isolated perfused rat hindquarter 
N/A GLN 15mM 60 min N/A ↓ N/A Insulin effect on MPB is less than GLN 
MacLennan 1988 
Rats  Swim 60 min/d for 6 weeks 1.5 g/kg ALA-GLN, or 1 g GLN 
Last 21 days N/A N/A ↑  Rogero 2006 
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Table 2.2. (continued) The impact of glutamine on muscle protein turnover 
 Subjects Special conditions supplements Measuring time period 
MPS MPB Intramuscular glutamine comments Ref. 
Rats  Dexamethasone 600µg/kg GLN 20g/kg for 5 days  N/A N/A N/A GLN ↓ myostatin Preserve muscle mass 
Salehian 2006 
Human  1.5h cycling @ 65% VO2m  CHO+EAA w/ or w/o 0.3g/kg GLN 
3 h <--> <--> <--> Sufficient AAs provision 
Wilkinson  2006 
L8 Stressed myotubes Heat-shock treatment GLN 0-15mM 24 h ↑ ↓  in long-lived proteins 
N/A ↑ HSP70 in stressed myotube, not in the nomrla myotube.  
Zhou  1997 
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Table 2.3. The impact of protein and/or carbohydrate on muscle protein turnover after an acute resistance exercise 
 Subjects Exercise protocol supplements Measuring time period MPS MPB Net change comments Ref. Young men 4 x 8 reps @ 10RM 5 x 10 reps @ 12 RM 
Infuse AAs 1h post ex.  Over 3 h after infusion 
↑ N/A N/A AA increases MPS post ex. than at rest 
Biolo 1997 
Young men 4 x 8 reps @ 10RM 5 x 10 reps @ 12 RM 
Infuse insulin  ↑ at rest ↑ tendency post ex. 
↓ N/A Ex. ↑ BF, which does not further increase by insulin 
Biolo 1999 
Young human 10 x 10 reps @ 80% 1RM EAA (0.087g/kg) 1 & 2 h post ex. 
4 h post ex. ↑ @ 1-2 h after 1st drink <--> ↑ @ 1-2 h after 1st drink 
 Borsheim 2002 
Young human 10 x 8 reps @ 80% 1RM CHO (100g) 1 h post ex. 3 h post drink <--> ↓ ↑ @ 3
rd h, but still negative 
 Borsheim 2004 
Young men 4 sets @ 90% or 30% to fatigue 
Whey isolate (15g) 21-24 h post ↑ N/A N/A Sensitivity of ex. Lasts for 24h 
Burd 2011 
Elderly 3 x 10 reps @ 1RM Whey protein or casein (20g) 
4 h ↑ both rest and ex. by WP & casein (WP>casein) 
N/A N/A ↑ Plasma EAA to peak @ 60 min post 
Burd 2012 
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Table 2.3. (continued) The impact of protein and/or carbohydrate on muscle protein turnover after an acute resistance exercise 
 Subjects Exercise protocol supplements Measuring time period MPS MPB Net change comments Ref. Elderly human 5 x 8 reps @ 80% 1RM caseinate 30 min before vs. after ex. Whey vs. caseinate after ex.   (0.45g/kg LM) 
6 h ↑ by treatments, but <--> among treatments 
N/A N/A  Dideriksen 2011 
Young men 10 x 10 reps @ 70% 1RM EAA (0.35g/kg LM) + CHO (0.5g/kg LM sucrose) 1 h post ex. 
2 h post drink ↑ N/A ↑ ↑ p-Akt, mTOR, p70S6K, and 4E-BP1 
Dreyer 2008 
Young men N/A Infuse AA (18g/h) And infuse insulin (5, 30,  72, 167 mU/L) 
3 h <--> among doses ↓ @ 30, 72, & 167 mU/L 
<--> among doses ↑ BF by insulin Greenhaff 2008 
Elderly men N/A 40g casein during the night 
5 h ↑ <--> ↑ Prolonged increase in plasma EAA 
Groen 2011 
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Table 2.3. (continued) The impact of protein and/or carbohydrate on muscle protein turnover after an acute resistance exercise 
 Subjects Exercise protocol supplements Measuring time period MPS MPB Net change comments Ref. Young human N/A Raised insulin 1000 fold above basal level 
4 h ↑ N/A ↑ Euglycemia Hillier 1998 
Young human 10 x 10 reps & 8 x 8 reps @ 75% 
CHO (35g)+EAA (6g) 1 & 2h post 
2-4h post ex. ↑ both by CP and AA <--> N/A Net balance by CP is roughly equal to that of by EAA & CHO alone 
Miller 2003 
Young men 4 x 8-10 RM (3 sessions) Protein (5, 10, 20, or 40g) 4 h post ↑ (40=20>10>5) N/A N/A Doses of protein did not change p-S6K, rpS6, and eIF2Bɛ  
Moore 2009 
Young men 5 x 8-10 RM Whey protein (25 g) 5 h post ↑ (in myofibril) @ 3 & 5h N/A N/A  Moore 2009 Young men 10 x 8 reps @ 80% 1RM Whey protein or casein (0.3g/kg) 
6 h ↑ (WP=casein over 6h) N/A N/A WP>casein @ 1-3h, casein > WP @ 3-6h, 
Reitelseder 2011 
Human 8 x 10 reps @ 85% 1RM CHO (1g/kg) @ 0 and 1 h post 
10 h post ↑ tendency ↓ ↑ ↓ 3-MH, ↓ urinary urea N excretion 
Roy 1997 
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Table 2.3. (continued) The impact of protein and/or carbohydrate on muscle protein turnover after an acute resistance exercise 
 Subjects Exercise protocol supplements Measuring time period MPS MPB Net change comments Ref. Young men 4 x 8-12 RM to fatigue whey isolate (25g) w/ or w/o CHO (50g) 
3 h ↑  But CHO did not further ↑ 
↑ N/A  Staples 2011 
Young human  Whey protein or casein (20g) 1 h post 
4 h ↑ (whey = casein) N/A ↑ Different patterns of blood amino acid responses 
Tipton 2004 
Young men 3 x 10 reps 4th set to fatigue @ 80% 1RM 
Milk or soy (18.2g) post ex. 
3 h ↑ (milk > soy) N/A ↑  Wilkinson 2007 
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Table 2.4. The impact of protein and/or carbohydrate on muscle mass change following chronic resistance training 
 Subjects  Training period supplements Fat free mass Fat mass CSA comments Ref. Rats  Totally 15 sessions in 5 wks 
N/A ↑ N/A N/A Cumulative measurement for 36 h 
Gasier 2011 
Rats  Progressive RE for 8 wks N/A ↑ in FHL N/A ↑ in FHL ↑ total and myofibrillar protein in FHL 
Hornberger 2004 
Young men  4 x 10 reps 8 wks N/A N/A N/A ↑ in type II fibers resting FSR: T > UT post ex. FSR: T < UT 
Kim 2005 
Young men 3 sessions/ wk for 12 wks N/A N/A N/A ↑ in both type I & II fibers of biceps 
 McCall 1996 
Young men  6 d/wk for 8 wks N/A ↑ at rest, but not further ↑ post ex. ↑ at rest, but not further ↑ post ex. 
N/A  Phillips 2002 
Young human  Progressive RE 2d/wk for 8 wks N/A <--> <--> ↑ tendency in men Neural may stimulate increased strength during early training 
Staron 1994 
Young men 2-3 d/ wk for 8 wks (20 sessions totally) 
N/A N/A N/A ↑ in both type I & II fibers MPS in T vs. UT:  ↑@ 4h ↓ @ 28 h post ex. 
Tang 2008 
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Table 2.4. (continued) The impact of protein and/or carbohydrate on muscle mass change following chronic resistance training 
 Subjects  Training period supplements Fat free mass Fat mass CSA comments Ref. Young men 3 x 8-10 reps @75% 1RM  2d/wk for 12 wks 
EAA (6g) and/or 6% CHO solution ↑ by EAA+CHO more than other groups 
<-->  ↓ cortisol  Bird 2006 
Young men   3d/wk for 10 wks Protein +glucose +creatine (1g/kg) Before/after or morning/evening 
↑ N/A ↑ in type II fibers Pre-post supplement is better than morning-evening supplement 
Cribb 2006 
Elderly men  3 d/wk for 12 wks from 20RM to 12RM to 8RM 
10g protein+7g CHO at 0 (P0) or 2h (P2) after each ex. 
↑ @ P0 <--> ↑ @ P0  Esmarck 2001 
Young human 60 min cycling @ 75-80% VO2max 4.5 wks 
CHO (0.94g/kg)+protein (0.31g/kg) or CHO (1.25g/kg) 0 & 1h post ex. 
↑ in all groups ↓ in all groups N/A  A larger lean and fat mass differentials by CHO+protein 
Ferguson-stegall 2011 
Young men 5 d/wk x 12 wks @80% 1RM 
Fat-free milk (17.5g) or soy (isonitrogenous) or CHO 0 and 1 h 
↑(milk>soy=CHO) ↓ ↑ in both type I & II fibers  Hartman 2007 
Young men  40-85% 1RM 2d/wk for 21 wks 
Whey protein (15g) before and after ex. 
N/A <--> ↑ (protein =placebo) ↑ body mass Hulmi 2009 
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Table 2.4. (continued) The impact of protein and/or carbohydrate on muscle mass change following chronic resistance training 
 Subjects  Training period supplements Fat free mass Fat mass CSA comments Ref. Young men 3 d/wk for 16 wks Protein 20g N/A N/A ↑ Protein ↑ SCs number Olsen 2006 Mice  EDL overloading  for 4 wks by TA Ablation 
Limb exposed γ-radiation ↓ N/A ↓  Rosenblatt 1992 
Young men 3 x 10 reps @75% 1RM 12 wks 
6% CHO solution <--> <--> ↑ in both type I & II fibers ↓ cortisol level post exercise Tarpenning 2001 
Young men 4d/w for 10 weeks @ 85% 1RM 
Whey+casein or CHO  (20g) before and after 
↑ <--> N/A ↑ IGF-1 mRNA and myofibrillar protein 
Willoughby 2007 
  MPS: muscle protein synthesis; MPB: muscle protein breakdown; Reps: repetitions; 1RM: one repetition maximum;   GLN: glutamine; ALA: alanine; ↑: increase; ↓: decrease; <-->: unchanged; CSA: cross-sectional area;           
  
 
Figure 2.1. The effect of exercise, whey protein, and carbohydrate on signaling proteins that control MPS and MPB
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Chapter III: L-alanylglutamine Inhibits Signaling Proteins that Activate Protein Degradation, but Does not Affect Proteins that Activate Protein Synthesis after an Acute Resistance Exercise 
ABSTRACT 
SustamineTM (SUS) is a dipeptide composed of alanine and glutamine (AlaGln). 
Glutamine has been suggested to increase muscle protein accretion, however, the underlying 
molecular mechanisms of glutamine on muscle protein metabolism following resistance exercise 
have not been fully addressed. In the present study, two-month-old rats climbed a ladder 10 
times with a weight equal to 75% of their body mass attached at the tail. Rats were then orally 
administered one of four solutions: placebo (PLA-glycine=0.52g/kg), whey protein 
(WP=0.4g/kg), low dose of SUS (LSUS=0.1g/kg), or high dose of SUS (HSUS=0.5g/kg). An 
additional group of sedentary (SED) rats were intubated with glycine (0.52g/kg) at the same time 
as the ladder-climbing rats. Blood samples were collected immediately after exercise, and either 
20 or 40 min after recovery. The flexor hallucis longus (FHL), a muscle used for climbing, was 
excised at 20 or 40 min post exercise and analyzed for proteins regulating protein synthesis and 
degradation. All supplements elevated the phosphorylation of FOXO3A above SED at 20 min 
post exercise, but only the SUS supplements significantly reduced the phosphorylation of AMPK 
and NF-kB p65. SUS supplements had no effect on mTOR signaling, but WP supplementation 
yielded a greater phosphorylation of mTOR, p70S6k, and rpS6 compared with PLA at 20 min 
post exercise. However, by 40 min post exercise phosphorylation of mTOR and rpS6 in PLA had 
risen to levels not different than WP. These results suggest that SUS blocks the activation of 
intracellular signals for MPB, whereas WP accelerates mRNA translation.  
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INTRODUCTION 
Glutamine is the most abundant amino acid in plasma (550-750 µM) and skeletal muscle 
(20 mmol/kg wet weight muscle) in humans (16, 23). Under normal conditions, the demand for 
glutamine can be met by synthesis within the skeletal muscle and from dietary proteins (39, 40). 
Under catabolic conditions such as severe illness, trauma, and overtraining, glutamine 
concentrations in plasma and skeletal muscle may fall below normal levels (33, 41). When the 
requirement for glutamine exceeds its de novo synthesis, exogenous glutamine intake becomes 
necessary. Thus, glutamine is classified as a conditionally essential amino acid (31). It was found 
that the intramuscular glutamine concentration was highly associated with the rate of muscle 
protein synthesis (MPS) in isolated perfused muscle (34). Therefore, maintaining or increasing 
glutamine concentration in skeletal muscle appears crucial for MPS, particularly under a 
catabolic state. In the past two decades, glutamine supplementation has been used by athletes 
because it has been reported to increase glycogen synthesis (12) and protein synthesis (30, 34), 
and prevent muscle atrophy (47). A dipeptide containing glutamine also was reported to improve 
cycling exercise performance by increasing time to exhaustion (26).  
MPS is primarily controlled by the phosphorylation of proteins in the mammalian target 
of rapamycin (mTOR) signaling pathway. mTOR is an important kinase that integrates upstream 
signals from muscle contraction, amino acids, and growth factors to stimulate MPS via 
mediating mRNA translation initiation. Once mTOR is activated by phosphorylation at its 
Ser2448 site, it further phosphorylates 70-kDa ribosomal S6 protein kinase (p70S6k) (17, 18). 
p70S6k activates Ribosomal protein S6 (rpS6), which results in translation of mRNA to increase 
capacity of protein synthesis (29). Conversely, the main suppressors limiting muscle protein 
breakdown (MPB) are the muscle ubiquitin E3 ligases. Expression of these ligases is regulated 
via the forkhead box O-3A (FOXO3A) and nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-kB) dependent signaling pathways (14, 38, 50). Protein intake can elicit 
MPS via the activation of the mTOR signaling pathway at rest or after exercise (4, 36). However, 
there is limited information on the effect of glutamine on signaling pathways that control protein 
synthesis and degradation. A recent research study suggested that glutamine alleviates the loss of 
muscle mass in diabetic rats via the activation of the mTOR signaling pathway as well as the 
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inhibition of ubiquitin E3 ligases expression (33). However, it remains unclear whether 
glutamine mediates these signaling pathways in conditions of resistance exercise.  
As a nutritional supplement, L-Gln is usually provided in the form of a capsule or as a 
powder. It can also be supplied in liquid form, but requires the liquid be of low pH to enhance 
palatability and reduce microbial growth. However, due to low solubility and stability of 
glutamine in low pH solutions (3, 22), glutamine dipeptides such as L-alanylglutamine (AlaGln) 
have been designed to improve upon these physical limitations in order for glutamine to be used 
in sports drinks and health products (25, 44). Compared with glutamine or wheat protein, AlaGln  
facilitates glutamine absorption and increases plasma glutamine concentration to a higher level 
(25, 44). AlaGln administration has also been found to attenuate muscle damage as suggested by 
lower inflammation biomarkers following prolonged endurance exercise (15). In the present 
study, we investigated the effects of acute SustamineTM (SUS) supplementation, a dipeptide 
composed of alanine and glutamine, on the signaling pathways controlling MPS and MPB post 
resistance exercise. Comparisons were made relative to whey protein (WP) supplementation.  
MATERIALS AND METHODS 
Animals A total of eighty-nine male Sprague-Dawley rats were obtained at approximately 
2 to 3 months of age from Charles River (Wilmington, MA).  Rats were housed 2 per cage and 
provided standard laboratory chow (Prolab RMH 1800 5LL2, LabDiet, Brentwood, MO) and 
water ad libitum. The temperature of the animal room was maintained at 21° C. A reverse 
artificial 12 h dark-light cycle was set with the light phase from 8:00 pm to 8:00 am. All 
experimental procedures were approved by the Institutional Animal Care and Use Committee 
(IACUC) of the University of Texas at Austin and conform to the guidelines for the use of 
laboratory animals published by the United States Department of Health and Human Resources.   
Exercise familiarization Following 1 week of acclimation to their new environment, each 
rat underwent 3 repeated sessions of ladder climbing separated by 1 day between each session to 
familiarize them with the exercise protocol.  During the familiarization period, the rats carried 
no weights. The rats climbed a ladder 1 meter in height on an incline of 85° with 2 cm grid rungs 
8 times each practice session with a 2-minute rest between climbs. The rats also completed 3 
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practice sessions of climbing separated by 1 day between each session with 50, 60 and 70% of 
their body mass attached to their tails, respectively. The weight was attached at the base of the 
tail with foam tape (3M Conan) and a Velcro strap. Rats were encouraged to climb by lightly 
tapping their tails with a bottle brush.   
Experimental protocol On the experimental day, following a two-hour fast, rats climbed 
the ladder 10 times with a weight equal to 75% of their body mass attached at the base of the tail.  
There was a 2-minute rest period between each climb. Once the exercise protocol was 
completed, a 0.7 ml blood sample was collected from the tip of the tail. Whey protein 
(WP=0.4g/kg), low-SustamineTM (LSUS=0.1g/kg, L-alanylglutamine (AlaGln); Kyowa Hakko 
Bio. Ltd., New York, NY), high-SustamineTM (HSUS=0.5g/kg), or placebo (PLA=0.52g/kg 
glycine, isonitrogenous to the HSUS), was given in randomized order immediately post 
resistance exercise by intubation. Sixteen rats were used as sedentary controls and received an 
intubation of glycine (SED: glycine=0.52g/kg) at the same time. Rats in each treatment group 
were subdivided by time of euthanasia, which occurred at 20 or 40 minutes post intubation (n = 
8-13 per group). A second blood sample was collected immediately prior to euthanasia. 
Following the second blood sample, rats were anesthetized with an intraperitoneal injection of 
sodium pentobarbital (75 mg/kg of body weight) at which time the flexor hallucis longus (FHL) 
muscles were excised, freeze clamped in liquid nitrogen and stored at -80° C for later analysis.  
Rats were then euthanized by cardiac injection of sodium pentobarbital (65 mg/kg of body 
weight).  
Blood Analysis From each blood sample, 0.1 ml was withdrawn and immediately 
transferred to a test tube containing 10% perchloric acid (PCA). All blood samples and the PCA 
tubes were centrifuged at 3,000 g for 10 min at 4ºC with a FS-20 microtube rotor in a Sorvall 
RC-6 centrifuge (Thermo Fisher Scientific Inc. Waltham, MA). After centrifugation, the cleared 
plasma samples were transferred to several test tubes and stored at -80°C for later analysis of 
glucose, insulin, growth hormone (GH) and IGF-1. The PCA extracts were analyzed for lactate. 
Plasma glucose was determined using a colorimetric method, which employs glucose oxidase 
and a modified Trinder color reaction (Trinder, 1969). Plasma insulin was measured using a 
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radioimmunoassay kit (Millipore Corporation, MA) with coefficient of variation (CV) <10%. 
Plasma GH was measured using a sandwich ELISA kit with CV<8% (Millipore Corporation, 
MA). The quantification was visualized at dual wavelengths of 450nm and 630nm. Plasma IGF-
1 was determined using a high-sensitivity ELISA kit with CV<10% (Immunodiagnostic Systems 
Inc., AZ) and read at dual wavelengths of 450nm and 630nm. Lactate was measured according to 
Hohorst (1965). 
Immunoblot analysis Immunoblot analysis was performed as previously described (7). In 
brief, ~80 mg of muscle was homogenized in ice-cold homogenization buffer (20 mM HEPES, 2 
mM EGTA, 50 mM (sodium fluoride) NaF, 100 mM potassium chloride (KCl), 0.2 mM EDTA, 
50 mM glycerophosphate, 1 mM DL-dithiothreitol (DTT), 0.1 mM phenylmethanesulphonyl 
fluoride (PMSF), 1 mM benzamidine, and 0.5 mM sodium orthovandate (Na2VO4)) at a 1:8 
dilution of wet weight muscle with a glass tissue grinder pestle (Corning Life Sciences, Lowell, 
MA; Caframo Stirrer Type RZR1, Wiarton, Ont. Canada). The homogenates were centrifuged at 
14,000 g for 10 minutes at 4C, and the supernatants were taken for measurement of total protein 
concentration and of the phosphorylation of designated cell signaling proteins by 
immunoblotting. All muscle homogenate aliquots were then stored at -80 ºC until analysis.  
Muscle samples (60µg) were combined with an equal amount of Laemmli sample buffer 
(125mM Tris, 20% glycerol, 20% SDS, 0.25% bromophenol blue, and β-mercaptoethanol, pH 
6.8) and boiled at 95 ºC for 10 min in order to denature muscle proteins (32).  Then, samples 
were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 
10% resolving gel at 130 V for 90 min (Bio-Rad Laboratories, Hercules, CA.). The resolved 
proteins were then electrically transferred onto a nitrocellulose membrane (pore size: 0.45 μm; 
GE Healthcare Life Sciences, Pittsburgh, PA.) using a wet transfer unit (Bio-Rad Laboratories, 
Hercules, CA.) at 90 V for 90 min. Ponceau S. (0.1% in 0.5% acetic acid) was used to verify the 
completeness of the transfer. The membranes were then washed in Tris-buffered saline (TBS) 
with 0.06% Tween20 (TTBS) to remove the Ponceau S. staining, and then the membranes were 
blocked in 7% nonfat milk in TTBS (blocking buffer) for 1 h at room temperature (RT). The 
membranes were then incubated with the appropriate primary antibody overnight at 4 ºC.  The 
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targeted phosphorylated proteins were mTOR (Ser2448), p70S6k (Thr389), rpS6 (Ser235/236), 
protein kinase B (Akt) (Ser473), 5' adenosine monophosphate -activated protein kinase (AMPK) 
(Thr172), FOXO3A (Ser318/321), and NF-kB p65 (Ser536). Alpha-tubulin (α-tubulin) was used 
as an internal loading control. All the antibodies were purchased from Cell Signaling Technology 
(Cell Signaling Technology, Beverly, MA). Following overnight primary antibody probing, all 
membranes were washed 5 min, 3 times with TTBS. Then, the membranes were incubated with 
HRP-conjugated secondary anti-rabbit IgG (Cell Signaling Technology, Beverly, MA). After 3 
additional 5 min washes, the membranes were visualized by enhanced chemi-luminescence 
(ECL) in accordance to the manufacture’s instructions (Perkin Elmer, Boston, MA). All 
membranes were stripped and re-probed for ɑ-tubulin as an internal loading control. All western 
blots were performed in duplicate for each muscle sample to ensure reproducibility (CV<8%). 
Images were captured using a charge-coupled device camera in a ChemiDoc system (Bio-Rad, 
Hercules, CA). Intensity of each band was quantified with Quantity One analysis software (Bio-
Rad) and expressed as a percentage of a standard. 
Statistical analysis A two-way analysis of variance (ANOVA) was performed to 
determine significant treatment, time and, treatment by time effects for all blood parameters. 
When there was a significant F test identified, differences among means were determined using 
Fisher’s least significance difference (LSD) post hoc analysis. A one-way ANOVA was used for 
analyzing the data obtained from western blots, and Fisher’s LSD post hoc test was performed to 
compare mean differences among treatments. Differences with P-values < 0.05 were considered 
statistically significant. All statistical analyses were performed using IBM SPSS Statistics v19.0 
software (IBM Corporation, Armonk), and all data were expressed as mean ± standard error of 
the mean (SEM). 
RESULTS  
Blood lactate, glucose, insulin, GH, and IGF-1 level 
Blood lactate was significantly elevated immediately post exercise (p<0.05), and then 
declined to basal level at 20 and 40 min post exercise. Blood lactate did not differ across 
treatments at 20 or 40 min post exercise (p>0.05) (Table 3.1.). Plasma glucose was not different 
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among groups immediately post exercise (p>0.05). However, plasma glucose was significantly 
reduced in the WP group both at 20 and 40 min post exercise. At 40 min post exercise, plasma 
glucose in WP was also significantly lower than that of the SED group (p<0.05) (Table 3.1.). 
Plasma insulin was transiently increased in SED, PLA and WP groups at 20 min post exercise 
(p<0.05), and reduced in the LSUS group (Table 3.1.). However, by 40 min post exercise insulin 
levels had returned to immediate post-exercise levels (p>0.05). Plasma GH was significantly 
reduced by exercise (p<0.05), but was not different than SED by 20 min post exercise. However, 
40 min post exercise GH was elevated in the HSUS group (p<0.05) above all other treatment 
groups (p<0.05) (Table 3.1.). There was no difference in plasma IGF-1 across treatments or time 
(Table 3.1.).  
The signaling proteins that control muscle protein breakdown 
FOXO3A phosphorylation for WP, LSUS and HSUS was significantly increased above 
SED at 20 min post exercise (p<0.05) (Figure 3.1.A). At 40 min post exercise, there was no 
difference across treatment groups (p>0.05) (Figure 3.1.B). The phosphorylation of AMPK and 
NFkB p65 were significantly inhibited by LSUS and HSUS at 20 min post exercise compared 
with SED and PLA (p<0.05). These effects were not seen at 40 min post exercise (Figure 3.2., 
3.3.). Akt is an upstream substrate of FOXO3A, but the phosphorylation of Akt did not show the 
same pattern as FOXO3A. Akt phosphorylation was significantly reduced in the WP, LSUS and 
HSUS groups compared with the SED group 20 min post exercise. This reduction in Akt 
phosphorylation was maintained within the WP and LSUS groups at 40 min post exercise 
(p<0.05) (Figure 3.4.).  
The signaling proteins that control muscle protein synthesis 
At 20 min post exercise, the phosphorylation of mTOR was significantly elevated in WP 
(p<0.05), but not increased in PLA. However, PLA demonstrated a significantly greater mTOR 
phosphorylation state relative to the SED at 40 min post exercise. Also, at 40 min post exercise 
mTOR phosphorylation was significantly increased above SED in WP and HSUS (Figure 3.5.). 
Phosphorylation of p70S6k was not increased in PLA at either 20 or 40 min post exercise. 
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However, WP significantly increased the phosphorylation of p70S6k at both 20 and 40 min post 
exercise above SED and PLA (p<0.05). p70S6k was also activated by LSUS and HSUS above 
the SED at 40 min post exercise (Figure 3.6.). Although rpS6 is a downstream target of p70S6k, 
phosphorylation of rpS6 both at 20 and 40 min post exercise was not enhanced above PLA for 
LSUS or HSUS. However, WP was able to elicit a greater phosphorylation of rpS6 PLA 20 min 
post exercise (p<0.05) (Figure 3.7.).  
DISCUSSION 
Glutamine, a conditionally essential amino acid, has been shown to play an important 
role in the regulation of muscle protein turnover under various conditions (30, 34, 56). When 
compared with glutamine, AlaGln ingestion produces a higher and more sustained plasma 
glutamine concentration (Harris et al. 2012). AlaGln has also been found to be more stable in 
solution than glutamine (3, 22). Positive correlations between plasma glutamine level and protein 
balance have also been seen in studies when a glutamine-containing dipeptide was given to 
clinical patients (15, 45, 49). However, to our knowledge, the present investigation provides the 
first insight into the phosphorylation states of enzymes controlling MPS and MPB in response to 
SUS supplementation after resistance exercise.   
The primary findings of the present study were that SUS altered, immediately post 
exercise, the phosphorylation state of signaling proteins in a manner that theoretically should 
reduce MPB, while WP accelerated the phosphorylation of proteins in the mTOR-dependent 
signaling pathway thereby theoretically activating MPS. With respect to the signaling proteins 
that control MPB, the principal proteolytic systems in skeletal muscle are classified into the 
ubiquitin-proteasome system, lysosomal proteolysis, and Ca2+-activated proteases (i.e. calpain) 
(28, 43). Among these proteolytic systems, the ubiquitin-proteasome system is the primary 
signaling pathway that mediates myofibrillar protein degradation (28). Two crucial ubiquitin E3 
ligases in the skeletal muscle, muscle atrophy F-box (MAFbx or atrogin-1) and muscle ring-
finger protein 1 (MuRF-1), have been shown to stimulate muscle proteolysis (5). The activation 
of these ubiquitin E3 ligases is under the regulation of FOXO3A, a critical transcription factor in 
the nucleus (55). In the present study, WP and two doses of SUS yielded a transient increase in 
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the phosphorylation of FOXO3A above the sedentary level at 20 min post exercise. 
Phosphorylated FOXO3A can be exported into the cytoplasm where it becomes inactive, and 
thereby reducing the expression of the ubiquitin E3 ligases in the nucleus. Akt, which is 
activated by insulin/IGF-1 via the phosphatidylinositol 3-kinase (PI3k) pathway, is considered an 
important regulator of FOXO3A phosphorylation (13). Nevertheless, we found that the 
phosphorylation of Akt was significantly reduced at 20 min post exercise when WP, LSUS and 
HSUS supplements were provided and at 40 min post exercise. Therefore, it seems unlikely that 
the insulin-Akt pathway was involved in the phosphorylation of FOXO3A in the present study. 
Rather, we found that the phosphorylation of AMPK was significantly reduced by both doses of 
SUS at 20 min post exercise, which was inversely related to the phosphorylation of FOXO3A. 
AMPK, an important energy sensor, is another upstream regulator of FOXO3A. Research has 
demonstrated that activation of AMPK can increase myofibrillar protein degradation by 
increasing the expression of atrogin-1 and MuRF-1 in C2C12 myotubes secondary to increasing 
the expression of FOXO3A (38). Starving cells of glutamine results in an increase in the 
phosphorylated to total AMPK cellular content (57). Moreover, glutamine supplementation has 
been found to attenuate MPB and muscle atrophy by blunting atrogin-1 and MuRF-1 expression 
(10, 33). Therefore, it is reasonable to assume that the phosphorylation of FOXO3A following 
SUS supplementation was mediated by the inhibition of AMPK, which in turn would likely 
reduce expression of atrogin-1 and MuRF-1 and prevent MPB after resistance exercise.  
It is noteworthy that the phosphorylation of NF-kB p65 was also transiently reduced by 
both doses of SUS at 20 min post exercise relative to the placebo and WP groups. Cai et al. 
reported that the activation of the NF-kB p65 signaling pathway leading to muscle loss was due 
to the activation of MuRF-1 (Cai et al. 2004). Accordingly, the inhibition of NF-kB p65 
phosphorylation by SUS might be another way of exerting an inhibitory effect on MPB post 
exercise. Interestingly, the phosphorylation states of AMPK and NF-kB p65 were not influenced 
by the WP supplement. Previous research suggests that protein ingestion can promote MPS 
without changing MPB relative to exercise alone (11, 35, 51), and our results support this 
position. Taken together, we suggest that SUS supplementation post exercise will inhibit MPB 
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via suppressing the activation of AMPK-FOXO3A and NF-kB p65, whereas WP has a negligible 
effect on the signaling pathways that control MPB.   
With respect to the signaling proteins that control MPS, the activation of mTOR 
stimulates the phosphorylation of p70S6k (19), which then phosphorylates its downstream 
substrate protein rpS6 resulting in translation of mRNA to increase the capacity for protein 
synthesis (29). In the current investigation, WP provided immediately after resistance exercise 
yielded a greater increase in the phosphorylation states of mTOR, p70S6k, and rpS6 relative to 
the placebo and sedentary groups at 20 min post exercise. These results are in concert with a 
previous study from our laboratory demonstrating that provision of whey isolate after endurance 
exercise transiently enhanced the phosphorylation of mTOR and p70S6k in the quadriceps 
muscles of rats (37). Similar results have also been found in human subjects when they were 
supplemented with whey protein post resistance exercise (27).  
When no supplement was provided, an increased phosphorylation of mTOR was delayed 
until 40 min post exercise. Interestingly, exercise alone resulted in the phosphorylation of rpS6 at 
both 20 and 40 min post exercise. However, the phosphorylation of p70S6k was not affected. In 
agreement with these results, Bolster et al. found an increase in rpS6 phosphorylation in response 
to resistance exercise without changing the phosphorylation status of p70S6k (9). Aside from 
being phosphorylated by p70S6k, rpS6 can be directly phosphorylated by 90-kDa ribosomal S6 
kinase (p90RSK), a component of the extracellular-signal-regulated kinase (ERK) 1/2 cascade (42, 
46). Therefore, activation of ERK 1/2 by muscle contraction may explain how exercise alone 
activated rpS6 post exercise without affecting the phosphorylation of p70S6k.  
Although MPS was not directly measured in the present study, protein/AAs 
supplementation has been clearly shown to stimulate MPS both at rest (4) and after different 
types of exercise (2, 11, 36, 52). This increase in protein synthesis has been correlated with the 
activation of the mTOR signaling pathway and modulation of its downstream target proteins 
involved in mRNA translation initiation (8, 24). Therefore, our results indicate that WP 
supplementation soon after exercise is capable of hastening the activation of the mTOR signaling 
pathway and muscle protein synthesis. Akt is an upstream activator of mTOR (48) and is 
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activated by insulin via the PI-3 kinase pathway. However, we found that although WP 
transiently increased the plasma insulin level, the phosphorylation of Akt was significantly 
decreased below the SED level. Accordingly, the activation of the mTOR signaling pathway by 
the WP supplement does not appear to have resulted from the activation insulin-PI3k-Akt 
pathway. Moreover, neither exercise nor WP influenced the plasma IGF-1 level suggesting this 
hormone also was not related to the phosphorylation of mTOR and its downstream target 
proteins. It is likely that the influence exerted over the mTOR pathway by the WP supplement 
was due to leucine activation of mTOR. Leucine is a strong independent activator of mTOR and 
a prominent amino acid in whey (1, 2, 9).   
It was of interest to note that both doses of SUS increased p70S6k phosphorylation 
relative to the SED at 40 min post exercise while p70S6k phosphorylation for placebo was not. 
The activation of p70S6k has been suggested to correlate with muscle hypertrophy (6), and 
therefore suggests that SUS may potentially impact MPS through activating p70S6k. Plasma GH 
level dampened immediately after exercise was elevated above the basal level by HSUS at 40 
min post exercise. Early investigations demonstrated that plasma concentration of GH can be 
elevated by the administration of glutamine (53), and that plasma GH was associated with 
skeletal MPS (20, 21). However, a recent study reported no effect of systemic concentration of 
anabolic hormones on MPS and phosphorylation of signaling proteins (54), but suggested local 
anabolic hormones may predominate MPS post exercise. Moreover, the present study showed 
that phosphorylation states of mTOR and rpS6 were not influenced by SUS at either 20 or 40 
min. Although SUS increased the phosphorylation of p70S6k, it appears that SUS only has a 
slight impact on the mTOR signaling pathway. A recent study demonstrated that the modulation 
of glutamine supplementation on expressions of mRNA and proteins controlling MPS and MPB 
was seen in diabetic rats but not in normal non-diabetic rats (33). In an in vitro study conducted 
by Zhou and colleagues, it was observed that the rate of protein synthesis after glutamine 
administration was only seen in stressed myotube (administered by a heat shock treatment) but 
not in normal-cultured myotube (56) indicating that the effect of glutamine on protein synthesis 
may be conditionally dependent. Perhaps our SUS supplementation would be more effective in 
stimulating MPS under states of stress when catabolism is high such as following muscle injury, 
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severe disease or burns, or over training when glutamine level falls below its normal 
physiological level.  
In conclusion, the results of the current study provide indirect evidence that SUS inhibits 
MPB via suppressing activation of AMPK-FOXO3A and NF-kB p65 post exercise, whereas WP 
appears to accelerate the activation of the mTOR signaling pathway and promote MPS. The 
actions of WP on the phosphorylation of mTOR does not appear to be hormonally controlled, but 
was most likely due to the actions of leucine, a prominent amino acid in whey. Together, these 
findings suggest that a combination of WP and SUS supplementation post exercise might result 
in the phosphorylation of metabolic regulatory enzymes in a manner that would increase MPS 
and decrease MPB, thereby maximizing muscle protein accretion.  
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Table 3.1. Blood lactate, plasma glucose, insulin, GH, and IGF-1 concentration at 0, 20, and 40 min post exercise 
   Data are presented as mean + SEM (n=6-13 per group). †, p<0.05 vs. 0 min in the same 
treatment. ƒ, p<0.05 vs. 20 min in the same treatment. *, p<0.05 vs. SED in the same time point. 
#, p<0.05 vs. PLA in the same time point. §, p<0.05 vs. WP in the same time point. ¶, p<0.05 vs. 
LSUS in the same time point. 
 
  
                             
Figure 3.1. FOXO3A phosphorylation
stimulated rat tissue standard at 20 min (A) and 40 min (B) post resistance exercise in the FHL 
muscle. Data are presented as mean 
 
 
96 
 at Ser318/321 expressed as a percentage of an insulin
+ SEM (n=6-9 per group). *, p<0.05 vs. SED. 
 
 
-
 
  
 
Figure 3.2. AMPK phosphorylation
rat tissue standard at 20 min (A) and 40 min (B) post resistance exercise in the FHL muscle. Data 
are presented as mean + SEM (n=6
p<0.05 vs. WP. 
 97 
 at Thr172expressed as a percentage of an insulin
-9 per group). *, p<0.05 vs. SED. #, p<0.05 vs. PLA. 
 
 
-stimulated 
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Figure 3.3. NF-kB p65 phosphorylation
stimulated rat tissue standard at 20 min (A) and 40 min (B) post resistance exercise in the FHL 
muscle. Data are presented as mean 
PLA. §, p<0.05 vs. WP. 98 
 at Ser536 expressed as a percentage of an insulin
+ SEM (n=6-9 per group). *, p<0.05 vs. SED. #, p<0.05 vs. 
 
 
-
 Figure 3.4. Akt phosphorylation
tissue standard at 20 min (A) and 40 min (B) post resistance exercise in the FHL muscle. Data 
are presented as mean + SEM (n=6
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 at Ser473 expressed as a percentage of an insulin
-9 per group). *, p<0.05 vs. SED.  
 
 
-stimulated rat 
  
Figure 3.5. mTOR phosphorylation
rat tissue standard at 20 min (A) and 40 min (B) post resistance exercise in the FHL muscle. Data 
are presented as mean + SEM (n=6
p<0.05 vs. WP. ¶, p<0.05 vs. LSUS
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 at Ser2448  expressed as a percentage of an insulin
-9 per group). *, p<0.05 vs. SED. #, p<0.05 vs. PLA. 
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-stimulated 
§, 
  
Figure 3.6. p70S6k phosphorylation
rat tissue standard at 20 min (A) and 40 min (B) post resistance exercise in the FHL muscle. Data 
are presented as mean + SEM (n=6
p<0.05 vs. WP. 
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 at Thr389 expressed as a percentage of an insulin
-9 per group). *, p<0.05 vs. SED. #, p<0.05 vs. PLA. 
 
 
-stimulated 
§, 
  
Figure 3.7. rpS6 phosphorylation
tissue standard at 20 min (A) and 40 min (B) post resistance exercise in the FHL muscle. Data 
are presented as mean + SEM (n=6
p<0.05 vs. WP. ¶, p<0.05 vs. LSUS
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 at Ser236 expressed as a percentage of an insulin
-9 per group). *, p<0.05 vs. SED. #, p<0.05 vs. PLA. 
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-stimulated rat 
§, 
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Chapter IV: Co-ingestion of Carbohydrate and Whey Protein Accelerates Muscle Protein Synthesis during Early Recovery of Resistance Exercise 
 
 
ABSTRACT 
The objective of the study was to investigate whether co-ingestion of carbohydrate and 
protein as compared with protein alone augments muscle protein synthesis (MPS) during early 
exercise recovery. Two months old rats performed 10 repetitions of ladder climbing with 75% of 
body weight attached to their tails. Placebo (PLA), whey protein (WP), or whey protein plus 
carbohydrate (CP) were then given to rats by intubation. An additional group of sedentary rats 
(SED) was used as controls. Blood samples were collected immediately and at either 1 or 2 h 
after exercise. The flexor hallucis longus muscle was excised at 1 or 2 h post exercise for 
analysis of MPS and related signaling proteins. MPS was significantly increased by CP 
compared with PLA (p<0.05), and approached significance compared with WP at 1 h post 
exercise (p=0.08). CP yielded a greater phosphorylation of mTOR compared with SED at 1 h 
post exercise and SED and WP at 2 h post exercise. CP also increased phosphorylation of 
p70S6K compared with SED at 1 and 2 h post exercise. 4E-BP1 phosphorylation was inhibited 
by PLA at 1 h but elevated by WP and CP at 2 h post exercise relative to SED. The 
phosphorylation of AMPK was elevated by exercise at 1 h post exercise, and this elevated level 
was sustained only in the WP group at 2 h. The phosphorylation of Akt, GSK3, and eIF2Bε were 
unchanged by treatments. Plasma insulin was transiently increased by CP at 1 h post exercise. In 
conclusion, CP supplementation post exercise hastens MPS post exercise relative to PLA or WP 
by enhancing activation of the mTOR signaling pathway. This result may be related to a greater 
insulin response following CP supplementation. 
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INTRODUCTION 
Resistance exercise (RE) is a potent stimulator of muscle protein synthesis (MPS), and 
the repeated activity can bring about skeletal muscle hypertrophy (45). However, some previous 
studies have suggested that MPS is inhibited or unchanged early after exercise (1, 24). When it 
comes to muscle protein breakdown (MPB), it was reported to be increased during RE and 
remain elevated for up to 24 h post exercise in the fasted state (5, 45). Under these conditions a 
negative muscle net protein balance can occur during the early recovery phase following RE (5). 
Therefore, nutritional supplementation immediately after exercise is crucial to increase MPS as 
well as inhibit MPB during the early phase of recovery. It is commonly accepted that protein 
supplementation provides sufficient amino acids and activation of the mammalian target of 
rapamycin (mTOR) signaling pathway to increase MPS after exercise (40, 54, 58). mTOR is a 
central kinase that integrates upstream signals from muscle contraction, amino acid (AA), and 
growth factors to stimulate MPS via mediating protein translation initiation. As such, a single 
bout of RE is able to activate the mTOR signaling pathway, which can be further potentiated by 
providing a post exercise protein supplement. 
Interestingly, Anthony and colleagues reported that high intensity endurance exercise 
stymied muscle anabolism at early recovery of exercise, and protein supplementation could not 
recover the synthetic rate back to basal level (1). It is still unclear whether the same situation 
occurs after RE. Additionally, 20 g of high-quality protein supplementation has been reported to 
sufficiently maximize MPS post RE in young adults (40), while excessive protein consumption 
leads to increased AA oxidation. Hence, it may be of benefit to investigate new nutritional 
strategies to enhance MPS during the early phase of exercise recovery aside from supplementing 
post exercise with protein alone. 
Recent studies suggest that adding carbohydrate (CHO) to a protein supplement may 
have potential benefits on muscle recovery after RE (26, 39, 41). Immediately after high 
intensity RE, the human body is under a catabolic state due to the reduction of insulin and the 
elevation of catabolic hormones, including cortisol and epinephrine. Insulin is a strong anabolic 
hormone. Numerous studies have clearly shown a suppressive effect of insulin on MPB (6, 13, 
48) through inhibition of forkhead box 3A (FOXO3A) (19). Insulin also activates the mTOR 
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signaling pathway via activation of phosphatidylinositol 3-kinase (PI3k). However, the role of 
carbohydrate supplementation, a major insulin secretagogue, on MPS remains controversial. 
Some in vitro studies demonstrated that insulin significantly increased myotube protein synthesis 
(30, 32), but only a few in vivo studies have found a positive effect of insulin on MPS (21, 25). 
The ineffectiveness of insulin to stimulate MPS in vivo, may be due to a lack of AA availability 
as insulin increases AA clearance from the blood. However, co-ingestion of CHO and protein 
could possibly maximize muscle protein accretion post exercise by supplying a sufficient 
concentration of AA while also promoting a hyperinsulinemic state. To date, studies 
investigating the combined effects of CHO and protein/AA supplementation on MPS have 
reported inconsistent results (33, 39). Hence, the primary objective of this study was to 
investigate if adding CHO to a whey protein (WP) supplement results in a greater MPS during 
the early period of exercise recovery relative to WP alone. The present study also examined the 
phosphorylation state of signaling proteins in a manner that increase MPS and reduces MPB.  
MATERIALS AND METHODS 
Animals Eighty male Sprague-Dawley rats were obtained at two months of age from 
Charles River (Wilmington, MA). Rats were housed two per cage and provided standard 
laboratory chow (Prolab RMH 1800 5LL2, LabDiet, Brentwood, MO) and water ad libitum. The 
temperature of the animal room was maintained at 21°C, with a reverse artificial 12:12 h dark-
light cycle. Experimental procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) of the University of Texas at Austin and conform to the guidelines for the 
use of laboratory animals published by the United States Department of Health and Human 
Resources.   
Exercise familiarization Following 1 week of acclimation, rats underwent 3 repeated 
sessions of ladder climbing to familiarize with the exercise protocol. Each session consisted of 4 
trials and was separated by 1 day. The rats carried no weight during this familiarization period. 
The ladder was 1 meter height with an incline of 85° with 2 cm grid steps. After the initial 
familiarization, the rats then completed another 3 practice sessions of climbing separated by 1 
day between each session with 50, 60 and 70% of their body mass attached to their tails, 
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respectively. The weight was secured to the tail with foam tape (3M Conan) and a Velcro strap. 
Rats were encouraged to climb by lightly tapping their tails with a bottle brush.   
Experimental protocol Following an overnight fast, rats underwent an acute resistance 
exercise, as described in our previous study (55). Briefly, rats were placed on a climbing ladder 
to ascend 10 times with a weight equal to 75% of their body mass attached to the tail.  There 
were two minutes rests between each climb. Upon the completion of the exercise protocol, each 
rat was wrapped separately in a towel. A 0.7 ml blood sample was obtained from the tips of their 
tails. Immediately after exercise, animals received either a placebo (PLA=ddH2O), whey protein 
(WP=0.375 g/kg), or carbohydrate plus WP (CP=1.2 g/kg dextrose+0.375 g/kg WP) supplement 
by intubation. Twenty rats were used as sedentary controls (SED) and received an intubation of 
ddH2O. All rats were randomly assigned to a treatment prior exercise familiarization. Rats in 
each treatment group were then subdivided by time of euthanasia, which occurred at 1 or 2 h post 
intubation (n=10). After intubation, rats were returned to their respective cage. Either 30 or 90 
min after intubation, 0.04 μmol/g body weight of puromycin dissolved in PBS (pH=7.4) was 
given to the rats by introperitoneal injection. Approximately, 20 min after the puromycin 
injection, rats were anesthetized with an intraperitoneal injection of sodium pentobarbital (75 
mg/kg of body weight). A second blood sample was collected, followed by the excision of the 
flexor hallucis longus (FHL) muscle at 1 or 2 h post intubation. Rats were then euthanized by 
cardiac injection of sodium pentobarbital (65 mg/kg body weight).  
Blood Analysis All blood samples were centrifuged at 3,000 g for 10 min at 4ºC with a 
FS-20 microtube rotor in a Sorvall RC-6 centrifuge (Thermo Fisher Scientific Inc. Waltham, 
MA). After centrifugation, the cleared plasma samples were stored at -80°C for later analysis of 
glucose, insulin, corticosterone, growth hormone (GH) and insulin-like growth factor (IGF)-1. 
Plasma glucose was determined using a colorimetric method, which employs glucose oxidase 
and a modified Trinder color reaction (no. 315, Sigma Chemical, St. Louis, MO). Plasma insulin 
was measured using a radioimmunoassay kit (Millipore Corporation, Billerica, MA) with 
CV<10%. The concentration of corticosterone was determined by an enzyme-linked 
immunosorbant assay kit (ELISA) with CV<10% (Enzo life sciences Inc. Ann Arbor, MI. Cat 
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ADI-900-097). Plasma GH (Millipore Corporation, Billerica, MA) and IGF-1 
(Immunodiagnostic Systems Inc., Scottsdale, AZ) were measured using ELISA kits with 
CV<10% and read at dual wavelengths of 450nm and 630nm.. 
Western blot analysis Immunoblot analysis was performed as previously described (55). 
In brief, ~50 mg of muscle was homogenized in ice-cold homogenization buffer (20 mM 
HEPES, 2 mM EGTA, 50 mM sodium fluoride (NaF), 100 mM potassium chloride (KCl), 0.2 
mM EDTA, 50 mM glycerophosphate, 1 mM DL-dithiothreitol (DTT), 0.1 mM 
phenylmethanesulphonyl fluoride (PMSF), 1 mM benzamidine, and 0.5 mM sodiumorthovandate 
(Na2VO4)) at a 1:8 dilution of wet weight muscle with a glass tissue grinder pestle (Corning Life 
Sciences, Lowell, MA; Caframo Stirrer Type RZR1, Wiarton, Ont. Canada). The homogenates 
were centrifuged at 14,000 g for 10 minutes at 4C, and the supernatants were taken for 
measurement of total protein according to Lowry (36), and protein synthesis and the 
phosphorylation of designated cell signaling proteins by western blot. All supernatants were 
stored at -80 ºC until analyzed. 
For western blots, supernatant samples containing 60µg protein were combined with an 
equal amount of Laemmli sample buffer (125mM Tris, 20% glycerol, 20% SDS, 0.25% 
bromophenol blue, and β-mercaptoethanol, pH 6.8) and boiled at 95ºC for 15 min in order to 
denature the muscle proteins (35). Then, samples were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) using 10-15% resolving gel at 130 V for 90 
min or 90 V for 2.5 h (Bio-Rad Laboratories, Hercules, CA.). The resolved proteins were then 
electrically transferred onto a nitrocellulose membrane (pore size: 0.45 μm; GE Healthcare Life 
Sciences, Pittsburgh, PA.) using a wet transfer unit (Bio-Rad Laboratories, Hercules, CA.) at 90 
V for 90 min.  Ponceau S. (0.1% in 0.5% acetic acid) was used to verify the completeness of the 
transfer. The membranes were then washed in Tris-buffered saline (TBS) with 0.06% Tween20 
(TTBS) to remove the Ponceau S. staining, and then the membranes were blocked in 7% nonfat 
milk in TTBS (blocking buffer) for 1 h at room temperature (RT). The membranes were then 
incubated with the appropriate primary antibody overnight at 4ºC.  The targeted phosphorylated 
proteins were mTOR (Ser2448), 70 kDa ribosomal protein S6 kinase (p70S6k) (Thr389), 
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ribosomal protein S6 (rpS6) (Ser235/236), 4E binding protein 1 (4E-BP1) (γ isoform), protein 
kinase B (Akt) (Ser473), glycogen synthase kinase (GSK)-3ɑ/β (ser21/9), eukaryotic initiation 
factor 2 (eIF2)-Bɛ (ser539), forkhead box (FOXO) 3A (Ser318/321), and 5' adenosine 
monophosphate-activated protein kinase (AMPK) (Thr172). Alpha-tubulin (α-tubulin) was used 
as an internal loading control. Anti-puromycin antibody was used to detect muscle protein 
synthesis according to a previous research (23). Antibodies for anti-p-eIF2Bɛ and anti-
puromycin were purchased from EMD Millipore Corporation (EMD Millipore Corporation, 
Chicago, IL). All other antibodies were purchased from Cell Signaling Technology (Cell 
Signaling Technology, Beverly, MA). Following overnight primary antibody probing, all 
membranes were washed 5 min, 3 times with TTBS. The membrane incubated with anti-
puromycin antibody was incubated with HRP-conjugated secondary anti-mouse IgG (EMD 
Millipore Corporation, Chicago, IL). All others were incubated with HRP-conjugated secondary 
anti-rabbit IgG (Cell Signaling Technology, Beverly, MA). After 3 additional 5 min washes, the 
membranes were visualized by enhanced chemi-luminescence (ECL) in accordance to the 
manufacture’s instructions (Perkin Elmer, Boston, MA). All membranes were stripped and re-
probed for ɑ-tubulin as an internal loading control. All western blots were performed in duplicate 
for each muscle sample to ensure reproducibility (CV<8%). Images were then captured using a 
charge-coupled device camera in a ChemiDoc system (Bio-Rad, Hercules, CA). Intensity of each 
band was quantified with Quantity One analysis software (Bio-Rad) and expressed as a 
percentage of a standard. 
Free puromycin concentration assay Free puromycin as a precursor can be delivered to 
the muscle and incorporated into nascent peptide chains. The measurement of free puromycin 
was used to normalize the value of MPS obtained from western blot analysis in the same sample. 
The analysis was conducted as described previously (23) with slight modifications. 
Approximately, 30 mg of muscle were homogenized in ice-cold homogenization buffer at a 1:15 
dilution of wet weight muscle with a glass tissue grinder pestle (Corning Life Sciences, Lowell, 
MA; Caframo Stirrer Type RZR1, Wiarton, Ont. Canada). A 250µl aliquot sample homogenate 
was precipitated with 28µl of 100% trichloroacetic acid and incubated for 30 min on ice 
followed by 5 min of centrifuge at 4,200g. This was followed by the addition of 15µl of Tris 
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buffer containing 1M Tris, 3M NaCl, and 1% Tween 20 at pH 7.0 and 30µl of 5.25M NaOH to 
250µl supernatant to adjust the pH to ~9.0 (8.97-9.03). Next, the samples were filtered through a 
>3kDa filter (Amicon Ultra-0.5ml; Millipore, Carrigtwohill, Ireland) at 14,000g for 60 min. 
Meanwhile, a range of standards (0-40 pmol/100µl) were made and adjusted to pH 9.0. A 100µl 
sample or standard was added to a 96-well amine-binding maleic anhydride activated plate 
(Pierce; Thermo Fisher Scientific) in duplicate and rocked overnight at 4ºC. The next day, the 
plate was washed 4 times using PBS with 1% Tween 20 (PBST with pH7.0) and blocked with 
1% BSA-PBST for 45 min at room temperature. 100µl of anti-puromycin antibody (clone 
12D10, 1:38,400) was added to each well and incubate for 105 min at RT. Followed this 
incubation period, the wells were washed 3 times. Next, horseradish peroxidase-conjugated anti-
mouse IgG Fc 2a (1:10,000; Millipore) was added to each well and incubated for 45min at RT. 
After another 4 washes, Ultra 3,3',5,5'-tetramethylbenzidine (TMB, Thermo Fisher) was added to 
each well and rocked for 15 min. The reaction was then stopped by 0.16 M sulfuric acid (Thermo 
Fisher). The absorbance was measured on a plate reader at a wavelength of 450nm. The 
concentration of free puromycin was calculated from a standard curve.  
Statistical analysis Data obtained from western blot were analyzed as a percentage 
change relative to an insulin-stimulated rat tissue standard or anti-puromycin-injected rat tissue 
standard. A two-way analysis of variance (ANOVA) (time x treatment) was performed on a 
between-within mixed model design for the measurement in data obtained from plasma assays 
and data obtained from western blots. When a significant F test was identified, differences 
among means were determined using LSD post hoc analysis. Differences with p < 0.05 were 
considered statistically significant. All statistical analyses were performed using IBM SPSS 
Statistics v19.0 software (IBM Corporation, Armonk), and all data are expressed as mean ± 
standard error of the mean (SEM). 
RESULTS  
Muscle protein synthesis 
The relative value of puromycin labeled peptides from western blot analysis represented 
muscle protein synthesis (Figure 4.1.A). Free puromycin is a precursor delivered to the muscle 
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and incorporated into nascent peptide chains. There was no significant difference in levels of free 
puromycin among groups (Figure 4.1.C). In order to eliminate the possibility that changes in 
MPS were due to the differences in precursor uptake, protein synthesis was normalized to the 
concentration of free puromycin in the muscle (Figure 4.1.D). The result showed that exercise 
(PLA) transiently decreased MPS at 1 h post exercise compared to the sedentary (SED) (p=0.08). 
However, this inhibition on MPS was completely rescued by the CP treatment (Figure 4.1.D). CP 
also showed a higher trend of MPS than that of in the WP group at 1 h post exercise (p=0.08) 
(Figure 4.1.D). No significant difference was observed among treatments at 2 h post exercise 
(Figure 4.1.D). 
Signaling pathways related MPS and MPB  
The phosphorylation of mTOR was significantly increased by CP at 1 and 2 h post 
exercise compared with SED (p<0.05). mTOR phosphorylation was also higher in CP than PLA 
at 1 h, and higher than WP at 2 h (Figure 4.2.A). p70S6k phosphorylation was significantly 
elevated by CP at 1 h post exercise. At 2 h, p70S6k phosphorylation was further elevated by CP, 
but it did not differ from that in the PLA or WP (Figure 4.2.B). rpS6 is a downstream factor of 
p70S6k. Exercise significantly enhanced the phosphorylation of rpS6 both at 1 and 2 h post 
exercise (p<0.05). There was no difference in levels of rpS6 phosphorylation among all three 
exercise groups (Figure 4.2.C). The phosphorylation of 4E-BP1 was reduced by PLA at 1 h post 
exercise (p<0.05). WP and CP reversed this reduction completely at 1 h and further increased the 
phosphorylation of 4E-BP1 at 2 h compared with SED (p<0.05). The phosphorylation of 4E-BP1 
also returned to the basal level at 2 h in the PLA group (Figure 4.2.D).  
Akt is an upstream substrate of mTOR, but the phosphorylation of Akt did not correlate 
with the mTOR activation. Akt phosphorylation did not differ statistically across treatments at 1 
or 2 h post exercise (p>0.05) (Figure 4.3.A). GSK3 is a downstream substrate of Akt. Neither 
GSK3 α nor β showed any significant differences among groups (Figure 4.3.B, C). Similarly, no 
significant difference in eIF2Bε phosphorylation was observed among groups at either 1 or 2 h 
post exercise (Figure 4.3.D).   
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The phosphorylation of AMPK and FOXO3A was significantly increased in all three 
exercise groups at 1 h post exercise (Figure 4.4.A, B). The phosphorylation of AMPK remained 
elevated at 2 h in WP (p<0.05) (Figure 4.4.A). The phosphorylation of FOXO3A was 
significantly increased in the CP compared with that in SED at 2 h post exercise (p<0.05) (Figure 
4.4.B).  
Glucose level and hormonal changes in plasma 
There was no significant difference in plasma glucose among groups immediately post 
exercise (p>0.05) (Table 4.1.). At 1 h post exercise plasma glucose was higher in the CP than 
that in the WP group. At 2 h post exercise plasma glucose was significantly reduced in both PLA 
and WP compared with immediately after exercise, and these levels were lower than that in CP 
(p<0.05) (Table 4.1.). There was no difference in plasma insulin levels among groups 
immediately post exercise (p>0.05). However, plasma insulin was transiently elevated in the CP 
group at 1 h post exercise (p<0.05) (Table 4.1.). Plasma GH was significantly reduced 
immediately post exercise, but it was not different among groups at either 1 or 2 h post exercise 
(Table 4.1.). Plasma IGF-1 did not differ across treatments at any time point (Table 4.1.). Plasma 
corticosterone was significantly elevated by exercise (p<0.05), but returned to the basal level at 1 
and 2 h post exercise (Table 4.1.). 
DISCUSSION 
It is commonly accepted that RE can induce muscle protein accretion primarily by 
stimulating MPS, and that this activation can remain elevated for many hours after a single bout 
of RE (14, 21, 45). However, within a short period of exercise recovery, MPS may be dampened 
in the fasted state even though the mTOR signaling pathway is activated (1, 24, 45). When the 
interval between exercise sessions is very short, an effective muscle recovery process can be of 
significant benefit. The major finding of this study is that co-ingestion of CHO plus WP rescued 
the reduction of MPS by exercise during the early recovery phase, and was associated with the 
activation of the mTOR signaling pathway.  
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At 1 h post exercise, MPS decreased if no supplement was provided. This is likely 
mediated through the elevated activation of AMPK and inactivation of 4E-BP1. Researchers 
suggested that AMPK activation might contribute to the inhibition of MPS during exercise and to 
the delayed activation of MPS during early post exercise recovery (16, 34). In the present study, 
phosphorylation of AMPK and inhibition of 4E-BP1 were significantly increased in PLA at 1 h 
post exercise relative to the SED group. However, the differences between these two groups 
disappeared at 2 h post exercise. The changes in these signaling proteins displayed a pattern 
similar to the changes in MPS. When the supplements were provided immediately after exercise, 
WP did not recover MPS at 1 h post exercise. Similar result was found by Anthony et al. when 
whey and soy protein were provided in an endurance exercise model (1). However, it is worth 
noting that CP supplementation significantly augmented MPS compared with that of PLA at 1 h 
post exercise. Moreover, MPS by CP showed a higher tendency than that in the SED and WP 
groups at 1 h post exercise. An early research paper compared independent and combined effects 
of AA and CHO over 3 h post exercise, and demonstrated that the coordinated effect of AA and 
CHO on MPS was roughly equal to the sum of their independent effects (39). Previous studies 
from our laboratory investigating the impact of protein and CHO on signaling proteins that 
control MPS and MPB post exercise also found that CP, compared with CHO or protein intake 
individually, had a greater effect on the activation of anabolic signaling proteins (26, 41). 
Some investigators, however, were unable to find any beneficial effect of adding CHO to 
a post exercise protein supplementation on MPS. For example, Koopman and colleagues 
compared casein plus different doses of CHO (0, 0.15, 0.6 g/kg) on whole body protein synthesis 
and breakdown 6 h after RE (33). They did not observe any differences in either protein 
synthesis or breakdown treatments. Similarly, Staples et al. reported neither MPS nor MPB could 
be further affected by CHO plus WP relative to WP supplement alone 3 h of recovery from RE 
(51). The discrepancy among studies might be partly due to the types of protein intake, timing of 
protein synthesis measurement, dosages of supplementation, and animal model. In the present 
study, we did not observe any difference in MPS among PLA, WP, and CP groups at 2 h post 
exercise. Perhaps, the effect of CP supplement on MPS is very rapid and occurs only during the 
first hour of recovery unless additional supplementation is supplied at a later period.  
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Regarding to the underlying mechanisms for the changes in MPS, mTOR is considered 
an essential kinase in the regulation of MPS. Once mTOR is activated, it further phosphorylates 
two downstream factors, p70S6k and 4E-BP1 (20). p70S6k can further activate rpS6, which then 
increases capacity of protein synthesis. The present study showed that CP provided immediately 
post exercise yielded a greater increase in the phosphorylation of mTOR and p70S6k relative to 
the SED group at 1 h. The phosphorylation of mTOR was also higher in the CP compared with 
PLA at 1 h and approached being significantly higher than WP. At 2 h post exercise, 
phosphorylation of mTOR for CP was significantly greater than SED and WP. Phosphorylation 
of p70S6K in CP was significantly increased above SED at 1 and 2 h post exercise. PLA and WP 
did not increase the phosphorylation of p70S6k until 2 h post exercise. Similar results have been 
reported in both animal and human subjects (15, 41). For example, Dreyer et al. explored the 
effect of essential AA (EAA) with CHO consumption on MPS in relation to the mTOR signaling 
pathway after RE (15). Subjects were provided either a placebo or CHO+EAA supplement post 
exercise. Their results indicated that the EAA+CHO stimulated a greater MPS 2 h post exercise 
than placebo and this MPS was related to a greater phosphorylation of mTOR and p70S6k.  
In the present study we found that exercise alone led to phosphorylation of rpS6 at both 1 
and 2 h post exercise, which was not further affected by nutritional supplementation. This result 
was not surprising because other studies haves provided strong evidence that muscle contraction 
is able to activate rpS6 directly via 90-kDa ribosomal S6 kinase (p90RSK) and without affecting 
p70S6k (10, 44, 47, 55). On the other hand, 4E-BP1 mediates binding of mRNA to the 40S 
ribosomal subunit (20). Hyperphosphorylation of 4E-BP1 dissociates itself from eIF-4E so that 
eIF-4E is able to bind to eIF4G and eIF4A to start the eIF4F complex (43, 56). This complex 
then becomes a bridge linking mRNA to the 43S pre-initiation complex, which increases rates of 
mRNA translation (1). As mentioned previously, phosphorylation of 4E-BP1 at 1 h post exercise 
was significantly restrained when no supplement was provided, but phosphorylation returned to 
the basal level at 2 h post exercise. When the supplements were provided, however, both WP and 
CP triggered a higher phosphorylation of 4E-BP1 relative to PLA at 1 h post exercise, and at 2 h 
post exercise phosphorylation levels were even higher than SED. The results suggest that WP 
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and CP supplementations were capable of inhibiting 4E-BP1 during the first hour of recovery 
and to maintain this inhibition for several hours. 
Akt is an upstream substrate of mTOR. Akt can be phosphorylated via the insulin-
dependent signaling pathway by phosphoinositide 3 (PI3)-kinase. The present study found that 
CP transiently increased plasma insulin levels at 1 h, whereas phosphorylation of Akt was not 
affected by any treatment. This suggests that the activation of mTOR by CP was not regulated 
through the insulin-signaling pathway. However, the phosphorylation and activation of Akt can 
be rapid and very transit. Therefore, there is the possibility that by 1 h post exercise it was too 
late to observe the phosphorylation of this protein. Glycogen synthase kinase (GSK) 3 is 
involved in another step of translation initiation. The activation of GSK3 phosphorylates 
eukaryotic translation initiation factor 2(eIF)-Bɛ to reduce its activity (29). Both phosphorylated 
Akt and p70S6k are capable of inhibiting GSK3ɑ/β, leading to activation of eIF2Bɛ (29, 31). 
eIF2ɑ then exchanges GDP for GTP on eIF2, which binds met-tRNA to the 40S ribosomal 
subunit and form the 43S pre-initiation complex (9). We, however, did not observe any changes 
in the phosphorylation levels of GSK3β, GSK3ɑ, or eIF2Bɛ across the various treatments or 
times. These results are in agreement with other previous research (10, 57). Bolster et al. also did 
not observe changes in eIF2Bɛ activity or the phosphorylation of eIF2α during 1 h of recovery 
from RE (10). Wilkinson and colleagues reported that GSK3β remained unchanged 4 h after 
exercise in the fed state, but, eIF4E was activated (57). In contrast, Glover et al. found a 
substantial change in eIF2Bɛ dephosphorylation 6 h after exercise in a human study (22). Earlier 
animal studies also revealed that MPS was enhanced as late as 16 h after RE due to an elevation 
of eIF2Bɛ activity (17), but not the dissociation of eIF4E from 4E-BP1 (18). It is possible that 
the regulation of MPS by the GSK3-eIF2Bɛ dependent signaling pathway only occurs during the 
later stages of exercise recovery. Accordingly, our results suggest that during the early phase of 
recovery, the activation of mTOR and inhibition of 4E-BP1, regulated by nutritional 
supplementation, play a more important role in the stimulation of MPS than the GSK3-eIF2Bɛ 
signaling pathway.  
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AMPK is another upstream regulator of mTOR. In the present study, the phosphorylation 
of AMPK was significantly elevated at 1 h post exercise. This observation is supported by 
previous studies demonstrating that exercise alone can increase the phosphorylation of AMPK, 
and reduce MPS via inhibiting mTOR and decreasing 4E-BP1 phosphorylation (8, 16). Thus, the 
increased AMPK phosphorylation at 1 h post exercise may count for the lack of change in the 
mTOR phosphorylation and the dampened MPS in the PLA and WP groups as compared to 
SED. In contrast, the mTOR phosphorylation and MPS for CP were significantly increased at 1 h 
post exercise although AMPK phosphorylation was also increased. It is speculated that the 
elevation in plasma insulin following the CP supplement overrode the inhibitor effects of AMPK 
on mTOR via the insulin-signaling pathway. A weakness in this hypothesis is that CP 
supplementation had no effect on the phosphorylation of Akt. However, as pointed out earlier, 
the phosphorylation of Akt is quite transient and may have occurred prior to muscle removal. A 
second possibility is related to insulin-stimulated AA membrane transport. An increase in plasma 
insulin can increase muscle blood flow and muscle AA transport, and block muscle AA output 
(4, 46). Hence, early enhancement of MPS by CP in the present investigation could have resulted 
from a rapid increase of AA uptake, particularly L-leucine uptake, which in turn could have 
activated mTOR. Further research is required to confirm either hypothesis.  
Interestingly, AMPK phosphorylation remained elevated at 2 h post exercise only 
following WP. Similarly, Iwanaka and colleague found that L-leucine increased contraction-
induced glucose transport and the activity of AMPK (27). Why an increase in AMPK 
phosphorylation was not observed at 2 h post exercise following CP supplementation is not 
known.   
Other growth factors were measured in our study. Plasma GH was dampened 
immediately post exercise, but no differences were observed at 1 and 2 h post exercise among all 
groups. Neither exercise nor nutrient supplementation affected IGF-1 plasma levels. Therefore, 
CP induced MPS was unlikely controlled by these hormones. 
With regards to MPB, the ubiquitin-proteasome system is primarily responsible for 
protein degradation (28). During the entire process of protein degradation, E3 enzyme mediated 
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ubiquitin ligation is considered the rate-limiting step (7, 52). There are two crucial ubiquitin E3 
ligases in the skeletal muscle, muscle atrophy F-box (MAFbx or atrogin1) and muscle ring-finger 
protein 1 (MuRF1). These ligases have been shown to stimulate muscle proteolysis (2). The 
activation of both E3 ligases is under the regulation of transcription factors such as FOXO3A in 
the nucleus (60). Once phosphorylated, FOXO3A is exported into the cytoplasm and becomes 
inactive. In the present study, the phosphorylation of FOXO3A was significantly elevated in all 
three exercise groups at 1 h post exercise, but only the CP group showed sustained 
phosphorylation of FOXO3A compared to the SED group at 2 h post exercise. Akt and AMPK 
mediate the phosphorylation of FOXO3A, but with opposing control over MPB (12, 42). In our 
results, Akt remained unchanged across time and treatment, and phosphorylation of AMPK did 
not follow the same pattern as FOXO3A.  
In terms of the hormonal regulation on MPB, RE can place the body into a catabolic state 
by elevating cortisol and suppressing insulin secretion (53, 59). Insulin has been shown to 
suppress MPB (6, 13, 48) due to its inhibition on FOXO3A (19). A high level of cortisol can 
result in rapid muscle atrophy (49), possibly by dampening MPS (37, 50) and increasing MPB 
(38). In the present study, plasma corticosterone was elevated immediately after exercise, and 
then returned to the basal level 1 h post exercise. Similar findings have been reported in a human 
study from our laboratory in which it was found plasma cortisol did not differ within 6 h post 
exercise with or without CP supplementation (3). However, it was found that 24 h post exercise 
plasma cortical in the PLA group was significantly elevated above that found in the CP group 
(3). Therefore, our results, together with previous research, suggest that corticosterone may not 
affect MPS or MPB within the first 2 h of recovery. Although plasma insulin was increased by 
CP at 1 h post exercise, all exercise groups were found to have similar levels of phosphorylation 
of FOXO3A at 1 h post exercise and were not significantly different at 2 h post exercise. These 
results suggest that CP supplementation was unlikely contributing to the inhibition of MPB 
during the early hours of exercise recovery. It is possible, however, that CP supplementation 
could have a delayed inhibitory effect on MPB. For example, Borsheimet al. demonstrated that 
CHO induced a rapid increases in plasma glucose and insulin, but the effect of insulin on MPB 
was detected 3 h after supplementation, but not at 1 or 2 h after (11). In addition, our laboratory 
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previously reported that a difference in plasma cortisol could not be observed between PLA and 
CP groups until 24 h post exercise, which further supports a delayed response of CP on MPB (3).  
In summary, adding CHO to a protein supplement accelerates MPS during the early 
period of exercise recovery compared with PLA and WP. This early enhancement in MPS could 
have been caused by a rise in plasma insulin, which in turn could have overridden the inhibitory 
effect of AMPK on the mTOR signaling pathway. Additional time course studies are warranted 
to determine changes in both MPS and MPB during extended recovery times. Although the exact 
mechanism is not known, our findings indicate that CP is more efficacious post resistance-
exercise than protein alone. The results suggest that over time regular supplementation with CP 
post resistance-exercise would produce a greater training adaptation than PLA or WP.  
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Table 4.1. Plasma glucose, insulin, GH, IGF-1, and corticosterone concentration at 0, 1, and 2 h post exercise 
  Treatment        
  SED PLA WP CP 
Glucose (mM) 
0 h 5.37±0.19 5.78±0.19 5.73±0.20 5.88±0.22 
1 h 5.67±0.13 5.63±0.27 5.11±0.22 6.05±0.25 § 
2 h 5.11±0.27 4.71±0.27ƒ 4.22±0.25* ƒ ‡ 5.69±0.29 †§  
Insulin (pM)         
0 h 218.45±19.01 199.53±11.97 274.84±23.47 265.59±53.29 
1 h 289.47±27.40 225.99±30.86 244.79±32.30 423.01±55.34†§ ƒ 
2 h 266.43±33.46 255.51±39.97 280.76±26.16 320.64±38.30 
GH (ng/ml) 
0 h 9.61±2.90 0.80±0.22* 1.46±0.53* 1.83±0.55* 
1 h 6.54±2.65 3.83±1.21 9.44±7.68 9.77±5.67 
2 h 3.89±0.73 7.50±2.54 7.13±3.88 2.24±0.85 
IGF-1 (ng/ml) 
0 h 815.89±30.03 843.49±45.87 760.91±23.71 809.29±46.81 
1 h 823.43±53.42 712.86±50.44 677.50±38.37 696.20±55.40  
2 h 723.41±55.82 772.45±47.33 729.08±46.57 700.11±58.99 
Corticosterone 
(ng/ml) 
0 h 144.84±14.63 270.94±16.84* 240.67±19.83* 227.61±25.77* 
1 h 157.33±14.90 169.57±13.08 ƒ 161.99±27.01 ƒ 155.65±26.06 ƒ 
2 h 117.35±17.47 127.43±14.78 ƒ 116.13±21.80 ƒ 119.12±19.49 ƒ 
Data are presented as mean ± SEM (n=10 per group). ƒ, p<0.05 vs. 0 h in the same treatment. ‡, 
p<0.05 vs. 1 h in the same treatment.*, p<0.05 vs. SED at the same time point. †, p<0.05 vs. 
PLA at the same time point. §, p<0.05 vs. WP at the same time point.   
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  Figure 4.1. Muscle protein synthesis. A) Quantification of puromycin-labeled peptide, expressed 
as a percentage of a standard sample obtained from an exercise rat tissue. B) Representative 
image of western blot analysis for puromycin using a charge-coupled device camera. C) Free 
puromycin concentration measured as described. D) Muscle protein synthesis expressed using 
the value of puromycin labeled peptidesrelative to the free puromycin concentration in the same 
sample. All values are mean ± SEM (n=10 per group). †, p<0.05 vs. PLA. ‡, p<0.05 vs. 1 h. 
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  Figure 4.2. The phosphorylation of mTOR signaling pathways. A) mTOR phosphorylation at 
Ser2448 expressed as a percentage of a standard sample obtained from an insulin-stimulated rat 
tissue. B) p70S6k phosphorylation at Thr389expressed as a percentage of a standard sample 
obtained from an insulin-stimulated rat tissue. C) rpS6 phosphorylation at Ser236 expressed as a 
percentage of a standard sample obtained from an insulin-stimulated rat tissue. D) 4E-BP1 
phosphorylation expressed as a percentage of the gamma isoform. All values are mean ± SEM 
(n=10 per group).*, p<0.05 vs. SED. †, p<0.05 vs. PLA. §, p<0.05 vs. WP. ‡, p<0.05 vs. 1 h. 
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  Figure 4.3. The phosphorylation of Akt-GSK signaling pathways. A) Akt phosphorylation at 
Ser473 expressed as a percentage of a standard sample obtained from an insulin-stimulated rat 
tissue. B) GSK3β phosphorylation at Ser9 expressed as a percentage of a standard sample 
obtained from an insulin-stimulated rat tissue. C) GSK3α phosphorylation at Ser21expressed as a 
percentage of a standard sample obtained from an insulin-stimulated rat tissue. D) eIF2Bε 
phosphorylation at Ser539expressed as a percentage of a standard sample obtained from an 
insulin-stimulated rat tissue. All values are mean ± SEM (n=10 per group). 
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 Figure 4.4. The phosphorylation of AMPK-FOXO3A signaling pathways. A) AMPK 
phosphorylation at Thr172 expressed as a percentage of a standard sample obtained from an 
insulin-stimulated rat tissue. B) FOXO3A phosphorylation at Ser318/321 expressed as a percentage 
of a standard sample obtained from an insulin-stimulated rat tissue. All values are mean ± SEM 
(n=10 per group).*, p<0.05 vs. SED. §, p<0.05 vs. WP. ‡, p<0.05 vs. 1 h. 
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Chapter V: Co-ingestion of Carbohydrate and Whey Protein Induces Greater Muscle Strength and Myofibrillar Protein Accumulation without a Requirement of Satellite Cell Activation 
 
ABSTRACT 
The present study compared the effects of a whey protein and carbohydrate (CP), whey 
protein (WP), and placebo (PLA) on resistance training adaptations. Two-month old rats were 
trained by ladder climbing every 3 days for 8 weeks. PLA, WP (WP = 0.5g/kg), or CP (Whey = 
0.5g/kg, CHO= 1.2g/kg) was given immediately after each exercise session. Non-exercise rats 
were used as a sedentary control (SED). Total body composition was assessed before, middle, 
and end of training using dual-energy X-ray absorptiometry (DEXA). Blood samples were 
collected 22-24 h after the 1st, 10th, and 20th exercise sessions. The flexor hallucis longus (FHL), 
a muscle used for climbing, was excised 24 h after the last exercise session and analyzed for 
muscle hypertrophy, total and myofibrillar protein, and proteins that regulate the activation of 
satellite cells (SC). Following training, maximal carrying capacity was significantly greater in 
CP than PLA and WP. This improved training performance was relevant to a greater increase in 
total and myofibrillar protein content in CP compared to PLA and WP groups. Resistance 
training significantly augmented FHL muscle mass and slightly reduced epididymis adipose 
mass, but total body composition did not differ across treatment groups. Muscle and fiber cross 
sectional area (CSA) were significantly increased by exercise training, with a concomitant 
increase in myonuclear domain, but there were no differences among exercise groups. CP 
significantly elevated IGF-1 expression over SED, but there were no significant differences in 
myostatin, Pax7, MyoD, and myogenin across treatment groups. There was also no difference in 
the number of total nuclei in each fiber CSA among groups. Corticosterone level was 
significantly elevated in PLA and WP over 8 weeks of training, whereas this change in 
corticosterone over time was not observed in the CP group. The results suggest that the greater 
improvement of maximal caring capacity for CP compared with PLA and WP was associated 
with a greater increase in myofibrillar protein content. The activation of SC did not appear to 
contribute to the observed gains in muscle hypertrophy and strength.  
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INTRODUCTION 
Skeletal muscle is a highly plastic tissue in response to exercise, inactivity, changes in 
hormonal environment, and nutritional supplementation. An increase in muscle size and muscle 
strength is of paramount importance for health as well as physical performance. Resistance 
exercise training is the most effective strategy to induce muscle development, while evidence 
exists indicating that post exercise nutrient supplementation may augment muscle training 
adaptations (6, 14, 16, 41, 59).  
Muscle development is controlled by the balance between muscle protein synthesis and 
protein degradation. The initial enlargement of muscle mass is primarily attributable to pre- and 
post-translational mechanisms, which stimulate muscle protein synthesis and inhibit protein 
degradation while correspondingly increasing the myonuclear domain (quantity of 
cytoplasm/number of nuclei within that cytoplasm) (46). According to the myonuclear domain 
theory (4), the area of cytoplasm that each nucleus can maintain is limited. Thus, expansion of 
the muscle cross sectional area (CSA) increases the demand of additional myonuclei once the 
myonuclear domain reaches a threshold level (46). Satellite cells (SC) have been identified as a 
major source of new myonuclei (50, 51). Myogenic regulatory factors (MRF), a superfamily of 
transcription factors, are composed of four members: MyoD, Myf5, myogenin, and MRF4. 
MyoD is predominantly upregulated during myogenic cell proliferation, and myogenin 
stimulates muscle differentiation (9, 54). These MRFs can be controlled by growth factors, such 
as insulin-like growth factor (IGF) -1 and myostatin. IGF-1 serves as a potential candidate for 
promoting skeletal muscle hypertrophy. It does not only activate the mammalian target of 
rapamycin (mTOR) signaling pathway contributing to protein synthesis, but also mediates the 
expression of MRFs to trigger SC proliferation and differentiation (5, 21, 46). Contrary to the 
actions of IGF-1, myostatin down-regulates muscle mass by inhibiting proliferation (60) and 
differentiation (33) of SC and reducing muscle growth. While the role of SC is commonly 
accepted during skeletal muscle regeneration, it is still under debate as to their relationship to 
muscle hypertrophy during resistance training (22, 25).  
Another important strategy to enhance muscle hypertrophy and strength is nutritional 
supplementation. The ability of protein supplementation post exercise to enhance protein 
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synthesis is widely accepted (15, 39). Protein supplementation supplies the amino acids (AA) 
pool and regulates mRNA translation initiation via activating the mTOR signaling pathway (18, 
40). During prolonged resistance training, protein supplementation has been found to increase 
the magnitude of muscle mass and strength development compared with the exercise stimulus 
alone (62). However, protein supplementation does not appear to attenuate protein degradation, 
which is also elevated during resistance exercise (11, 48). In addition, an increase in plasma 
cortisol during  strenuous exercise may also counter an increase in muscle protein synthesis 
(32). Carbohydrate (CHO) supplementation has been shown to reduce the exercise-induce rise in 
cortisol (8, 59). Recently, we found that adding CHO to a post exercise protein supplementation 
accelerated muscle protein synthesis acutely [unpublished results]. Moreover, several resistance 
training studies suggest muscle mass and strength development may be enhanced when a 
CHO/protein supplement is provided around the time of each exercise session compared with 
either provided alone (10, 38). However, the few studies that have investigated the combined 
effects of CHO and protein supplementation on MPS have provided inconsistent results (10, 31, 
38, 56). Therefore, the first aim of this study was to investigate whether adding carbohydrate to a 
post exercise protein supplement would induce a greater muscle hypertrophy and strength 
development than protein supplementation alone. The second aim of the study was to determine 
the influence of exercise and post exercise nutrition on SC activation, and their involvement in 
muscle development during resistance exercise training.  
MATERIALS AND METHODS 
Animals A total of 31 male Sprague-Dawley rats were obtained at approximately 2 
months of age from Charles River (Wilmington, MA). Rats were singly housed in their cages in 
order to monitor diets and feeding patterns. PVC pipes were used as an environmental 
enrichment in each cage. Rats were provided standard laboratory chow (Prolab RMH 1000 5P07) 
and water ad libitum. The temperature of the animal room was maintained at 21 °C. A reverse 
artificial 12 h of dark-light cycle was set with the light phase from 8:00 pm to 8:00 am. All 
experimental procedures were approved by the Institutional Animal Care and Use Committee 
(IACUC) of the University of Texas at Austin and conform to the guidelines for the use of 
laboratory animals published by the United States Department of Health and Human Resources.  
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Exercise familiarization The resistance exercise training program employed consisted of 
ladder climbing. The ladder was 1 m high with 2 cm grid steps on an incline of 85°. Following 
one week of acclimation to their new environment, each rat underwent ladder climbing with 
three repeated sessions separated by one day between each session to familiarize them with the 
exercise protocol. During these three sessions, rats carried no weights. Rats also completed three 
practice sessions of climbing separated by one day between each session with 50, 60, and 70% of 
their body mass attached to their tails, respectively. The weight was attached at the base of the 
tail with foam tape (3 m Conan) and a Velcro strap. Rats were encouraged to climb by lightly 
tapping their tails with a bottlebrush.  
Experimental design Following familiarization with the ladder climbing, rats began a 
high-intensity progressive resistance exercise regimen according to Hornberger and Farrar (28). 
In brief, the initial climb consisted of carrying a load equal to 75% of the rat’s body weight. 
Upon successful completion of climbing the ladder with this load, an additional 30 g weight was 
added to the tail of the rat and the climb repeated after 2 min of rest. This procedure was repeated 
until a load was reached, which prevented the rat from completing the climb. In the subsequent 
training session, the first 4 ladder climbs consisted of 50%, 75%, 90%, and 100% of maximum 
load, respectively. Then, an additional 30 g load was progressively added until a new maximal 
carrying capacity (indicative of strength) was established. The training regimen was repeated 
every 3 days for 8 weeks, which consisted of a total of 20 exercise sessions. Whey hydrolysate 
(WP = 0.5 g/kg) (#8360, Hilmar Ingredients, Hilmar, CA), whey plus carbohydrate (CP: Whey 
=0.5 g/kg, CHO = 1.2 g/kg), or placebo (PLA = 8 ml/kg water) was provided by intubation 
immediately after each exercise regimen. Food was withdrawn 3 h before and after each exercise 
session with water provided ad libitum. Seven non-exercised rats were used as a sedentary group 
and received an intubation of water (8 ml/kg) during the times of training. The day before 1st 
exercise session, the days after the 9th and 19th exercise sessions, the rats were fasted for 3 hours 
and body mass obtained. Body composition was then determined via dual-energy X-ray 
absorptiometry (DEXA). Blood was collected 22-24 h after the 1st, 10th, and 20th exercise 
sessions. Following the last blood collection, rats were anesthetized to remove the flexor hallucis 
longus (FHL) from both legs and the epididymis adipose tissue. Muscle and adipose tissue 
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weights were obtained quickly. Then, the muscle from the left leg was embedded in optimal 
cutting temperature (OCT) medium and frozen in cooled isopentane for later determination of 
fiber cross sectional area (CSA), quantification of myonuclei, and myonuclear domain. The FHL 
from the right leg was freeze clamped in liquid nitrogen, and stored at -80°C for later 
determination of protein expression of IGF-1, myostatin, Pax 7, MyoD, and Myogenin, and total 
and myofibrillar protein content.  
Body composition DEXA (enCORE 14.10, GE Healthcare, Madison, WI) was used to 
determine the body composition of each rat. On the day of testing, rats were fasted for 3 hours 
and then anesthetized via intraperitoneal injections of ketamine (70mg/kg) and xylazine 
(7mg/kg). Each rat was then placed in a supine position with attention to body alignment on a 
platform grid. The forelimbs and hindlimbs of the rat were placed perpendicular to the long axis 
of the body. The tail was positioned in a left curve toward the head so the entire body was 
contained within the scan area. Body mass, bone mineral density, fat mass, lean mass， and 
percent body composition were obtained. 
Blood Analysis Approximately, 22-24 h after exercise sessions 1, 10, and 20, 0.7 ml of 
blood was collected into a 1.5 ml test tube containing 50 μl of EDTA (24 mg/ml, pH 7.4). All 
collected blood samples were centrifuged for 10 min at 3,000 g at 4ºC with a FS-20 microtube 
rotor in a Sorvall RC-6 centrifuge (Thermo Fisher Scientific Inc. Waltham, MA). After 
centrifugation, the plasma samples were placed in capped microfuge tubes and stored at -80°C 
for later analysis of corticosterone. The concentration of corticosterone was determined by an 
enzyme-linked immunosorbant assay kit (ELISA) with CV<10% (Enzo life sciences Inc. Ann 
Arbor, MI. Cat ADI-900-097).  
Morphological analysis Frozen OCT embedded muscle was transversely cut into 10µm 
sections on a cryostat (Leica cm1900; Leica Microsystems Inc., Buffalo Grove, IL) set at -20°C. 
Sections were mounted on glass slide. Hematoxylin and eosin (H&E) staining (Fisher scientific 
Inc.) was performed to identify muscle fiber CSA and the number of myonuclei. Slides were 
observed under a light microscope (Nikon Diaphot, Nikon Corp.; Tokyo, Japan) with a 20x 
objective lens for fiber CSA and with a 40x objective lens for quantification of nuclei and 
myonuclear domain. Three random histological fields were collected in each muscle for analysis. 
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Images were then taken using a mounted digital camera, and measured and counted using Image 
J software.  
Determination of muscle cross-sectional area The following formula was used to 
calculate muscle CSA. 
Muscle CSA (mm2) = muscle mass (mg) * cos θ (0.944) / [density (1.056mg/mm3) * 
muscle length (mm) * (FL/ML)] 
Immunoblot analysis Immunoblot analysis was performed as previously described (61). 
The frozen muscle samples weighing 80~100 mg were homogenized in ice-cold homogenization 
buffer (20 mM HEPES, 2 mM EGTA, 50 Mm sodium fluoride (NaF), 100 mM potassium 
chloride (KCl), 0.2 mM EDTA, 50 mM glycerophosphate, 1 mM DL-dithiothreitol (DTT), 0.1 
mM phenylmethanesulphonyl fluoride (PMSF), 1 mM benzamidine, and 0.5 mM sodium 
orthovandate (Na2VO4) at a 1:8 dilution of wet weight muscle with a glass tissue grinder pestle 
(Corning Life Sciences, Lowell, MA; Caframo Stirrer Type RZR1, Wiarton, Ont. Canada). The 
crude muscle homogenates were centrifuged at 14,000 g for 10 minutes at 4C, and the 
supernatants were taken for measurements of protein concentration. Aliquots of muscle 
homogenates were stored at -80 ºC until analyzed.  
Muscle samples (60µg) were combined with an equal amount of Laemmli sample buffer 
(125 mM Tris, 20 % glycerol, 20 % SDS, 0.25 % bromophenol blue, and β-mercaptoethanol, pH 
6.8) and boiled at 95°C for 10 min in order to denature muscle proteins. Samples were then 
subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using 10-
15% resolving gel at 100 V for 75 min (Bio-Rad Laboratories, Hercules, CA.). The resolved 
proteins were then electrically transferred onto a nitrocellulose membrane (pore size: 0.45 μm; 
GE Healthcare Life Sciences, Pittsburgh, PA) using a wet transfer unit (Bio-Rad Laboratories, 
Hercules, CA) at 90 V for 60 min. The membranes were blocked in 7 % nonfat milk in Tris-
buffered saline with 0.06 % Tween20 (TTBS) for 30 min at room temperature (RT). Then, the 
membranes were incubated with the appropriate primary antibody overnight at 4°C. The targeted 
proteins were IGF-1 (sc-9013), myostatin (sc-134345), pax 7 (sc-81975), myoD (sc-71629), and 
myogenin (sc-12732).  The above antibodies were purchased from Santa Cruz Biotechnology 
(Santa Cruz Biotechnology, Inc. Dallas, TX). Alpha-tubulin was used as an internal loading 
control (Cell Signaling Technology, Beverly, MA). Following overnight primary antibody 
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probing, all membranes were washed 5 min with TTBS three times. Then, the membranes were 
incubated with HRP-conjugated secondary anti-rabbit IgG (Cell Signaling Technology, Beverly, 
MA) or anti-mouse IgG (EMD Millipore Corporation, Chicago, IL). After another three washes 
using TTBS, the membranes were visualized by enhanced chemi-luminescence (ECL) in 
accordance with the manufacturer’s instructions (Perkin Elmer, Boston, MA). All western blots 
were performed in duplicate for each muscle sample to ensure reproducibility (CV<10%). 
Images were then captured using a charge-coupled device camera in a ChemiDoc system (Bio-
Rad, Hercules, CA). Intensity of each band was quantified with Quantity One analysis software 
(Bio-Rad) and expressed as a percentage of a standard. 
Total and myofibrillar protein measurements Myofibrillar protein measurement was 
described previously (28). In brief, 50 mg muscle was homogenized in ice-cold solution 
containing 8.5% sucrose, 5 mM EGTA, 50 mM KCl, and 100 mM MgCl2 using a Polytron 
homogenizer (Virtishear, Virtis, Gardiner, NY, USA). An aliquot of the crude muscle 
homogenate (0.1ml) was used to determine total protein concentration. The remaining 
homogenate was centrifuged at 2500 g for 15 min at 4C. The supernatant was discarded and the 
pellet was resuspended in a solution (pH 6.8) containing 5 mM EGTA, 100 mM KCl, 5 mM 
MgCl2, and 0.05% Triton X-100. The suspension was then centrifuged at 2500 g for 10 min at 
4C and the supernatant was discarded. This step was repeated two more times. The remaining 
pellet was washed in solution (pH 6.8) containing 5 mM EGTA and 100 mM KCl and 
centrifuged at 2500 g for 10 min at 4C. This step was repeated one more time. The myofibrillar 
pellet was then resuspended in a solution (pH 7.4) containing 150 mM KCl and 5 mM tris-
hydroxymethyl aminomethane. This suspension was used to determine myofibrillar protein 
concentration. Total and myofibrillar protein concentrations were determined by a modified 
Lowry Protein Assay (35).  
Statistical approach A repeated analysis of variance (ANOVA) was performed on a 
between-within mixed model designs (treatment x time) for the measurements of body 
composition, maximal carrying capacity, and corticosterone. When the interactive effect 
(treatment x time) was statistically significant, differences among means were determined using 
Fisher’s LSD post hoc analysis. A one-way ANOVA was used for all the other data, and Fisher’s 
LSD post hoc test was performed to compare mean differences among treatments. Differences 
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with p-values ≤ 0.05 were considered statistically significant. All statistical analyses were 
performed using IBM SPSS Statistics v19.0 software (IBM Corporation, Armonk), and all data 
was expressed as mean ± standard error of the mean (SEM). 
RESULTS 
Rat physical characteristics 
Body mass, FHL muscle mass, epididymis adipose mass, and daily food and caloric 
consumptions are presented in table 5.1.. There were no differences in initial body mass, daily 
food and caloric consumptions across treatment groups. After 8 weeks of training, all rats had 
significant increases in body mass. The gains in body mass, for the exercise groups, however, 
were significantly lower than occurred in the sedentary (SED) group. Body mass gains did not 
differ among the exercise groups. Likewise, resistance training significantly augmented FHL 
muscle mass, but the muscle mass did not differ among exercise groups. Both placebo (PLA) (p 
= 0.05) and CP (p = 0.06) groups showed a trend for lower epididymis adipose mass relative to 
the SED group. In spite of mass differences in the FHL muscle and epididymis adipose tissue 
after 8 weeks of training, total body composition measured by DEXA did not differ among 
groups (Figure 5.1.). Percent of fat body mass was elevated whereas percent of lean body mass 
was reduced in all treatment groups after 4 weeks, and did not change during the subsequent 8 
weeks of training (Figure 5.1.A, B). Additionally, there were no differences in percent fat or lean 
body mass across treatment groups (Figure 5.1.A, B). Changes in fat and lean mass showed a 
similar pattern as percent body composition (Figure 5.1.C, D). However, compared to week 4, 
SED and WP groups had a higher fat mass at week 8, and all groups had a greater increase in 
lean mass at week 8 (Figure 5.1.C, D).    
Maximal carrying capacity 
After 8 weeks of resistance training, rats in the PLA group increased their maximal 
carrying capacity by 2.7-fold (from 475±10 g to 1,280±37 g). Rats receiving WP immediately 
after each exercise session also increased their maximal carrying capacity by 2.74-fold (from 462 
g± 13 to 1,260± 49 g). Rats receiving CP immediately after each exercise session increased their 
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maximal carrying capacity by 3.04-fold (from 461±14 g to 1,390±54 g) (Figure 5.2., 5.3.). The 
percentage increase in maximal carrying capacity was significantly greater in the CP group 
compared with the PLA and the WP groups (Figure 5.3.).  
Muscle and fiber CSA 
Eight weeks of resistance training produced a larger FHL and FHL muscle fiber cross 
sectional area (CSA) relative to the FHL of the SED group. Nevertheless, no significant 
differences were observed among the three exercise groups for either muscle mass or fiber CSA 
(Figure 5.4.A, B).  
Total and myofibrillar proteins 
To investigate the underlying mechanisms on increases in maximal carrying capacity, 
total and myofibrillar proteins were measured. Exercise training did not affect total protein 
concentration (Figure 5.5.A), but total protein content for CP was significantly increased above 
SED (Figure 5.5.B), with a trend for PLA to be also greater than SED (p = 0.07). No difference 
occurred among the exercise trained groups. From the total protein extracted for each muscle, we 
determined the myofibrillar protein component. Our results showed myofibrillar protein per g 
muscle from CP was significantly greater than SED (Figure 5.5.C). Myofibrillar protein of all 3 
exercise groups was greater than SED when myofibrillar protein content was expressed as 
mg/muscle (Figure 5.5.D).  Also, myofibillar protein content of CP was significantly greater 
than WP, and approached significance relative to PLA (p = 0.06).  
Signaling proteins that regulate the activation of SC  
Expression of proteins involved in the activation of satellite cells was then investigated 
using western blot. IGF-1 is a growth factor stimulating muscle protein synthesis and 
myogenesis. The results suggested that CP elicited a greater IGF-1 protein expression compared 
with SED (Figure 5.6.A). No other differences were noted for IGF-1 across treatments. 
Myostatin, another growth regulator, which plays a role in the down-regulation of muscle mass 
hypertrophy was investigated. However, no significant differences were found for myostatin 
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protein expression across treatment groups (Figure 5.6.B). To investigate the possibility of 
satellite cell activation with training, protein expression of Pax 7, Myo D and Myogenin were 
examined (Figure 5.6. C, D, E). Neither exercise training nor nutrient supplementation appeared 
to have an effect on these proteins. To eliminate the possibility that the activation of satellite 
cells was not seen due to a missed time point, number of nuclei per observed FHL muscle fiber 
was measured. However, the amount of nuclei per fiber did not differ across treatments (Figure 
5.7.A), whereas nuclear domain per nucleus was significantly augmented by resistance training 
(Figure 5.7.B).  
Corticosterone level  
Plasma corticosterone level was measured 22-24 hours after the 1st (week 0), 10th (week 
4), and 20th (week 8) exercise sessions. Corticosterone level was significantly elevated by 
exercise at week 8 compared to week 0 for the PLA and WP groups (Figure 5.8.). Corticosterone 
level also showed a significant increase from week 4 to week 8 in the PLA group. There was no 
difference in corticosterone level in the CP group over the 8 weeks of training, and there were no 
differences between exercise groups at any time point.  
DISCUSSION 
The primary finding of the present study was that maximum carrying capacity， 
indicative of muscle strength, was significantly greater in the CP group than the PLA or WP 
groups following 8 weeks of resistance training. Maximal carrying capacity during the first 4 
weeks did not differ among exercise groups, and it may be explained by neural adaptation (57). 
The subsequent gains in carrying capacity were greater for CP than for the PLA and WP groups. 
CHO seemed to play a role in muscle protein accretion and strength. During the last week of 
training, however, the gain in the maximal carrying capacity became progressively more 
difficult. This phenomenon might be attributed to a “ceiling effect” where rat genetic potential is 
reached (45, 52).  
Previous studies have clearly demonstrated that FHL muscle in lower extremity was 
highly responsive to this resistance training model (28, 34). In line with these literatures, our 
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study showed that FHL muscle mass was significantly increased by exercise training, but did not 
differ among exercise groups. Also, while FHL muscle mass was enhanced by exercise training, 
a single muscle hypertrophy was not sufficient to impact changes of total body composition. 
Muscle hypertrophy only occurred in the active muscle during the training. Therefore, no 
significant treatment differences were detected in the percent of fat and lean mass. Interestingly, 
percent of fat mass was increased after 4 weeks in all groups while percent of lean mass was 
correspondingly reduced. To our knowledge, no evidence exists to show this phenomenon in 
animal study. Two months old young adult healthy rats were used in our study. Over 8 weeks of 
training, rats were at puberty stage, which age range is comparable to 12-18 years old in human 
(7, 53). It has been well established that the puberty stage in human results in rapid body growth, 
increased weight, and fat deposition (49). Therefore, it was not surprising to observe an 
increased percent of fat mass in the present study. The absolute value of fat mass measured by 
DEXA in SED and WP was elevated from week 4 to week 8, which pattern was not seen in the 
PLA and the CP groups. Additionally, a slight, nonsignificant lower epididymis adipose mass 
was detected with PLA and CP relative to SED.  
Resistance training significantly increased muscle and fiber CSA leading to an increase in 
FHL muscle mass, indicative of muscle hypertrophy. Muscle hypertrophy could be due to the 
accumulation of protein content in the muscle or edema-induced muscle swelling. In the present 
study, total protein concentration did not differ across groups. Total protein content for CP was 
significantly elevated above SED. PLA and WP groups also showed a slight increase in total 
protein content than SED. These data indicate that muscle hypertrophy is most likely due to the 
accumulation of protein content, but we cannot rule out the possibility of muscle edema, which 
remained determined in future studies. Muscle protein pools consist of myofibril, mitochondria, 
and sarcoplasm, etc. Among the different types of proteins, myofibrillar protein contains myosin 
and actin contractile proteins, and their accumulation can add to muscular strength. Our results 
demonstrated that myofibrillar protein content was enhanced for CP over the SED or the WP 
group. CP also showed a higher myofibrillar protein content trend relative to PLA (p=.06). 
Despite that such an increase in myofibrillar protein for CP did not result in a greater increase in 
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size of muscle mass compared to that occurred in PLA or WP, CP induced rise in myofibrllar 
protein content seemed to bring about a greater strength relative to the other two exercise groups.  
The net balance between muscle protein synthesis and protein degradation determines the 
accumulation of myofibrillar protein and muscle size. The underlying mechanism of increasing 
myofibrillar protein was then investigated in the present study. Our result showed that muscle 
IGF-1 protein expression was upregulated in the CP group compared to the SED group. IGF-1 
has been demonstrated to have autocrine/paracrine functions within muscle fibers (1, 24). It is 
capable of stimulating protein synthesis and satellite cell (SC) activation (23, 26). Although not 
investigated directly in this study, an acute study from our laboratory clearly demonstrated that 
CP accelerated MPS via activating mTOR signaling pathway compared to exercise alone. 
Moreover, Lee and colleagues found that protein synthesis was the source of muscle hypertrophy 
via increased IGF-1 expression in muscle (34). These results, along with the finding of the 
present study, support the hypothesis that CP can augment protein synthesis via increasing IGF-1 
protein expression in skeletal muscle, as compared to the other two exercise groups.  
From another point of view, elevated cortisol level post exercise has enormous 
implications for strength athletes. The harder the resistance training is, the greater the cortisol is 
released, and the greater protein degradation occurs (32). Thus, the generation of cortisol during 
high intensity of RE can lead to negative net protein balance and muscle damage (27). In the 
current study, we observed that exercise significantly elevated plasma corticosterone level at the 
end of week 8 over week 0 and week 4 in PLA, and corticosterone was also increased for WP in 
week 8 relative to week 0. As such, the elevation of circulating corticosterone may compensate 
for the anabolic effect caused by resistance training. In contrast, plasma corticosterone did not 
differ over 8 weeks of training in the CP group. This result is in agreement with the findings in 
human studies, which reported an attenuation of cortisol level by CHO intake after acute or 
chronic resistance exercise (8, 10). Therefore, our results reveal that CHO may attenuate MPB 
over 8 weeks of resistance training, and it can explain a higher myofibrillar protein concentration 
and content in the CP group. As mentioned previously, corticosterone is a strong catabolic 
hormone causing muscle damage, so elevated level of corticosterone in the PLA and the WP 
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groups at the end of 8 weeks of training may cause damaged sarcolemmas, and consequently 
lead to muscle edema to some extent. This could also account for our findings that CP resulted in 
a greater strength than the PLA and the WP groups but no significant differences existed in 
muscle CSA among training groups.  
In addition to increased protein accumulation, muscle hypertrophy may also be 
accompanied by an increase in the number of myonuclei in response to muscle loading (3). As 
mentioned above, muscle IGF-1 contributes to the activation of SC. SC represents muscle 
precursor cells. Its activation, proliferation and differentiation provide new myonuclei in the 
muscle fiber. This crucial role of SC in muscle hypertrophy was first found in a study utilizing 
gamma-irradiation to kill SC (50). In this study, muscle size was not able to be increased by 
overload in the irradiated rats due to the lack of SC (50). A later research by Patrella et al. 
reported that a greater hypertrophy was driven by a greater SC activation (46). Some myogenic 
regulatory factors (MRF) are responsible for the activation of SC. The increased expression of 
IGF-1 has been reported to mediate MRFs expression and to enhance myoblast proliferation and 
differentiation (5, 21). On the other hand, myostatin, a member of the transforming growth 
factor-β superfamily, plays a role in the down-regulation of muscle mass change. In the current 
study, however, changes of Pax 7, MyoD, and myogenin were not observed among all groups. 
Early research provided strong evidence showing that 8 weeks of resistance training using 
weight lifting model induced an increased mRNA expression of MyoD and myogenin (2), but 
the protein expression was not examined. One possible reason that no differences in MRFs 
protein expression was observed may be due to a missed activating window, because these 
protein expressions were only examined at 24 h after last exercise session in this study. To 
further investigate whether SC has been fused into the myofiber for muscle hypertrophy, the 
number of nuclei per FHL muscle fiber CSA was measured. The amount of nuclei per fiber CSA 
did not differ across treatment groups, though the myonuclear domain was increased in the 
exercise groups. These results indicate that resistance training promotes protein synthesis without 
additional nuclei involvement. Although some studies have reported an increase in the amount of 
nuclei per muscle fiber by resistance training (42, 47), other studies failed to observe the same 
change (30, 36). This discrepancy may be due to the intensity of exercise training, the magnitude 
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of muscle hypertrophic response, muscle damage, and genetic factors. An early investigation 
examined muscle hypertrophy using surgical synergistic ablation in soleus muscle (55). The 
significant increased in the number of SC only occurred in the first stage when muscle fiber was 
severely disrupted and muscle regeneration was required. However, during the second stage of 
increased muscle activity, 30% increase in muscle hypertrophy was not accompanied by the 
activation of SC (55). The myonuclei fusion by SCs may be required to provide sufficient 
cytoplasmic space for muscle protein expansion only when the myonuclear domain reaches a ceiling 
size, below which the stimulation of MPS is probably the sole factor to induce hypertrophy (46). Lee 
and colleagues also pointed out that 8 weeks of resistance training was not sufficient to cause SC 
fusion to the existing fibers by detecting the lack of central nuclei in the training group (34). 
Therefore, the necessity of SCs relies on the magnitude of muscle hypertrophy. The lack of 
changes in the MRF and total number of observed nuclei in the current study suggest that our 
training load may not be adequate to induce the new myonuclei infusion by activating SC. In 
agreement with our finding, McCarthy et al. observed the same increases in muscle mass induced 
by mechanical overload between normal mice and SC-depleted mice (37). Myonuclear domain 
was expanded without an increase in myonuclei in hypertrophic muscle. Moreover, the ladder-
climbing regimen used in our study was relatively modest in intensity compared to some other 
training protocols (20, 58), so muscle damage may not be severe to result in the SC activation.  
It was widely reported that consumption of additional protein supplementation after 
exercise led to an augmentation of protein synthesis and subsequent muscle hypertrophy (19, 
44). Compared to casein and other whey protein isolate, whey hydrolysate has been shown to 
hasten muscle recovery after exercise and achieved substantially greater gains in lean mass and 
muscle strength (13, 17). Surprisingly, WP provided immediately after each exercise session did 
not stimulate a greater increase in muscle maximal carrying capacity, muscle mass, and 
myofibrillar protein compared to resistance training alone in the present study. There are several 
possible explanations for the discrepancy found in our study and other literatures. First, a daily 
supply of AAs may be adequate to promote muscle hypertrophy and no additional protein 
supplementation was needed. Second, WP was provided after each exercise session rather than 
every day. Therefore, average daily protein intake between the PLA and WP groups did not 
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differ (4.54±0.05 g / rat in the PLA group versus 4.68±0.12g / rat in the WP group). Third, some 
other studies did not see any effect of protein supplementation on muscle adaptation (29, 43, 52), 
suggesting that the potential benefit of post-exercise protein supplementation may be affected by 
intensity of training, nutritional states, and timing (12, 44). 
In summary, postexercise CP supplementation increased the magnitude of maximal 
carrying capacity following 8 weeks of resistance training. This greater increase in strength by 
CP, as compared to the PLA or the WP group, appears to be due to higher myofibrillar protein 
content in the FHL muscle. However, muscle hypertrophy in response to resistance training was 
not sufficient to involve additional nuclei infusion into muscle fibers. We conclude that 
providing CHO to a protein supplement can be recommended for the postexercise nutrition to 
promote greater muscle strength during prolonged resistance training.   
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Table 5.1. Food consumption, total calories, body mass, FHL muscle mass, and epididymis adipose tissue mass 
 Data are presented as mean ± SEM (n = 7 - 8 per group). †, p ≤ 0.05 vs. initial body weight in the 
same treatment. *, p ≤ 0.05  vs. SED at the same time point.  
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 Figure 5.1. Effect of resistance training and nutrients on total body composition measured by 
DEXA. A) Fat percentage. B) Lean mass percentage. C) Fat mass. D) Lean mass. Data are 
presented as mean ± SEM (n= 7 - 8 per group). †, p ≤ 0.05 vs. week 0 in the same treatment. ‡, p 
≤ 0.05 vs. week 4 in the same treatment. 
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Figure 5.2. Maximal carrying load per training session over 8 weeks. Data are presented as mean 
± SEM (n= 7 - 8 per group). ƒ, significant treatment effect in CP vs. PLA and WP. #, p ≤ 0.05 vs. 
PLA. §, p ≤ 0.05 vs. WP. 
           
 153 
        
 Figure 5.3. Percentage increase in maximal carrying capacity over 8 weeks of training. Data are 
presented as mean ± SEM (n = 7 - 8 per group). #, p ≤ 0.05 vs. PLA. §, p ≤ 0.05 vs. WP.  
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 Figure 5.4. Cross sectional area. A) Fiber cross sectional area. B) FHL muscle cross sectional 
area. C) Cross section of FHL muscle in untrained rats (20 x objective lens) . D) Cross section of 
FHL muscle in trained rats (20 x objective lens). Data are presented as mean ± SEM (n = 7 - 8 
per group). *, p ≤ 0.05 vs. SED. 
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Figure 5.5. Total and myofibrillar proteins. A) Total protein concentration. B) Total protein 
content per muscle. C) Myofibrillar protein concentration. D) Myofibrillar protein content per 
muscle. Data are presented as mean ± SEM (n = 7 - 8 per group). *, p ≤ 0.05  vs. SED. §, p ≤ 
0.05 vs. WP. 
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 Figure 5.6. Markers for new nuclei involvement. A) IGF-1 protein expression as a percentage of 
a standard sample obtained from an insulin-stimulated rat tissue. B) Myostatin protein expression 
as a percentage of a standard sample obtained from an insulin-stimulated rat tissue. C) Pax 7 
protein expression as a percentage of a standard sample obtained from an insulin-stimulated rat 
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tissue. D) Myo D protein expression as a percentage of a standard sample obtained from an 
insulin-stimulated rat tissue. E) Myogenin protein expression as a percentage of a standard 
sample obtained from an insulin-stimulated rat tissue. Data are presented as mean ± SEM (n = 7 - 
8 per group). *, p ≤ 0.05 vs. SED. 
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   Figure 5.7. Number of nuclei and myonuclear domain. A) Number of nuclei per FHL muscle 
fiber. B) Myonuclear domain per nucleus. Data are presented as mean ± SEM (n = 7 - 8 per 
group). *, p ≤ 0.05 vs. SED 
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 Figure 5.8. Plasma corticosterone level 22-24 hours after 1st (week 0), 10th (week 4), and 20th 
(week 8) exercise session. Data are presented as mean ± SEM (n = 7 - 8 per group). †, p ≤ 0.05 
vs. week 0 in the same treatment. ‡, p ≤ 0.05  vs. week 4 in the same treatment.  
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Chapter VI: GENERAL DISCUSSION 
The purpose of this series of studies was to determine the effect of carbohydrate (CHO) 
and amino acids (AAs) on signaling pathways that regulate muscle protein synthesis (MPS) and 
muscle protein breakdown (MPB) following acute resistance exercise (RE), and muscle 
adaptations following prolonged resistance training and the underlying mechanisms.  
Two major strategies have been well documented to improve skeletal muscle adaptation: 
RE and feeding. Skeletal muscle is a plastic tissue that is highly responsive to mechanical 
loading (13). With respect to nutritional supplements, many investigations have reported that 
protein supplementation, in particular whey (WP), enhances MPS by ensuring sufficient essential 
AA and activating the mTOR signaling pathways (6, 19, 23, 26). However, not all AA in the 
composition of protein equally contribute to muscle accretion. Glutamine, a conditionally 
essential amino acid (EAA), has been reported to play an important role to regulate muscle 
protein turnover under different conditions, particularly under a catabolic state (17, 18, 25, 27). 
Compared with glutamine, however, AlaGln is more stable in solution, and produces a higher 
plasma glutamine concentration (1, 9, 16), but the effect of AlaGln on protein accretion was 
unknown. Therefore, in the first study, we compared the effectiveness of AlaGln and WP on 
signaling proteins that control MPS and MPB. The results showed that AlaGln may inhibit MPB 
via restraining the activation of AMPK-FOXO3A and NF-kB p65 post exercise, but it did not 
have any effect on signaling proteins related to MPS. We also found that WP appears to 
accelerate the activation of the mTOR signaling pathway, but this effect did not appear to be 
regulated by plasma hormonal circulation. Signaling proteins that control MPB were not 
influenced by the WP supplementation. Collectively, our findings suggest that a combination of 
WP and AlaGln supplementation provided post exercise may result in the phosphorylation of 
signaling proteins in a manner that increase MPS and decrease MPB.  
In addition to the beneficial effect of protein/AA supplementation on muscle accretion, 
lines of evidence have demonstrated that CHO can reduce circulating the cortisol level after 
exercise (2, 20) and suppress MPB (5). Although CHO has been shown to significantly increase 
the plasma insulin level, the role of CHO on MPS and subsequently muscle hypertrophy remain 
inconsistent. Therefore, in studies 2 and 3, we investigated whether adding CHO to a protein 
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supplement can promote an increase in MPS after an acute resistance exercise, and enhance 
greater muscle hypertrophy and strength over 8 weeks of resistance training. In the second study, 
we found that post exercise supplementation with CHO plus protein (CP) hastened MPS during 
the early period of exercise recovery compared with placebo (PLA) or WP alone. With regard to 
the phosphorylation of signaling proteins that are involved in MPS and MPB, CP yielded a 
greater phosphorylation of mTOR than SED at 1 h post exercise, and SED and WP at 2 h post 
exercise. Because CP significantly elevated the plasma insulin level at 1 h post exercise, the 
increased MPS for CP appears to be associated with a greater insulin response. Both WP and CP 
increased 4E-BP1 phosphorylation relative to PLA at 1 h post exercise, and this phosphorylation 
level was higher for CP and WP than SED at 2 h. Earlier research suggested that reduced 4E-
BP1 phosphorylation may result in the inhibition of protein synthesis during resistance exercise 
(7). Therefore, inhibition of 4E-BP1 by supplementation during early hours of exercise recovery 
might contribute to an enhancement of MPS.  
Another signaling pathway mediating MPS is GSK3-eIF2Bɛ, and is independent of the 
mTOR signaling pathway. We observed no differences in the phosphorylation of Akt, GSK3, 
and eIF2Bɛ across time or treatment. These results implied that the regulation of MPS by the 
GSK3-eIF2Bɛ dependent signaling pathway occurs during the later stages of exercise recovery, 
which tends to agree with earlier research findings (4, 8, 12). In contrast, our results indicate that 
the activation of mTOR and the inhibition of 4E-BP1 by CP play important roles in the 
stimulation of MPS during the early phase of exercise recovery.  
AMPK, an energy dependent kinase, has been shown to inhibit mTOR activation, which 
then suppresses MPS (3, 7). AMPK can also activate FOXO3A, which in turn stimulates MPB 
(24). An interesting finding was that exercise significantly elevated the phosphorylation of 
AMPK at 1 h post exercise, and this level remained elevated only in the WP at 2 h post exercise. 
It is possible that at 2 h post exercise, WP induced MPS but energy availability was insufficient 
resulting in an elevated ADP/ATP to activate AMPK. With regard to MPB, the phosphorylation 
of FOXO3A was significantly elevated by exercise at 1 h post exercise, and only the CP group 
showed sustained phosphorylation of FOXO3A relative to the SED group at 2 h post exercise. 
However, the change of FOXO3A did not follow the same pattern as AMPK. Furthermore, the 
plasma corticosterone level was elevated immediately after exercise, but returned to the basal 
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level at 1 h post exercise. Cortisol is a strong catabolic hormone stimulating MPB as well as 
inhibiting MPS (21, 22). In agreement with our findings, previous results from our laboratory 
showed that plasma cortisol did not differ within 6 h post exercise with or without CP provision, 
but plasma cortisol was elevated for PLA as compared with the CP group at 24 h post exercise 
(2). According to our FOXO3A and corticosterone results, it is unlikely that CP supplementation 
contributed to the inhibition of MPB during the early phase of exercise recovery. Together, it is 
concluded that CP accelerates MPS during the early recovery of resistance exercise relative to 
PLA and WP. This enhancement in MPS could have been the result of a rise in plasma insulin 
and the activation of the mTOR signaling pathway.  
It was speculated that CP supplementation, which induces MPS after acute resistance 
exercise, might produce a greater training adaptation than PLA and WP during prolonged 
resistance training. Therefore, in the third study, we compared the effect of CP, WP, and PLA on 
muscle hypertrophy and muscle strength. Rats underwent progressive resistance exercise training 
every three days for 8 weeks. Nutritional supplementation was provided immediately after each 
exercise session. The primary finding was that maximal carrying capacity, indicative of muscle 
strength, was enhanced by 2.7-fold in both PLA and WP groups after 8 weeks of training, and 
the capacity was further increased by CP (3.04-fold) relative to the PLA and WP. This 
improvement in training performance for CP was likely to be due to the greater increase in total 
and myofibrillar protein content than in the PLA and WP groups. Myofibrillar protein contains 
contractile proteins, such as myosin and actin. The more myofibril is packed in the muscle fibers, 
the greater the muscle hypertrophy, and the stronger force the muscle can produce. It is worth 
noting that muscle and fiber cross sectional area (CSA) were significantly increased by exercise 
training, but there were no differences among exercise groups. Skeletal muscle is composed of 
various proteins, including myofibrillar protein, mitochondria, and sarcoplasm, and they 
demonstrate different responses to resistance exercise. We cannot rule out the possibility that CP 
brings about more myofibrillar synthesis with a compensatory decrease in other types of proteins 
in muscle. It is also possible that PLA and WP develop more muscle damage than CP, and 
consequently lead to muscle edema. This may explain the greater enhancement of muscle 
strength with CP supplementation, but with the same muscle CSA among exercise groups. The 
accumulation of myofibrillar protein results from increased MPS and decreased MPB. We found 
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that plasma corticosterone level was elevated in PLA and WP over 8 weeks of training, whereas 
corticosterone level did not change in the CP. As discussed in the second study, corticosterone is 
a strong catabolic hormone, leading to a negative nitrogen balance by increasing MPS and 
decreasing MPB. Low corticosterone level in the CP group may have attenuated MPB. 
Additionally, IGF-1 protein expression was upregulated in the CP group compared to the SED 
group. Skeletal muscle IGF-1 is capable of stimulating protein synthesis and satellite cell (SC) 
activation (14, 15). Therefore, CP appears to promote greater accumulation of myofibrillar 
protein, as compared with PLA and WP, by increasing IGF-1 and attenuating exercise induced 
elevation in corticosterone circulation.  
Once protein accretion reaches a certain level, further enhancement in muscle 
hypertrophy may be accompanied by an increased number of myonuclei in order to maintain a 
efficient functioning myonuclear domain (area of cytoplasm per nuclei). It is believed that 
satellite cells (SC) are the sole source for providing new myonuclei. Myogenic regulatory factors 
(MRF) that are relevant to the recruitment of new nuclei were examined in the third study. 
Changes in Pax 7, MyoD, and myogenin were not observed across all treatment groups. We then 
measured the total number of nuclei per fiber and calculated the myonuclear domain. The 
amount of nuclei per fiber did not differ among groups, but exercise training did enlarge the 
myonuclear. Therefore, muscle hypertrophy induced by resistance training was not accompanied 
by an increase in myonuclei, indicating that the existing number of myonuclei were capable of 
supporting the enlargement of muscle fibers.  
Resistance training also produced a greater increase in the FHL muscle and slight 
reduction in the epididymis adipose tissue. However, no differences were observed among the 
exercise groups. In addition, percent of fat and lean mass did not differ among treatment groups.  
Taken together, these three studies suggest that nutritional supplementation provided 
immediately post exercise will enhance muscle protein accretion. In particular, AlaGln may 
inhibit MPB via phosphorylating AMPK-FOXO3A and NF-Kb p65 signaling pathways. Co-
ingestion of CHO and WP accelerates MPS during the early recovery phase from acute 
resistance exercise relative to PLA and WP, and its cumulative effect during resistance training 
is to accelerate strength gains by increasing production of more myofibrillar protein per unit 
muscle.  
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FUTURE DIRECTIONS 
This series of studies has demonstrated that protein/AAs and CHO supplementation are 
beneficial for acute resistance exercise recovery and prolonged training adaptation. These three 
studies also addressed the underlying signaling pathways that are involved in MPS, MPB, and 
muscle hypertrophy. Clearly, this is an area for more research to be performed in order to better 
understand the role of nutritional supplementation, in particular of CHO and WP, on exercise 
performance and training adaptation.  
In the first study, we did not observe the effect of AlaGln on signaling proteins that 
regulate MPS. Perhaps the glutamine level did not fall below its normal physiological level 
during exercise; therefore its de novo synthesis was sufficient to maintain MPS. However, we did 
not measure the blood glutamine level directly. In the second study, we speculated that the 
beneficial effect of CHO on MPS and the mTOR signaling pathway might be due to a rise of 
insulin level, which then trigger more AA transported into the muscle fiber. However, we did not 
measure plasma and intracellular AA concentration directly. L-Leucine uptake is crucial to 
activation of the mTOR signaling pathway, so the measurement of intracellular leucine is also 
important. According to these limitations in studies 1 and 2, a future study could be designed to 
address the impact of AA concentration in plasma and muscle on MPS. Moreover, additional 
time course studies are needed to determine the effect of CHO and WP on MPS during the later 
stages of exercise recovery. Alternatively, an isotopic (2H2O) methodology could be used to 
measure 36 h fractional rates of MPS to determine cumulative MPS (10, 11).  
In the third study, we did not see an improvement in rat body composition (increase in 
lean mass percent and/or decrease in fat mass percent) after 8 weeks of resistance training. Only 
the FHL muscle demonstrates a hypertrophic response to ladder climbing, and hypertrophy of a 
single muscle is not adequate to observe changes in body composition. Therefore, other 
resistance exercise models, such as squat resistance exercise, should be considered for future 
resistance exercise studies. Furthermore, to better investigate CP and resistance training 
adaptations, other animal models, as well as different age ranges, need to be considered. 
Eventually, it will be necessary to confirm these findings in human research studies. Also, to 
fully examine how CP supplementation affects MPS, MPB, and training adaptation, we could 
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expand our investigations into various populations, such as elite athletes, adolescents, the elderly 
undergoing sarcopenia, and type 2 diabetics. CP supplementation could also be applied a bed rest 
population to determine its effect on muscle atrophy prevention. Applying CP supplementation 
to a wider population would broaden our understanding of how CP enhances/maintains muscle 
mass and strength, and improves quality of life.  
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Appendices  
APPENDIX A: BLOOD SUBSTRATE AND HORMONE MEASUREMENT 
Glucose Assay 
Plasma glucose was determined using a colorimetric method, which employs glucose 
oxidase (GOD) and a modified Trinder color reaction [1] (Sigma Chemical, St. Louis, MO). The 
modified Trinder reagent contains the enzymes peroxidase (HPOD), 4-aminoantipyrine (4-AAP) 
and p-hydroxybenzene sulfonate (p-HBS). GOD oxidizes glucose to D-gluconate and forms an 
equal amount of hydrogen peroxide. 4-AAP and p-HBS are oxidized by hydrogen peroxide and 
form a quinoneimine dye. The dye is intensely red in color. The absorbance of the reaction 
solution is measured using a Beckman DU 640 spectrophotometer (Beckman Coulter, Inc., 
Fullerton, CA) at a wavelength of 500 nm. The intensity of the color in the reaction solution is 
proportional to the glucose concentration in the sample. All samples were run in duplicate. 
Difference between duplicate results of a sample of < 7% CV was acceptable. 
Three different concentrations of glucose were used as standards and controls to monitor 
the performance of assay procedures. Within and between assay variations was performed on the 
three standards containing varying concentrations of glucose.   
     Sample No.       Mean mg/dl     Within % CV    Between % CV 
1 50 1.9 9.3 
2 100 3.7 7.3 
3 200 3.8 2.1 
   
Lactate Assay 
Blood lactate was determined from the PCA extract according to the protocol of Hohorst 
[2].  Coupled with β-NAD and hydrazine, lactate can be converted to pyruvate and generate 
NADH by lactate dehydrogenase (LDH). The amount of lactate is then determined by the 
generation of NADH using a Beckman DU 640 spectrophotometer (Beckman Coulter, Inc., 
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Fullerton, CA) at a wavelength of 340nm. All samples were measured in duplicate. Difference 
between duplicate results of a sample of < 10% CV was acceptable. 
Growth Hormone Assay 
Plasma growth hormone was measured using sandwich ELISA kit with CV < 10% 
(Millipore Corporation, MA). The growth hormone from samples is captured by a pre-titered 
amount of anti-growth hormone polyclonal antibodies coated in a microtiter plate. It is then 
recognized by a secondary polyclonal antibody, which is conjugated with horseradish 
peroxidase. The quantification of the conjugation is visualized at dual wavelengths of 450nm and 
630nm. 
Insulin-Like Growth Factor 1 (IGF-1) Assay  
Plasma IGF-1 was determined using a high-sensitivity ELISA kit with CV <10% 
(Immunodiagnostic Systems Inc., AZ). Samples were pretreated prior to assay to separate the 
IGF-1 from the IGFBPs, and then diluted for assay. A monoclonal anti-mouse IGF-1 is coated 
onto the inner surface of microtitre wells. The diluted samples are incubated with biotin labeled 
polyclonal goat anti-mouse IGF-1 for 1 h at room temperature. Horseradish peroxidase labeled 
avidin is added to bind to biotin, followed by a wash step. Color is developed using a 
chromogenic substrate (TMB). The absorbance of the stopped reaction mixtures are read at a 
wavelength of 450nm (reference 630nm).   
Corticosterone Assay 
The concentration of corticosterone was determined by an enzyme-linked immunosorbant 
assay kit (ELISA) (Enzo life sciences Inc. Ann Arbor, MI. Cat ADI-900-097). This kit is a 
competitive immunoassay. Plasma samples were diluted (1:40). In brief, 10µl of each sample 
was added into microfuge tube. Then, 10 µl 1:100 diluted steroid displacement reagent (SDR) 
solution was added to each sample tube, and vortex. The sample tube then stayed at room 
temperature for 5 min. 380 µl ELISA assay buffer was added to each tube and vortex. Then, 100 
µl of standard diluents was added into the NSB and the Bo (0pg/ml standartd) wells. After 
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dilution, 100 µl of standard and or samples was added into the appropriate wells. A polyclonal 
antibody was added into the well which bound to corticosterone in the standard or sample tubes 
or an alkaline phosphoatase molecule which has corticosterone covalently attached to it. After 
incubation, the enzyme reaction was stopped and each well read on a microplate reader at 
405nm.  
Rat Insulin Radioimmunoassay (RIA) 
Rat plasma insulin was determined using an RIA method (#RI-13K, Millipore, Millipore 
Corporation, MA). 125I-labeled insulin was added to glass tubes (12 x 75 mm) containing 
standards, controls, or plasma samples. Rat insulin antibody was added to the tubes containing 
standards or samples. All tubes were incubated at 4°C overnight (20-24 hours). During that time, 
125I-labeled and unlabeled insulin competed for binding sites on the antibody. Thus, the amount 
of tracer bound to antibody was decreased as the concentration of unlabeled antigen increased. 
The next day, the antigen-antibody complex was precipitated by adding precipitating solution, 
incubating the tubes, and centrifugation. Once the supernatant was poured off, the tubes were 
counted for 2 min in a gamma counter (Perkin Elmer life sciences, Turku, Finland). A standard 
curve was generated by the counter and used to calculate sample concentration. In studies 1 and 
2, the insulin in plasma samples was measured in duplicate. If the difference between duplicates 
was greater than 10% CV, the sample was reanalyzed. The fasting level of insulin in the rat is 
generally in a range of 0.5-2.0 ng/ml.      
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APPENDIX B: MUSCLE HOMOGENIZATION 
Muscle homogenization buffer (100ml, pH7.4) 
Reagent Concentration (mM) Amount (g) 
HEPES 20 0.477 
EGTA 2 0.076 
NaF 50 0.209 
KCl 100 0.746 
EDTA 0.2 0.0074 
β-Glycerophosphate 50 1.08 
DTT 1 0.015 
PMSF 0.1 0.00174 
Benzamidine 1 0.0157 
Soduim vanadate 0.5 0.0092 
Add reagents in order to 80ml ddH2O, adjust pH to 7.4, and bring the volume to 100ml 
with stirring on a magnetic plate. 
Homogenization procedure 
1. Weigh approximately 80-100 mg of muscle sample. 
2. Dilute muscle to 1:8 (wt/vol) in homogenization buffer. 
3. Homogenize muscle on ice (3 x 10sec strokes) with a glass tissue grinder pestle at 3,000   
  rpm by an electrically-powered stirrer (Corning Life Sciences, Lowell, MA). 
4. Centrifuge muscle samples at 14,000 g for 10 minutes at 4°C. 
5. Aliquot the supernatant into 1.5ml test tubes and store them at -80°C. 
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APPENDIX C: WESTERN BLOT 
Solutions 
30% Acrylamide and 1% Bisacrylamide Mixture (200ml) 
Add 58g Acrylamide and 2g Bisacrylamide in order to 150ml ddH2O while stirring on a 
magnetic plate, and bring to 200ml volume with ddH2O. Filter this mixed solution through 
Whatman #1 filter paper and stored in a dark bottle due to the high light sensitivity at 4°C. 
1.5M Tris, pH8.8 (500ml) 
Add 90.82g Trisbase to 400ml ddH2O while stirring on a magnetic plate and bring to 
500ml volume with ddH2O. Adjust pH to 8.8 with 12N and 1N HCl. Store it at 4°C. 
1.0M Tris, pH 6.8 (500ml) 
Add 60.57g Trisbase to 400ml ddH2O while stirring on a magnetic plate and bring to 
500ml volume with ddH2O. Adjust pH to 6.8 with 12N and 1N HCl. Store it at 4°C. 
10% SDS (100ml) 
Add 10g SDS to 80ml ddH2O while stirring on a magnetic plate and bring to 100ml 
volume with ddH2O. Filter this solution through Whatman #1 filter paper. 
20% SDS (100ml) 
Add 20g SDS to 80ml ddH2O while stirring on a magnetic plate and bring to 100ml 
volume with ddH2O. Filter this solution through Whatman #1 filter paper. 
10% APS (1ml) 
Add 0.1g APS to 1.5ml test tube with 1ml ddH2O and vortex until dissolve. Make fresh 
daily. 
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10 x Running Buffer (2L) 
Reagent Amount (g) 
Trisbase 60.56 
Glycine 288.4 
SDS 20g 
Add the reagents into 1.5L ddH2O stirring on a magnetic plate and bring to the volume 
with ddH2O 
10x TTBS (2L, pH7.4) 
Reagent Amount 
TrisBase 24.2 g 
NaCl 175.36 g 
Tween 20 12 ml 
Add the reagents into 1.5L ddH2O while stirring on magnetic plate and bring to the 
volume 
Ponceau S.  
Reagent Amount 
Dye-Ponceau S 0.05 g 
Acetic Acid 2.5ml 
Add the reagents into 50ml ddH2O and vortex until dissolve. Recycled to be used later. 
Wet-transfer Buffer (2L for 2 tanks) 
Reagent Amount 
Glycine 28.8g 
Trisbase 6.04g 
Methanol 300ml 
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SDS 0.75g 
Add reagents in order into 1400ml ddH2O while stirring on a magnetic plate. Bring the 
volume into 2L with ddH2O.  
0.25% Bromophenol Bule  
Add 0.0125g Bromophenol Bule into 5ml ddH2O 
Sample buffer (50ml) 
Reagent Amount 
1.25M Tris-HCl (Ph 6.8) 5ml 
Glycerol 10ml 
20% SDS 5ml 
Β-Mercaptoethanol 2.25ml 
0.25% Bromophenol Blue 1.6ml 
Add reagents in the order listed to 20ml ddH2O while stirring on a magnetic plate and 
bring to volume with ddH2O. 
 
Western blot procedure 
1. Preparing resolving gel solution (10% and 15% resolving gel for 2 gels). 
 10% gel 15% gel 
Reagent Amount Amount  
H2O 3.2 ml 1.8 ml 
Acrylanide mix 2.67 ml 4 ml 
1.5M Tris (pH 
8.8) 
2 ml 2 ml 
20% SDS 0.08 ml 0.08 ml 
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10% APS 0.08 ml 0.08 ml 
TEMED 0.008 ml 0.008 ml 
Add all reagents above into 50ml test tube. Then mix them and fill ¾ full caster with 
a glass pipette. Overlay with 300ul butanol. Allow 40 min for gel to polymerize. 
2. After gel polymerization, pour off butanol from the resolving gel and rinse between 
casting plates with ddH2O and dry it with KimWipes. 
3. Preparing stacking gel solution (for 2 gels). 
Reagent Amount 
H2O 3.4 ml 
Acrylanide mix 0.83 ml 
1.0M Tris (pH 6.8) 0.63 ml 
20% SDS 0.05 ml 
10% APS 0.05 ml 
TEMED 0.005 ml 
Add all reagents above into 15ml test tube. Then mix them and fill the caster with 
stacking gel solution then put combs into place. Allow 45 min for stacking gel to 
polymerize. 
4. Preparing samples. 
a. Take the samples out of -80°C and thaw them on ice; 
b. Dilute samples 1:2 with sample buffer in labeled microcentrifuge tubes; 
c. Vortex and place in boiling water (~90-95°C) for 10 min. 
5. Preparing 1 x running buffer. 
Add 100ml 10x running buffer into 900ml ddH2O stirring on a magnetic plate. 
6. After stacking gel has polymerized, carefully remove the combs and assemble gel 
apparatus. Fill inner chamber and outer chamber with 1 x running buffer. 
7. Load 12 ul of standard, 12-20 ul of sample, or 8 ul of molecular weight marker to 
corresponded gel lane.  
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8. Electrophoresis at 100-135 V for 60-90 min or 90 V for 150 min. 
9. After the electrophoresis, prepare for wet-transfer buffer showed as above. 
10. Cut 9 x 6 cm rectangle Nitric Cellular Membrane, label it, and place membrane in wet-
transfer buffer for 5 min on a shaker. 
11. Carefully separate casing plates, cut off stacking gel and place resolving gel in wet-
transfer buffer for 5 min on a shaker. 
12. Soak four of the spongy pads and filter paper (2 for each gel) in the wet-transfer buffer 
for a few minutes.  
13. Making the gel “sandwich”. 
a. Place cassette in a container filled with transfer buffer. Black side down; 
From bottom to top, add a spongy pad, a filter paper, a gel, a NC membrane, another 
filter paper, another spongy pad. Roll out bubbles with wetted glass tube.  
b. Close cassette. Place in transfer apparatus; 
c. Add ice to the small container and place in transfer apparatus as well; 
d. Fill the transfer apparatus with transfer buffer and add the top piece with electrodes to the 
apparatus; 
e. Place transfer apparatus in a larger plastic container and fill the large plastic container 
with ice; 
f. Electrophoresis at 90V for 45 - 90 min. 
14. During the transfer, prepare 1 x TTBS. 
Add 100ml 10 x TTBS into 900ml ddH2O while stirring on a magnetic plate. 
15. Prepare 7% non-fat dry milk (NFDM) - 30ml per membrane. 
Add 4.2g NFDM into a 100ml beaker containing 60ml 1 x TTBS while stirring on a 
magnetic plate.  
16. After the transfer, take out the “sandwich”. Stain each NC membrane with Ponceau S. for 
5 seconds and put membrane into 1 x TTBS on a shaker to wash out Ponceau S. on Membrane. 
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17. Place NC membrane in a container with 7% NFDM and block for 20 min with gentle 
agitation. 
18. During blocking, prepare antibody with 2% NFDM. 10ml per membrane. 
Add 0.4g NFDM into 20ml 1 x TTBS stirring on a magnetic plate. Then add 
appropriate ratio of antibody into 2% NFDM. 
19. After blocking the membrane, wash 5 min in 25ml TTBS. 
20. Incubate membrane with the primary antibody overnight at 4 °C with gentle agitation. 
21. After overnight incubation with the primary antibody, wash membrane 3 x 5 min in 25 ml 
TTBS. 
22. Incubate membrane with species specific secondary antibody for 1 h at room temperature 
with gentle agitation. 
23. After incubation with the secondary antibody, wash membrane 3 x 5 min in 25 ml TTBS. 
24. Visualize protein bands using an ECL detection kit and Bio-Rad ChemiDoc detection 
system according to the manufacturer’s instructions. 
25. Quantify the density of bands using Quantity One Analysis software.     
Membrane stripping and re-probing 
1. Wash membrane in the ddH2O for 5 min. 
2. Add membrane to 0.2N NaOH for 5-7 min. 
3. Wash membrane in the ddH2O for 5 min, followed by another 5 min wash using TTBS. 
4. After washing, membrane can be re-blocked and then re-probed with another antibody. 
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APPENDIX D: LOWRY PROTEIN ASSAY 
        1. Thaw one aliquot of 5mg/ml bovine serum albumin (BSA) stock (-20°C) and 
serially dilute it with deionized water to generate a standard curve as follows.  
   Water (ml) Protein (ml) Protein Conc.(mg/ml) 
 Blank  1.0  0  0 
 A  1.8  0.2 of stock  0.5 
 B  0.2  0.8 of A  0.4 
 C  0.5  0.5 of B  0.2 
 D  0.5  0.5 of C  0.1 
 E  0.5  0.5 of D  0.05 
 F  0.5  0.5 of E  0.025 
Set up duplicate 12x75mm glass assay tubes of each standard. 
 2.  Dilute samples with deionized water in 1:30 ratio. Keep on ice. Set up duplicate glass 
assay tubes for each sample.  
 3.  Make Solution A: add 48 ml of sodium carbonate (20 g/l of 0.1 NaOH) to a 125 ml 
Erlenmeyer flask. Gently layer 1 ml of 2% sodium potassium tartate over the surface of the 
sodium carbonate. Then gently layer 1 ml of 1% cupric sulfate over the sodium potassium tartate. 
Mix Solution A by swirling, then by vigorously vortexing.  
 4. To the duplicate 12x75mm glass assay tubes, add 0.1 ml of standards or samples. Add 
1.0 ml of Solution A to each tube. Next vortex each individual tube. Incubate tubes at room 
temperature for 10 minutes. 
 5. Dilute phenol reagent 1:2 with deionized water. After the tubes have incubated for 10 
minutes, add 0.1 ml of the diluted phenol reagent into each glass tube while vortexing the glass 
tube. Incubate at room temperature for 30 minutes. 
 6. Turn on the spectrophotometer and let the bulb warm up at a wavelength of 750 nm. 
Once the 30 min incubation period is complete, blank the spectrophotometer with the “blank” 
tube. Then read every sample. Use the standard curve to determine protein concentration of the 
samples.  
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APPENDIX E: MUSCLE PROTEIN SYNTHESIS MEASUREMENT  
SUnSET 
 Surface Sensing of Translation (SUnSET) is a non-radioactive technique used in the 
measurement of MPS. Puromycin is a structural analog of aminoacyl-transfer RNA (tRNA). Due 
to its special structure, puromycin can compete with tRNA and be incorporated into the nascent 
polypeptide chain, which then terminates the peptide elongation. Puromycin-labeled peptide can 
be detected using Western blotting and reflect changes in muscle protein synthesis. In our study, 
100 mg puromycin (puromycin-DiHCl: PJ593 Bio Basic, Markham, Ontario, Canada) is 
dissolved in 10 ml phosphate buffered saline (PBS) solution (pH 7.4). 30 min before muscle 
extraction, 0.04µmol/g body weight puromycin is given via intraperitoneal injection. Rats then 
are put back into their respective cages. Around 15 min after puromycin injection, rats are 
anesthetized using a combination of ketamine (80mg/kg) and xylazine (8mg/kg) so to assure that 
rats are unconscious entirely and ready for muscle dissection at exactly 30 min after puromycin 
injection.    
Free Puromycin Measurement 
Free puromycin as a precursor can be delivered to the muscle and incorporated into 
nascent peptide chains. The measurement of free puromycin was used to normalize the value of 
MPS obtained from western blot analysis in the same sample. The analysis was conducted as 
described previously [3] with slight modifications. Approximately, 30 mg of muscle were 
homogenized in ice-cold homogenization buffer at a 1:15 dilution of wet weight muscle with a 
glass tissue grinder pestle (Corning Life Sciences, Lowell, MA; Caframo Stirrer Type RZR1, 
Wiarton, Ont. Canada). A 250µl aliquot sample homogenate was precipitated with 28µl of 100% 
trichloroacetic acid and incubated for 30 min on ice followed by 5 min of centrifuge at 4,200g. 
This was followed by the addition of 15µl of Tris buffer containing 1M Tris, 3M NaCl, and 1% 
Tween 20 at pH 7.0 and 30µl of 5.25M NaOH to 250µl supernatant to adjust the pH to ~9.0 
(8.97-9.03). Next, the samples were filtered through a >3kDa filter (Amicon Ultra-0.5ml; 
Millipore, Carrigtwohill, Ireland) at 14,000g for 60 min. Meanwhile, a range of standards (0-40 
pmol/100µl) were made and adjusted to pH 9.0. A 100µl sample or standard was added to a 96-
 181 
well amine-binding maleic anhydride activated plate (Pierce; Thermo Fisher Scientific) in 
duplicate and rocked overnight at 4ºC. The next day, the plate was washed 4 times using PBS 
with 1% Tween 20 (PBST with pH7.0) and blocked with 1% BSA-PBST for 45 min at room 
temperature. 100µl of anti-puromycin antibody (clone 12D10, 1:38,400) was added to each well 
and incubate for 105 min at RT. Following this incubation period, the wells were washed 3 
times. Next, horseradish peroxidase-conjugated anti-mouse IgG Fc 2a (1:10,000; Millipore) was 
added to each well and incubated for 45 min at RT. After another 4 washes, Ultra 3,3',5,5'-
tetramethylbenzidine (TMB, Thermo Fisher) was added to each well and rocked for 15 min. The 
reaction was then stopped by addition of 0.16 M sulfuric acid (Thermo Fisher). The absorbance 
was measured on a plate reader at a wavelength of 450nm. The concentration of free puromycin 
was calculated from a standard curve.  
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APPENDIX F: DETERMINATION OF FIBER CROSS SECTIONAL AREA  
Tissue freezing 
1. Excise fresh muscle tissue. 
2. Place the distal half part of tissue in the cryo-mold submerging completely in the OCT 
compound. 
3. Drop it immediately into nitrogen-cooled 2-methylbutane for 1 min. 
4. Quickly wrap frozen tissue into a labeled aluminum foil and transfer into a freezer set at -
80°C for later sectioning. 
Tissue sectioning 
1. Set the cryostat “specimen head” temperature to -20°C (Leica cm1900; Leica 
Microsystems Inc., Buffalo Grove, IL). 
2. Transport frozen tissue into the cryostat chamber. 
3. Mount tissue onto “specimen disks” using OCT compound, and insert the disk into 
“specimen head”.  
4. Adjust the blade holder and bring blade close to tissue. 
5. Transversely section frozen tissue into 10µm on a cryostat. 
6. Gently touch glass slide to sectioned tissue 
Hematoxylin and Eosin (H & E) Staining 
Frozen OCT embedded muscle was transversely sectioned into 10µm section on a 
cryostat (Leica cm1900; Leica Microsystems Inc., Buffalo Grove, IL) and mounted on a glass 
slide. Hematoxylin and eosin (H&E) staining (Fisher scientific Inc.) was performed to identify 
fiber CSA and quantify the number of myonuclei. 5 slides were put in a jar filled with Harris 
Hematoxylin for 5 min, followed by rinsing slides using tap water gently until water runs clear. 
Then, slides were put in a jar filled with Eosin for 2 min, followed by rinsing slides gently using 
tap water until water runs clear. Next, slides were rinsed by 70% ethanol, 100% ethanol, and 
xylene for 2-3 seconds, respectively in sequence so that the tissue could be dehydrated and 
hydrophobic. Stained slides were dried in the hood and covered by coverslip. Permount. 
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Hematoxylin stained nucleic acids to a deep blue-purple color, while eosin stained proteins 
nonspecifically with a pink color. Slides were observed with a light microscope (Nikon Diaphot, 
Nikon Corp.; Tokyo, Japan) with a 20x objective lens. Images were then taken using a mounted 
digital camera. Muscle fiber CSA and the number of nuclei were measured and counted using 
Image J software.  
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APPENDIX G: FLOW CHARTS FOR EXPERIMENTS 
Study 1 
Rats (Sprague Dawley rats; N=89) housed in cages  
(2 rats/cage) 
↓ 
One-week acclimation 
↓ 
Repeated sessions of ladder climbing every other day for 3 days without weight 
(12 rats in sedentary groups stayed on the top of ladder for 20 min) 
↓ 
3 practice sessions of climbing separated by 1 day with 50, 60, 70% of their weight, respectively 
Attempt to climb to the top 8 times each practice session with a 2-min rest between climbs 
(12 rats in sedentary groups stayed on the top of ladder for 20 min) 
↓ 
Rats fasted on the testing day for 2 hours 
↓ 
Start experiment 
↓ 
Climb to the top of the ladder 10 times carrying 75% of their body weight with a 2-min rest between climbs 
(12 rats in sedentary groups stayed on the top of ladder for 20 min) 
↓ 
Rats were wrapped in a towel, and the tips of their tails cut and bled 
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↓ 
Blood sampling (0.7 ml) 
↓ 
Rats were gavaged (8 ml/kg) with treatment solutions 
↓ 
Immediately following either the 20 min or 40 min post intubation period, a drop of blood from the tail (0.7 ml) was collected 
↓ 
Rats anesthetized IP (Na pentobarbital, 75 mg/kg) 
↓ 
The Flexor Hallucis Longus (FHL) muscles were surgically excised 
↓ 
Muscle samples were freeze-clamped and stored @ -80 °C until analyzed 
↓ 
Rats were euthanized by cardiac injection of sodium pentobarbital (65 mg/kg body weight), wrapped in paper and stored in the freezer until picked up by the Safety Office. 
Measurements:  
 Blood: glucose, insulin, GH, IGF-1, and lactate  Muscles: p-mTOR, p-p70S6k, p-rpS6, p-Akt, p-FOXO3A, p-AMPK, and p-NF-kB p65 
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Study 2  
After familiarization,  
2-3 month old male Sprague-Dawley rats were fasted overnight (12h) 
↓ 
Climbed to the top of the ladder 10 times carrying 75% of their body weight with a 2-min 
rest between climbs 
(20 rats in sedentary groups stayed on the top of ladder for 20 min) 
↓ 
Blood sampling (0.7 ml) 
↓ 
Rats were gavaged (8 ml/kg) with treatment solutions 
↓ 
0.04µmol/g puromycin was injected via IP 30 min before muscle extraction 
↓ 
Rats anesthetized IP injection with a combination of ketamine (80mg/kg) and xylazine 
(8mg/kg) (15min after injection) 
↓ 
Blood sampling (0.7 ml) 
Excised the flexor hallucis longus (FHL) at 1 or 2 hours after gavage 
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(exacted 30 min after puromycin injection)  
↓ 
Freeze clamped muscle samples and stored @ -80 °C until analyzed 
↓ 
Rats were euthanized by cardiac injection of sodium pentobarbital (65 mg/kg body 
weight). Wrapped in paper and stored in freezer until picked up by the Safety Office. 
Measurements:  
 Blood: glucose, insulin, corticosterone, GH, IGF-1 
 Muscles: MPS, p-mTOR, p-p70S6k, p-rpS6, p-4E-BP1, p-Akt, p-
GSK3α/β, p-eIF2Bɛ, p-FOXO3A and p-AMPK 
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Study 3 
2-3 month old male Sprague-Dawley rats   
↓ 
The day before resistance training started:  
After 3 h (2-5pm) fast, rats were anesthetized IP (a combination of ketamine (70 mg/kg) 
and xylazine (7 mg/kg)) followed by the 1st body composition measurement by DEXA  
↓ 
8 weeks resistance training: every 3 days 
The initial exercise session: Food was deprived 3 h before exercise session  
75% of body weight attached to the tail, +30g, +30g, … until maximal carrying capacity.  
Blood sampling (0.7 ml) 
Intubate different nutritional supplements 
Food was provided 3 h after exercise session 
↓ 
The subsequent training sessions: Food was deprived 3 h before exercise session, 50%, 
75%, 90%, and 100% load of their previous maximal carrying capacity, +30g, +30g,… until 
maximal carrying capacity was determined  
Intubate different nutritional supplementations 
Food was provided 3 h after exercise session 
↓ 
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2nd and 3rd DEXA the day after 9th and 19th exercise session: 
Food was deprived 3 h before exercise session 50%, 75%, 90%, and 100% load of their 
previous maximal carrying capacity, +30g, +30g,… until maximal carrying capacity was 
determined  
Blood sampling (0.7 ml)  
Intubate different nutritional supplementations 
Rats anesthetized IP (a combination of ketamine and xylazine) 3 h after exercise session 
2nd and 3rd body composition measurement by DEXA  
Food was then provided after DEXA 
↓ 
Sacrificing day: 
21 h after the last exercise session, rats were fasted for 3 h 
Rats anesthetized IP injection of a combination of ketamine and xylazine  
The FHL on right side was excised and freeze clamped in liquid nitrogen. Distal half of 
the FHL on left side was embedded in OCT medium 
Rats were euthanized by cardiac injection of sodium pentobarbital (65 mg/kg body 
weight). Wrapped in paper and stored in freezer until picked up by the Safety Office. 
 
 Groups:  ex-PLA, ex-WP, ex-CP, SED   
 Measurements 
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 Blood (24 h after 1st, 10th, and 20th exercise sessions): 
corticosterone 
 Body weight measurement on the exercise day 
 Muscle hypertrophy: 
 Muscle weight in the FHL muscle 
 Body composition: percentage of lean muscle mass and fat 
mass, absolute value of lean and fat mass using DEXA 
 Muscle cross section area (CSA) and mean fiber CSA 
 Total and myofibrillar proteins 
 Muscle strength was determined by maximal carrying capacity 
 The activation of SC 
 Indicators: Pax 7/Myo D/ Myogenin protein expression 
 Hormonal expression in muscle: IGF-1 and myostatin  
 Quantification of myonuclei and myonuclear domain 
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APPENDIX H: RAW DATA FOR STUDY 1 
Study 1 Blood lactate (mM) 20 min 40 min Rat # Group 0 min 20 min Rat # Group 0 min 40 min 2 SED 1.65 1.08 11 SED 1.22 1.64 23 SED 1.30 2.18 21 SED 1.90 1.65 26 SED 1.07 1.45 22 SED 1.40 1.24 37 SED 0.64 0.74 26 SED 1.10 0.91 42 SED 0.98 0.42 35 SED 1.7 1.78 50 SED 0.52 1.00 38 SED 1.03 1.16 15 PLA 4.80 1.27 4 PLA 1.44 1.06 17 PLA 6.56 1.82 12 PLA 4.35 1.55 24 PLA 2.50 1.23 20 PLA 3.94 1.64 29 PLA 3.81 1.38 27 PLA 2.27 1.57 35 PLA 2.78 1.18 28 PLA 3.35 0.88 40 PLA 3.55 1.40 42 PLA 3.21 1.25 44 PLA 2.84 0.94 44 PLA 3.06 1.24 48 PLA 2.58 1.01 45 PLA 1.69 1.38 22 WP 2.18 1.29 13 PLA 2.54 1.24 25 WP 1.58 1.18 20 PLA 1.88 2.28 31 WP 1.56 0.66 6 PLA 3.91 1.10 33 WP 1.41 1.37 7 PLA 2.32 1.46 34 WP 2.84 1.45 13 WP 4.99 1.37 45 WP 2.89 2.64 19 WP 3.92 1.14 46 WP 3.89 1.58 24 WP 3.23 0.91 47 WP 2.43 0.67 29 WP 2.86 1.14 1 LSUS 5.22 1.88 32 WP 1.45 1.05 10 LSUS 3.30 1.82 34 WP 2.34 2.47 18 LSUS 3.15 1.56 46 WP 1.39 1.08 21 LSUS 2.13 0.94 18 WP 1.54 1.25 28 LSUS 2.67 1.31 4 WP 3.40 1.01 36 LSUS 2.87 0.69 19 WP 3.01 1.30 43 LSUS 1.74 0.79 8 WP 2.98 1.25 52 LSUS 2.52 0.58 11 WP 2.95 1.07 9 HSUS 2.95 1.73 3 LSUS 2.83 1.10 16 HSUS 3.39 2.57 10 LSUS 5.04 1.37 27 HSUS 2.06 1.97 14 LSUS 2.28 0.75 30 HSUS 1.66 0.84 16 LSUS 3.41 1.98 32 HSUS 2.68 1.16 17 LSUS 2.33 1.79 38 HSUS 3.38 1.68 30 LSUS 3.05 0.99 39 HSUS 2.48 1.04 39 LSUS 2.32 0.97 41 HSUS 2.86 1.73 41 LSUS 3.21 1.1 8 HSUS 2.28 1.86 9 HSUS 3.18 1.28 15 HSUS 2.06 1.24 23 HSUS 2.35 1.39 25 HSUS 2.29 1.51 31 HSUS 1.83 1.25 33 HSUS 4.20 2.01 40 HSUS 2.65 1.77 3 HSUS 2.21 1.10 14 HSUS 2.59 1.32 5 HSUS 3.18 1.29 12 HSUS 2.24 1.03   
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Study 1 Plasma glucose (mM) 20 min 40 min Rat # Group 0 min 20 min Rat # Group 0 min 40 min 2 SED 5.18 4.58 11 SED 6.87 6.50 23 SED 6.37 6.87 21 SED 6.72 6.57 26 SED 5.99 5.62 22 SED 8.41 7.32 37 SED 5.39 5.69 26 SED 6.62 6.54 42 SED 5.89 4.84 35 SED 6.96 6.13 50 SED 4.53 4.67 38 SED 5.55 5.78 15 PLA 6.40 5.17 4 PLA 7.65 6.34 17 PLA 6.32 5.82 12 PLA 6.02 5.52 24 PLA 5.18 4.80 20 PLA 7.49 5.97 29 PLA 6.61 5.80 27 PLA 6.66 5.53 35 PLA 5.85 5.05 28 PLA 9.01 7.28 40 PLA 5.91 6.22 42 PLA 6.40 5.38 44 PLA 5.67 6.23 44 PLA 7.13 6.27 48 PLA 9.48 8.66 45 PLA 7.14 5.62 22 WP 7.44 5.04 13 PLA 6.98 5.51 25 WP 5.91 5.53 20 PLA 5.37 4.55 31 WP 7.26 5.59 6 PLA 5.26 5.07 33 WP 7.18 5.25 7 PLA 6.80 5.16 34 WP 4.56 4.34 13 WP 5.85 5.37 45 WP 4.72 5.51 19 WP 7.74 6.52 46 WP 5.76 5.50 24 WP 6.40 5.52 47 WP 5.06 4.37 29 WP 7.68 6.17 1 LSUS 6.78 6.18 32 WP 7.50 5.82 10 LSUS 5.06 4.78 34 WP 5.28 4.81 18 LSUS 5.28 4.89 46 WP 7.83 6.32 21 LSUS 8.39 7.98 18 WP 6.91 5.51 28 LSUS 4.85 5.45 4 WP 5.68 6.57 36 LSUS 5.15 5.31 19 WP 5.86 3.66 43 LSUS 5.69 5.16 8 WP 5.71 4.25 52 LSUS 6.32 6.27 11 WP 7.76 4.28 9 HSUS 5.67 4.64 3 LSUS 5.88 4.85 16 HSUS 5.18 5.72 10 LSUS 7.57 6.73 27 HSUS 7.21 6.65 14 LSUS 7.18 6.75 30 HSUS 6.75 6.96 16 LSUS 6.16 5.28 32 HSUS 5.91 5.65 17 LSUS 8.04 6.52 38 HSUS 6.04 5.71 30 LSUS 6.13 5.23 39 HSUS 6.21 7.05 39 LSUS 6.36 5.32 41 HSUS 4.99 5.07 41 LSUS 7.02 6.42 8 HSUS 8.30 6.63 9 HSUS 5.28 5.96 15 HSUS 7.43 6.38 23 HSUS 8.54 6.40 25 HSUS 7.63 6.57 31 HSUS 6.38 6.10 33 HSUS 6.32 6.66 40 HSUS 5.83 6.23 3 HSUS 5.69 6.05 14 HSUS 5.24 5.62 5 HSUS 6.56 5.60 12 HSUS 5.22 5.37  
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Study 1 Plasma insulin (pM) 20 min 40 min Rat # Group 0 min 20 min Rat # Group 0 min 40 min 2 SED 229.34 322.66 11 SED 469.01 475.90 23 SED 361.23 877.75 21 SED 251.03 261.71 26 SED 344.01 775.14 22 SED 483.13 427.34 37 SED 360.88 537.88 26 SED 349.52 264.46 42 SED 128.79 218.32 35 SED 598.48 361.57 50 SED 185.26 257.58 38 SED 311.98 395.66 15 PLA 683.20 625.69 4 PLA 185.61 342.63 17 PLA 305.79 259.99 12 PLA 129.82 119.49 24 PLA 204.89 258.61 20 PLA 329.20 603.99 29 PLA 230.03 404.96 27 PLA 136.71 177.00 35 PLA 229.68 253.44 28 PLA 466.94 449.72 40 PLA 374.66 625.69 42 PLA 199.72 278.24 44 PLA 164.26 269.28 44 PLA 466.25 391.18 48 PLA 259.30 460.74 45 PLA 245.52 240.70 22 WP 663.22 595.39 13 PLA 271.35 342.98 25 WP 505.85 527.20 20 PLA 270.66 356.06 31 WP 365.01 669.77 6 PLA 169.08 269.28 33 WP 196.28 205.23 7 PLA 213.50 623.62 34 WP 166.67 141.53 13 WP 315.08 207.99 45 WP 196.63 322.31 19 WP 403.93 346.42 46 WP 246.56 558.20 24 WP 272.38 282.71 47 WP 162.88 329.89 29 WP 210.06 130.51 1 LSUS 142.22 143.25 32 WP 429.06 342.29 10 LSUS 376.72 237.95 34 WP 82.99 131.20 18 LSUS 303.72 158.40 46 WP 180.44 171.49 21 LSUS 424.59 326.79 18 WP 307.85 300.96 28 LSUS 126.03 140.15 4 WP 165.29 127.75 36 LSUS 262.40 187.33 19 WP 199.04 178.37 43 LSUS 246.56 200.07 8 WP 194.90 412.19 52 LSUS 163.91 367.08 11 WP 606.75 81.27 9 HSUS 190.08 326.79 3 LSUS 92.98 140.15 16 HSUS 347.45 625.69 10 LSUS 371.21 194.90 27 HSUS 250.34 315.77 14 LSUS 286.16 336.09 30 HSUS 206.27 407.37 16 LSUS 245.87 192.49 32 HSUS 359.85 324.38 17 LSUS 192.84 128.10 38 HSUS 305.79 261.36 30 LSUS 357.09 219.70 39 HSUS 388.43 322.31 39 LSUS 298.55 182.16 41 HSUS 140.15 268.60 41 LSUS 302.00 330.92 8 HSUS 453.17 325.07 9 HSUS 275.48 350.90 15 HSUS 270.66 325.41 23 HSUS 809.23 348.83 25 HSUS 298.21 280.30 31 HSUS 118.11 194.56 33 HSUS 287.53 265.15 40 HSUS 57.51 205.23 3 HSUS 131.20 78.86 14 HSUS 326.79 430.10 5 HSUS 158.06 235.54 12 HSUS 154.96 342.98  
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Study 1 Plasma growth hormone (ng/ml) 20 min 40 min Rat # Group 0 min 20 min Rat # Group 0 min 40 min 2 SED 2.96 3.61 11 SED 7.42 2.51 23 SED 1.62 1.14 21 SED 16.86 1.86 26 SED 38.70 6.18 22 SED 10.85 2.33 37 SED 14.99 29.29 26 SED 3.07 1.10 42 SED 28.88 16.47 35 SED 40.10 21.04 50 SED 1.82 1.03 38 SED 10.67 1.54 15 PLA 1.41 0.82 4 PLA 1.71 1.17 17 PLA 8.89 3.52 12 PLA 1.11 2.84 24 PLA 2.07 1.01 20 PLA 4.84 2.13 29 PLA 9.03 4.48 27 PLA 1.78 17.45 35 PLA 0.63 24.70 28 PLA 0.66 17.26 40 PLA 1.88 1.46 42 PLA 8.18 3.19 44 PLA 6.12 35.31 44 PLA 0.67 9.25 48 PLA 3.37 1.90 45 PLA 0.63 50.37 22 WP 7.80 3.43 13 PLA 0.88 0.8 25 WP 2.48 1.39 20 PLA 3.31 1.19 31 WP 4.08 2.15 6 PLA 8.08 2.64 33 WP 0.59 73.72 7 PLA 0.84 0.4 34 WP 5.91 19.10 13 WP 2.45 1.05 45 WP 0.94 0.49 19 WP 0.73 9.85 46 WP 0.56 1.22 24 WP 2.93 1.41 47 WP 2.88 1.65 29 WP 4.42 1.96 1 LSUS 1.06 1.44 32 WP 5.29 1.62 10 LSUS 0.55 6.78 34 WP 1.90 2.40 18 LSUS 0.19 1.10 46 WP 1.19 1.17 21 LSUS 0.29 1.20 18 WP 4.21 1.29 28 LSUS 6.42 3.07 4 WP 2.96 0.79 36 LSUS 1.15 0.80 19 WP 0.71 6.89 43 LSUS 0.44 1.07 8 WP 1.92 0.96 52 LSUS 16.46 6.77 11 WP 0.77 87.12 9 HSUS 1.18 0.78 3 LSUS 1.90 1.36 16 HSUS 3.52 1.53 10 LSUS 1.63 1.11 27 HSUS 3.57 2.98 14 LSUS 2.08 3.21 30 HSUS 0.91 32.93 16 LSUS 0.72 13.37 32 HSUS 7.08 0.88 17 LSUS 1.95 1.22 38 HSUS 1.39 0.75 30 LSUS 0.93 0.82 39 HSUS 3.11 1.90 39 LSUS 1.86 1.54 41 HSUS 39.21 36.22 41 LSUS 2.29 1.19 8 HSUS 0.90 42.55 9 HSUS 1.22 4.35 15 HSUS 0.82 66.20 23 HSUS 3.80 1.42 25 HSUS 0.87 12.00 31 HSUS 2.25 1.03 33 HSUS 1.43 47.63 40 HSUS 14.56 4.22 3 HSUS 0.69 0.38 14 HSUS 1.23 5.71 5 HSUS 2.35 1.24 12 HSUS 0.56 49.51    
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Study 1 Plasma IGF-1 (ng/ml) 20 min 40 min Rat # Group 0 min 20 min Rat # Group 0 min 40 min 2 SED 740.01 772.34 11 SED 969.03 957.41 23 SED 959.78 1085.56 21 SED 1301.33 1432.04 26 SED 902.36 916.32 22 SED 980.71 1032.36 37 SED 1291.33 1351.13 26 SED 1355.89 1077.36 42 SED 934.88 788.58 35 SED 999.47 1087.73 50 SED 1265.14 836.17 38 SED 1162.68 976.77 15 PLA 852.25 832.93 4 PLA 986.57 895.06 17 PLA 952.64 951.63 12 PLA 1047.64 957.94 24 PLA 1156.47 1249.84 20 PLA 939.05 933.31 29 PLA 1219.12 1114.78 27 PLA 782.61 973.00 35 PLA 852.29 838.26 28 PLA 1180.72 1467.31 40 PLA 981.51 1123.33 42 PLA 964.40 1084.40 44 PLA 1052.91 852.29 44 PLA 1191.00 1099.38 48 PLA 1101.20 941.48 45 PLA 1115.54 1099.94 22 WP 910.33 982.34 13 PLA 801.20 799.51 25 WP 1033.39 1165.33 20 PLA 1317.44 1435.64 31 WP 986.46 958.76 6 PLA 708.36 937.08 33 WP 1575.59 1530.21 7 PLA 1143.54 1180.29 34 WP 931.95 896.41 13 WP 1010.17 826.51 45 WP 1008.60 987.50 19 WP 1384.15 1123.18 46 WP 1013.90 1277.72 24 WP 1113.86 1071.68 47 WP 1076.16 1297.96 29 WP 994.60 986.48 1 LSUS 947.56 976.16 32 WP 1116.09 1307.35 10 LSUS 895.41 918.32 34 WP 1130.07 1179.65 18 LSUS 1102.83 1204.44 46 WP 946.90 1014.48 21 LSUS 1247.56 1408.51 18 WP 1411.39 1603.68 28 LSUS 965.86 909.40 4 WP 1006.30 935.61 36 LSUS 839.66 1024.55 19 WP 827.70 921.01 43 LSUS 917.37 882.07 8 WP 1060.08 1559.28 52 LSUS 1349.18 1582.35 11 WP 1146.62 1280.24 9 HSUS 743.68 794.84 3 LSUS 1063.00 988.18 16 HSUS 933.40 1154.25 10 LSUS 1119.80 1354.05 27 HSUS 1182.02 1207.82 14 LSUS 1050.92 1053.66 30 HSUS 1465.72 1528.96 16 LSUS 1057.91 964.40 32 HSUS 974.04 779.07 17 LSUS 1084.01 964.80 38 HSUS 857.22 742.17 30 LSUS 1013.59 1071.68 39 HSUS 1057.54 1065.28 39 LSUS 1208.66 1171.73 41 HSUS 1124.91 1248.46 41 LSUS 1140.17 1189.87 8 HSUS 890.46 897.11 9 HSUS 963.22 822.05 15 HSUS 933.83 970.09 23 HSUS 1491.47 1335.77 25 HSUS 957.42 1055.71 31 HSUS 1099.94 1116.09 33 HSUS 1004.90 1067.82 40 HSUS 1142.97 1419.03 3 HSUS 978.80 1136.05 14 HSUS 922.03 1186.78 5 HSUS 1086.32 1161.70 12 HSUS 1096.15 1175.43 
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Study 1 Western blot results at 20 min (% of standard) Rat # Group p-FOXO3A p-AMPK p-NFkB p65 p-Akt p-mTOR p-p70S6k p-rpS6 α-tubulin 2 SED 40.10 81.80 17.60 79.00 88.80 5.00 19.20 214.40 23 SED 222.10 64.50 48.00 65.40 100.10 8.20 60.30 247.10 26 SED 155.20 70.20 26.90 66.30 56.70 5.70 39.40 282.70 37 SED 223.40 43.30 27.40 37.20 59.60 0.60 36.10 338.20 42 SED 197.10 112.10 53.30 45.00 98.90 7.70 53.60 242.70 50 SED 241.90 31.10 28.70 26.20 55.90 1.60 24.50 402.60 15 PLA 338.80 32.80 56.90 56.50 167.90 8.20 92.60 337.60 17 PLA 320.10 35.50 57.90 27.00 41.70 3.60 73.80 318.90 24 PLA 240.90 26.00 23.60 14.20 53.50 3.60 70.00 211.10 29 PLA 219.70 42.40 45.90 28.10 90.50 9.60 75.10 318.90 35 PLA 243.30 43.40 23.40 32.10 93.70 3.60 67.40 292.00 40 PLA 182.30 107.20 25.30 26.00 62.40 12.70 72.50 352.60 44 PLA 279.10 60.30 28.30 30.10 79.20 10.90 62.40 249.30 48 PLA 127.50 29.00 60.60 22.60 52.70 5.50 49.80 214.30 22 WP 328.70 27.90 37.30 32.60 206.60 23.20 85.70 309.60 25 WP 264.10 58.80 59.40 26.80 106.70 38.50 79.90 317.50 31 WP 203.70 91.50 59.00 42.70 131.40 45.00 76.30 308.00 33 WP 229.90 27.10 40.30 13.10 105.20 12.40 87.60 225.80 34 WP 422.60 27.00 42.70 16.50 94.40 10.10 97.30 352.80 45 WP 293.70 26.30 43.20 33.00 144.60 23.70 116.50 383.50 46 WP 193.20 201.50 31.00 27.40 113.50 20.60 86.00 211.20 47 WP 332.40 24.80 30.00 17.50 137.70 10.30 78.70 289.20 1 LSUS 377.60 1.70 26.50 8.20 104.50 5.20 76.00 359.10 10 LSUS 365.30 17.00 27.10 24.20 75.80 2.10 52.40 282.70 18 LSUS 213.20 17.40 40.20 22.30 56.70 2.80 42.70 347.20 21 LSUS 279.10 14.70 18.20 18.10 39.60 3.40 42.70 246.50 28 LSUS 407.60 9.50 26.90 20.40 118.50 3.10 46.60 384.80 36 LSUS 323.60 8.70 18.10 13.10 69.40 4.10 62.10 353.60 43 LSUS 260.30 17.50 13.50 14.40 96.80 3.70 74.30 300.20 52 LSUS 277.60 3.30 14.30 24.60 41.60 1.90 49.90 278.50 9 HSUS 332.50 4.40 23.80 14.90 62.90 9.90 73.10 300.80 16 HSUS 376.90 10.70 24.40 21.20 134.00 2.00 78.50 412.10 27 HSUS 204.10 16.20 23.90 25.20 104.00 2.20 60.70 253.80 30 HSUS 376.70 11.90 23.80 21.40 95.50 4.10 52.00 391.10 32 HSUS 318.60 21.60 16.40 18.00 112.40 3.80 94.50 326.40 38 HSUS 252.20 9.20 11.30 38.90 90.50 5.20 76.80 304.90 39 HSUS 275.70 8.70 12.00 21.10 68.30 5.30 78.90 241.80 41 HSUS 229.30 8.40 14.40 19.20 65.70 5.10 63.80 202.60 
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Study 1 Western blot results at 40 min (% of standard) Rat # Group p-FOXO3A p-AMPK p-NFkB p65 p-Akt p-mTOR p-p70S6k p-rpS6 α-tubulin 11 SED 304.29 300.55 122.32 21.60 64.90 30.57 66.16 178.81 21 SED 207.63 161.25 91.31 45.34 28.14 25.66 57.39 243.99 22 SED 249.84 277.66 124.00 42.03 62.73 78.53 67.30 199.24 26 SED 261.52 257.26 50.04 41.56 50.55 8.43 22.64 237.02 35 SED 314.42 232.92 91.40 66.41 27.95 9.69 38.00 244.13 38 SED 193.72 272.12 99.91 37.01 65.72 22.15 32.81 204.52 4 PLA 302.31 165.78 172.01 30.09 131.09 86.70 80.88 263.86 12 PLA 239.74 91.10 96.41 27.33 87.26 36.29 89.00 196.56 20 PLA 296.98 258.79 108.81 29.71 64.61 57.88 94.43 224.45 27 PLA 344.71 228.96 108.38 54.72 84.43 76.74 61.01 267.76 28 PLA 310.28 198.31 69.88 28.63 48.60 45.92 92.80 232.05 42 PLA 289.35 148.89 101.61 25.87 114.20 59.23 85.18 189.00 44 PLA 202.69 508.40 55.14 31.17 70.19 23.68 53.89 166.73 45 PLA 238.92 201.12 177.19 58.14 78.00 30.70 84.61 190.01 13 PLA 332.40 195.70 142.10 28.70 89.80 54.00 111.70 217.00 20 PLA 290.70 159.00 122.40 34.60 117.60 19.00 71.70 256.90 6 PLA 278.80 262.90 152.70 16.80 183.40 34.20 98.90 232.50 7 PLA 299.40 264.60 100.20 21.30 127.60 28.30 72.40 220.40 13 WP 313.31 164.50 109.07 24.69 83.45 54.00 69.74 213.89 19 WP 303.74 186.12 100.11 22.11 67.48 55.70 87.59 207.91 24 WP 225.55 193.66 116.18 15.05 54.60 89.40 78.67 197.70 29 WP 279.62 247.84 90.41 34.69 105.76 114.03 83.78 263.87 32 WP 352.07 261.02 195.55 46.84 76.39 178.04 86.06 217.12 34 WP 228.17 160.97 100.53 13.92 89.30 59.50 74.42 163.96 46 WP 227.22 189.80 81.76 33.04 128.87 90.42 78.34 194.99 18 WP 370.30 170.10 135.30 18.50 171.00 53.70 113.90 249.50 4 WP 519.30 197.00 164.60 19.30 117.60 64.60 117.60 325.90 19 WP 319.90 245.00 106.00 20.90 152.90 137.10 120.30 237.90 8 WP 442.20 191.70 99.60 27.80 204.80 95.30 116.00 218.00 11 WP 215.57 283.10 76.79 37.09 189.36 87.11 68.79 165.17 3 LSUS 294.53 128.79 125.09 25.49 67.07 79.60 75.85 222.92 10 LSUS 198.60 300.66 89.48 23.15 72.21 54.06 80.63 151.25 14 LSUS 466.80 583.55 87.75 27.27 30.80 39.60 63.37 287.29 16 LSUS 340.07 105.00 77.64 18.26 30.67 70.64 94.64 154.37 17 LSUS 258.95 115.39 123.55 28.72 55.96 88.20 82.94 174.87 30 LSUS 230.06 301.24 86.49 23.48 67.84 56.11 89.37 176.37 
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39 LSUS 201.11 147.20 74.72 25.88 83.84 88.72 77.24 170.60 41 LSUS 245.89 194.42 235.73 44.43 75.18 38.50 84.16 249.12 8 HSUS 297.29 162.80 155.84 38.21 54.84 88.89 82.39 297.00 9 HSUS 241.91 137.25 88.23 25.97 52.85 35.40 73.98 234.87 15 HSUS 369.40 274.18 103.37 26.22 89.98 123.01 59.17 242.50 23 HSUS 341.32 195.17 140.04 35.70 53.02 76.88 78.86 204.75 25 HSUS 298.80 198.56 141.10 42.76 129.27 97.52 83.74 212.84 31 HSUS 251.25 278.23 109.93 28.80 109.14 72.03 97.92 182.33 33 HSUS 209.11 374.90 76.90 23.13 89.61 67.33 83.74 203.64 40 HSUS 165.73 171.85 110.80 63.10 71.40 11.30 61.47 170.74 3 HSUS 320.10 166.90 136.10 17.60 160.80 44.90 110.50 297.90 14 HSUS 455.70 264.60 129.20 27.70 193.20 56.50 101.20 205.00 5 HSUS 381.50 297.70 147.80 33.20 155.90 54.20 75.20 277.10 12 HSUS 271.20 236.20 103.20 18.60 83.60 21.20 61.00 194.60 
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APPENDIX I: RAW DATA FOR STUDY 2 
Study 2 Plasma glucose (mM) 
1 h 2 h 
Rat # Group 0 h 1 h Rat # Group 0 h 2 h 
1 SED 5.83 6.10 17 SED 6.46 6.87 
8 SED 5.06 5.23 19 SED 5.53 6.41 
12 SED 6.79 5.67 47 SED 5.14 5.01 
52 SED 4.93 5.40 51 SED 4.43 5.35 
57 SED 5.72 5.83 55 SED 4.44 5.41 
73 SED 5.34 5.56 60 SED 5.05 4.08 
74 SED 5.71 5.93 69 SED 4.69 4.75 
2 PLA 7.06 5.79 24 PLA 5.01 4.78 
7 PLA 6.37 6.35 32 PLA 5.12 5.03 
34 PLA 6.72 6.05 41 PLA 6.44 5.43 
37 PLA 5.94 5.92 66 PLA 5.64 4.85 
50 PLA 5.38 4.46 67 PLA 5.79 4.75 
54 PLA 4.85 4.77 70 PLA 4.99 3.19 
68 PLA 6.11 6.05 71 PLA 5.48 4.96 
30 WP 5.38 5.11 21 WP 6.58 5.03 
43 WP 5.37 3.97 28 WP 6.35 4.64 
46 WP 5.03 5.12 44 WP 5.22 4.27 
49 WP 5.81 5.27 45 WP 4.48 3.76 
53 WP 7.04 5.96 61 WP 5.06 3.04 
56 WP 5.68 5.04 63 WP 6.27 4.06 
64 WP 6.64 5.31 65 WP 5.36 4.72 
3 CP 6.24 5.12 13 CP 4.34 5.74 
4 CP 6.35 5.72 15 CP 6.72 6.53 
33 CP 7.24 6.52 29 CP 6.11 6.25 
38 CP 5.37 5.55 35 CP 5.07 6.36 
42 CP 5.30 5.95 48 CP 6.63 4.43 
59 CP 5.20 7.03 58 CP 5.79 5.39 
62 CP 6.60 6.42 72 CP 5.31 5.12            
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Study 2 Plasma insulin (pM) 
1 h 2 h 
Rat # Group 0 h 1 h Rat # Group 0 h 2 h 
1 SED 266.53 381.54 17 SED 347.11 384.30 
8 SED 131.89 298.90 19 SED 240.01 297.86 
12 SED 172.66 274.62 47 SED 179.75 280.99 
52 SED 326.10 357.44 51 SED 264.12 157.02 
57 SED 174.24 200.76 55 SED 134.30 139.81 
73 SED 184.92 403.58 60 SED 281.34 328.17 
74 SED 355.72 375.00 69 SED 146.01 276.86 
2 PLA 139.19 148.07 24 PLA 165.29 312.67 
7 PLA 182.51 122.59 32 PLA 201.10 173.90 
34 PLA 159.78 327.82 41 PLA 291.32 203.51 
37 PLA 261.71 268.60 66 PLA 231.40 266.18 
50 PLA 166.67 263.09 67 PLA 241.74 480.72 
54 PLA 173.55 156.34 70 PLA 152.89 160.12 
68 PLA 215.56 295.45 71 PLA 210.74 191.46 
30 WP 279.61 297.52 21 WP 316.80 289.94 
43 WP 190.77 121.90 28 WP 298.90 322.18 
46 WP 225.21 297.52 44 WP 376.03 292.01 
49 WP 355.37 181.82 45 WP 190.77 139.81 
53 WP 210.74 269.28 61 WP 217.63 347.11 
56 WP 141.18 180.44 63 WP 471.07 252.07 
64 WP 270.66 365.01 65 WP 303.03 322.18 
3 CP 154.96 389.46 13 CP 128.44 336.78 
4 CP 197.31 239.67 15 CP 247.93 456.61 
33 CP 914.26 576.45 29 CP 217.63 128.10 
38 CP 146.01 250.00 35 CP 139.81 328.51 
42 CP 232.78 469.70 48 CP 303.37 326.45 
59 CP 164.60 618.46 58 CP 305.79 385.67 
62 CP 362.26 417.36 72 CP 203.17 282.37            
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Study 2 Plasma growth hormone (ng/ml) 
1 h 2 h 
Rat # Group 0 h 1 h Rat # Group 0 h 2 h 
1 SED 2.21 7.63 17 SED 0.54 3.92 
8 SED 27.51 2.57 19 SED 0.54 5.74 
12 SED 0.92 19.88 47 SED 31.86 1.74 
52 SED 5.40 1.62 51 SED 2.16 1.84 
57 SED 0.74 11.32 55 SED 22.64 5.09 
73 SED 13.11 1.99 60 SED 5.13 6.47 
74 SED 5.20 0.79 69 SED 16.56 2.44 
2 PLA 0.82 1.66 24 PLA 1.95 4.13 
7 PLA 0.43 3.13 32 PLA 0.51 4.92 
34 PLA 0.57 6.18 41 PLA 1.11 2.58 
37 PLA 2.42 3.06 66 PLA 0.06 12.28 
50 PLA 0.03 1.43 67 PLA 0.05 6.87 
54 PLA 0.05 10.00 70 PLA 1.47 20.43 
68 PLA 0.02 1.37 71 PLA 1.68 1.30 
30 WP 0.56 1.58 21 WP 1.30 2.43 
43 WP 0.53 1.63 28 WP 7.94 29.63 
46 WP 0.99 55.48 44 WP 1.29 3.33 
49 WP 0.78 0.80 45 WP 1.98 8.95 
53 WP 0.89 1.77 61 WP 2.18 1.40 
56 WP 0.86 3.42 63 WP 1.07 1.43 
64 WP 0.02 1.38 65 WP 0.05 2.72 
3 CP 3.82 10.33 13 CP 0.73 1.21 
4 CP 6.44 6.40 15 CP 0.70 4.11 
33 CP 0.54 0.21 29 CP 0.80 0.31 
38 CP 5.57 42.65 35 CP 1.24 0.58 
42 CP 0.27 7.16 48 CP 0.02 6.48 
59 CP 1.87 0.94 58 CP 0.84 1.45 
62 CP 2.77 0.73 72 CP 0.03 1.55            
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Study 2 Plasma IGF-1 (ng/ml) 
1 h 2 h 
Rat # Group 0 h 1 h Rat # Group 0 h 2 h 
1 SED 1024.36 796.63 17 SED 871.01 649.25 
8 SED 809.64 983.56 19 SED 840.06 761.12 
12 SED 885.67 965.66 47 SED 940.99 931.29 
52 SED 841.71 668.32 51 SED 629.09 492.43 
57 SED 643.96 678.90 55 SED 669.50 723.41 
73 SED 809.34 717.13 60 SED 740.77 709.65 
74 SED 875.72 953.82 69 SED 840.64 796.72 
2 PLA 1117.91 725.44 24 PLA 1184.06 985.04 
7 PLA 775.18 861.67 32 PLA 987.98 744.62 
34 PLA 811.69 739.46 41 PLA 925.93 772.87 
37 PLA 661.32 482.33 66 PLA 705.07 889.95 
50 PLA 887.99 736.62 67 PLA 645.11 641.66 
54 PLA 668.32 536.95 70 PLA 746.01 651.75 
68 PLA 956.77 760.53 71 PLA 735.54 721.24 
30 WP 839.25 720.68 21 WP 782.73 712.14 
43 WP 761.12 651.97 28 WP 829.86 850.31 
46 WP 921.62 800.79 44 WP 828.67 927.00 
49 WP 735.39 545.43 45 WP 614.38 588.76 
53 WP 599.84 569.07 61 WP 677.72 695.50 
56 WP 757.59 797.84 63 WP 794.02 727.72 
64 WP 802.15 656.70 65 WP 708.37 602.09 
3 CP 717.83 618.84 13 CP 1004.61 843.42 
4 CP 1053.12 819.72 15 CP 931.29 912.93 
33 CP 1004.61 843.42 29 CP 649.29 644.37 
38 CP 688.36 519.14 35 CP 538.01 446.79 
42 CP 642.81 518.10 48 CP 729.28 615.51 
59 CP 758.84 594.29 58 CP 735.54 667.88 
62 CP 1097.30 819.92 72 CP 779.20 769.84            
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Study 2 Plasma corticosterone (ng/ml) 
1 h 2 h 
Rat # Group 0 h 1 h Rat # Group 0 h 2 h 
1 SED 174.83 187.82 17 SED 130.32 99.97 
8 SED 50.39 119.19 19 SED 150.02 93.30 
12 SED 71.42 161.57 47 SED 138.26 102.75 
52 SED 198.89 162.78 51 SED 243.02 99.00 
57 SED 135.79 159.92 55 SED 131.62 83.78 
73 SED 70.03 96.38 60 SED 158.68 218.38 
74 SED 212.10 213.68 69 SED 162.34 124.25 
2 PLA 239.63 173.58 24 PLA 236.22 120.44 
7 PLA 248.49 167.68 32 PLA 187.43 63.43 
34 PLA 229.01 136.22 41 PLA 349.60 131.26 
37 PLA 181.14 111.76 66 PLA 216.68 112.63 
50 PLA 322.37 192.79 67 PLA 362.32 195.82 
54 PLA 322.37 203.59 70 PLA 324.89 130.60 
68 PLA 231.87 201.35 71 PLA 341.17 137.86 
30 WP 307.94 210.63 21 WP 294.98 128.47 
43 WP 167.68 153.40 28 WP 190.23 93.99 
46 WP 140.32 49.65 44 WP 246.65 63.90 
49 WP 382.63 200.45 45 WP 189.81 55.87 
53 WP 348.48 243.54 61 WP 218.38 227.05 
56 WP 289.06 194.30 63 WP 164.76 104.74 
64 WP 184.18 81.97 65 WP 244.24 138.89 
3 CP 154.78 183.82 13 CP 138.26 53.47 
4 CP 194.51 172.74 15 CP 118.31 50.77 
33 CP 239.44 198.89 29 CP 206.41 139.29 
38 CP 234.24 134.73 35 CP 307.65 174.22 
42 CP 351.21 255.19 48 CP 464.89 163.70 
59 CP 121.51 97.24 58 CP 271.00 99.43 
62 CP 202.85 46.96 72 CP 181.47 152.97             
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Study 2 Western blot results at 1 h 
Rat # Group Puromycin labeled peptide Free puromycin Protein synthesis 
% of standard (pmol/mg protein) (PLP/free puromycin) 
1 SED 131.00 4.40 29.76 
8 SED 100.00 6.02 16.61 
12 SED 113.60 2.27 50.01 
52 SED 207.10 14.44 14.35 
57 SED 229.90 5.12 44.89 
73 SED 106.80 7.47 14.30 
74 SED 178.40 7.10 25.13 
77 SED 138.20 7.91 17.47 
82 SED 110.50 8.55 12.92 
88 SED 174.30 7.70 22.64 
2 PLA 58.50 7.44 7.86 
7 PLA 77.40 7.35 10.53 
34 PLA 70.00 2.85 24.52 
37 PLA 101.00 4.10 24.64 
50 PLA 165.00 6.21 26.58 
54 PLA 67.20 8.19 8.21 
68 PLA 166.20 6.94 23.95 
78 PLA 76.10 8.36 9.10 
91 PLA 87.80 9.86 8.90 
97 PLA 72.50 8.14 8.91 
30 WP 208.10 10.50 19.82 
43 WP 87.40 6.48 13.49 
46 WP 183.10 10.87 16.84 
49 WP 134.72 7.16 18.82 
53 WP 134.80 7.42 18.18 
56 WP 209.10 4.92 42.52 
64 WP 83.30 3.74 22.25 
80 WP 99.10 6.94 14.28 
93 WP 80.80 6.37 12.68 
94 WP 126.80 7.23 17.54 
3 CP 177.20 3.36 52.74 
4 CP 118.10 6.89 17.14 
33 CP 203.10 6.64 30.59 
38 CP 307.10 9.36 32.80 
42 CP 172.00 8.32 20.66 
59 CP 108.00 6.18 17.48 
62 CP 204.90 4.24 48.28 
79 CP 81.60 6.12 13.33 
90 CP 145.20 4.06 35.76 
96 CP 157.50 6.61 23.83   
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Study 2 Western blot results at 1 h 
Rat # Group p-4E-BP1 polyclonol p-mTOR p-p70S6k p-rpS6 
(% of γ isoform) (% of standard) 
1 SED 33.60 32.00 112.35 80.50 
8 SED 41.10 48.50 155.56 47.10 
12 SED 37.70 53.70 172.84 40.90 
52 SED 39.50 34.90 86.42 72.70 
57 SED 34.10 13.50 86.42 22.50 
73 SED 27.20 13.50 51.85 24.40 
74 SED 41.60 30.70 34.57 47.60 
77 SED 33.56 52.92 70.46 102.62 
82 SED 32.43 26.60 81.25 99.18 
88 SED 34.90 32.00 148.29 151.96 
2 PLA 14.90 63.40 185.80 99.30 
7 PLA 25.80 50.60 341.36 106.40 
34 PLA 26.00 43.10 146.91 97.00 
37 PLA 39.40 32.70 151.23 88.60 
50 PLA 22.60 51.00 272.22 175.70 
54 PLA 18.20 24.20 237.65 91.90 
68 PLA 41.00 18.90 207.41 93.80 
78 PLA 21.34 37.69 126.54 121.66 
91 PLA 20.29 41.40 167.99 141.50 
97 PLA 21.90 102.70 193.53 177.35 
30 WP 48.60 74.20 639.51 167.90 
43 WP 32.20 38.70 142.59 49.00 
46 WP 35.80 35.90 103.70 73.30 
49 WP 34.53 52,44 245.68 114.38 
53 WP 40.20 39.30 341.36 89.10 
56 WP 34.50 53.20 90.74 85.60 
64 WP 31.80 34.10 129.63 68.80 
80 WP 32.38 74.55 169.16 110.06 
93 WP 29.95 81.50 304.26 180.29 
94 WP 25.34 40.54 290.16 205.39 
3 CP 35.20 96.10 216.05 107.40 
4 CP 29.50 70.20 371.60 211.90 
33 CP 43.20 63.90 639.51 143.60 
38 CP 42.30 64.00 164.20 85.50 
42 CP 42.30 47.30 220.37 89.40 
59 CP 31.60 35.70 362.96 71.40 
62 CP 42.60 55.70 259.26 135.80 
79 CP 32.07 125.10 368.37 189.14 
90 CP 27.02 116.80 192.41 159.27 
96 CP 20.30 30.72 190.19 164.13     
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Study 2 Western blot results at 1 h 
Rat # Group p-Akt p-GSKβ p-GSKα p-eIF2Bε p-AMPK p-FOXO3A α-tubulin 
(% of standard) 
1 SED 22.80 57.40 47.40 156.50 80.30 137.30 273.32 
8 SED 13.60 23.80 32.20 107.00 86.10 102.60 253.30 
12 SED 15.10 53.60 69.70 85.70 43.70 126.70 198.83 
52 SED 22.40 75.20 51.90 111.60 49.10 75.90 188.03 
57 SED 16.90 48.60 56.40 85.80 90.10 73.10 107.38 
73 SED 12.10 65.10 60.80 105.30 68.20 128.10 209.32 
74 SED 13.00 40.20 44.80 110.50 54.10 94.90 198.00 
77 SED 49.48 76.81 65.90 119.77 30.20 104.51 189.37 
82 SED 34.40 86.44 94.80 109.44 20.34 107.00 170.95 
88 SED 25.56 69.19 49.60 127.29 10.40 82.27 219.83 
2 PLA 10.20 35.60 31.40 104.50 143.40 144.60 220.74 
7 PLA 10.90 33.80 36.00 102.80 58.40 118.90 201.75 
34 PLA 18.50 37.00 34.50 94.90 98.90 236.20 198.43 
37 PLA 20.30 33.70 41.10 124.10 116.40 105.80 199.74 
50 PLA 11.60 68.70 67.40 117.40 73.50 169.40 175.47 
54 PLA 8.50 67.00 82.00 79.80 134.20 105.90 157.38 
68 PLA 16.00 51.30 55.90 93.10 158.60 95.30 198.38 
78 PLA 19.75 106.39 83.60 110.00 20.21 155.85 248.43 
91 PLA 23.53 127.30 83.80 130.73 90.80 150.31 229.73 
97 PLA 16.03 88.74 40.37 134.14 20.90 128.64 187.74 
30 WP 24.30 31.10 42.90 182.60 205.10 197.90 199.08 
43 WP 10.20 58.50 49.10 96.50 195.40 152.00 179.46 
46 WP 4.60 41.40 34.70 88.20 121.30 173.60 166.95 
49 WP 18.83 58.33 47.44 104.27 89.23 146.13 204.86 
53 WP 14.50 42.80 50.10 70.90 121.00 102.10 222.20 
56 WP 15.40 32.00 28.30 76.60 114.20 84.00 183.74 
64 WP 13.20 35.00 31.60 66.30 76.90 66.00 176.95 
80 WP 36.61 81.76 87.20 110.99 20.67 175.60 190.74 
93 WP 31.14 89.19 50.81 116.79 68.80 183.75 201.88 
94 WP 19.56 113.19 52.28 129.59 89.70 180.26 119.84 
3 CP 12.10 42.20 39.40 76.50 164.20 175.10 198.74 
4 CP 9.30 58.50 44.40 133.80 107.30 144.10 200.83 
33 CP 30.60 37.80 42.10 123.30 207.10 286.30 248.88 
38 CP 13.70 36.40 29.50 102.80 120.80 132.80 228.83 
42 CP 14.40 41.50 33.00 114.00 94.70 124.50 202.48 
59 CP 20.20 63.50 55.40 72.30 170.30 120.90 169.84 
62 CP 10.10 37.40 30.40 83.60 117.60 135.00 164.99 
79 CP 23.76 103.22 96.60 148.34 28.19 216.37 200.93 
90 CP 31.81 86.11 48.98 103.88 76.00 168.86 269.88 
96 CP 22.74 101.90 49.89 123.87 97.40 108.90 177.95 
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Study 2 Western blot results at 2 h 
Rat # Group Puromycin labeled peptide Free puromycin Protein synthesis 
% of standard (pmol/mg protein) (PLP/free puromycin) 
17 SED 144.10 4.94 29.17 
19 SED 197.00 2.83 24.30 
47 SED 180.00 11.01 16.35 
51 SED 268.10 4.24 24.30 
55 SED 192.90 6.10 31.60 
60 SED 122.00 7.02 17.38 
69 SED 288.30 6.73 42.84 
75 SED 100.00 6.04 16.56 
86 SED 159.75 8.62 18.53 
98 SED 215.40 9.81 21.96 
24 PLA 109.80 7.89 13.91 
32 PLA 148.50 6.16 24.10 
41 PLA 124.70 4.86 25.65 
66 PLA 222.30 6.71 33.12 
67 PLA 152.80 7.01 21.80 
70 PLA 107.30 9.49 11.31 
71 PLA 265.50 7.07 37.54 
76 PLA 135.10 10.68 12.65 
84 PLA 166.99 6.07 27.51 
89 PLA 159.22 7.33 21.72 
21 WP 104.80 4.75 22.05 
28 WP 138.90 9.25 15.02 
44 WP 162.80 13.93 11.69 
45 WP 283.80 6.67 42.52 
61 WP 233.30 3.67 63.57 
63 WP 130.90 3.05 42.92 
65 WP 98.90 8.10 12.21 
81 WP 177.40 5.68 31.23 
92 WP 116.00 6.55 17.71 
95 WP 140.90 7.15 19.71 
13 CP 194.90 5.00 38.99 
15 CP 137.90 7.06 19.53 
29 CP 179.50 9.25 19.41 
35 CP 168.80 8.39 20.13 
48 CP 270.30 12.83 21.07 
58 CP 172.80 2.82 61.28 
72 CP 325.40 7.06 46.09 
83 CP 112.80 5.94 18.99 
85 CP 139.80 6.77 20.65 
87 CP 130.90 5.50 23.80  
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Study 2 Western blot results at 2 h 
Rat # Group p-4E-BP1 polyclonol p-mTOR p-p70S6k p-rpS6 
(% of γ isoform) (% of standard) 
17 SED 30.00 26.40 103.70 26.90 
19 SED 49.30 30.70 259.26 78.10 
47 SED 42.70 57.30 116.67 85.50 
51 SED 41.70 82.30 90.74 45.00 
55 SED 24.90 37.30 21.60 27.10 
60 SED 17.60 21.40 17.28 19.80 
69 SED 31.10 25.50 64.81 16.40 
75 SED 25.43 21.74 162.37 90.87 
86 SED 22.06 51.35 96.94 19.03 
98 SED 37.95 33.64 239.89 111.94 
24 PLA 38.70 69.30 816.67 227.50 
32 PLA 46.40 60.30 566.05 166.00 
41 PLA 28.40 22.70 95.06 42.00 
66 PLA 52.30 83.60 466.67 171.70 
67 PLA 42.70 22.40 82.10 93.10 
70 PLA 18.80 36.90 30.25 34.00 
71 PLA 45.20 31.40 112.35 156.00 
76 PLA 38.43 45.62 345.69 133.73 
84 PLA 32.52 42.64 557.50 139.58 
89 PLA 38.16 46.10 341.37 129.29 
21 WP 45.60 54.30 639.51 187.20 
28 WP 50.70 40.40 916.05 131.00 
44 WP 38.40 18.90 406.17 143.30 
45 WP 44.20 29.60 272.22 63.60 
61 WP 44.90 28.20 211.73 97.40 
63 WP 27.20 52.40 259.26 72.00 
65 WP 51.50 48.70 211.73 86.20 
81 WP 34.08 33.67 259.14 118.40 
92 WP 33.24 78.50 443.85 167.89 
95 WP 34.59 37.54 304.26 150.96 
13 CP 46.50 62.20 1075.93 208.70 
15 CP 42.00 16.90 700.00 114.70 
29 CP 38.80 75.00 142.59 94.70 
35 CP 57.90 82.40 725.93 183.40 
48 CP 35.00 48.40 211.73 93.00 
58 CP 34.00 33.40 216.05 56.50 
72 CP 44.80 82.30 419.14 128.20 
83 CP 33.79 54.07 363.78 124.52 
85 CP 35.16 98.65 406.40 139.74 
87 CP 36.57 69.64 543.52 160.71   
 209 
Study 2 Western blot results at 2 h 
Rat # Group p-Akt p-GSKβ p-GSKα p-eIF2Bε p-AMPK p-FOXO3A α-tubulin 
(% of standard) 
17 SED 16.30 34.30 46.20 101.00 9.40 131.40 198.93 
19 SED 13.30 48.10 95.00 126.40 13.20 125.40 191.02 
47 SED 15.60 60.30 50.30 145.20 71.10 123.80 220.98 
51 SED 19.80 49.60 44.80 135.00 68.60 123.30 158.98 
55 SED 17.60 79.70 62.00 181.40 52.20 100.80 198.83 
60 SED 14.90 42.20 46.60 96.30 30.20 75.20 224.95 
69 SED 16.80 41.60 45.10 89.10 51.40 62.50 290.84 
75 SED 26.10 92.29 63.31 112.10 46.10 135.17 180.84 
86 SED 17.69 74.47 47.86 109.74 47.20 146.14 199.84 
98 SED 35.90 53.97 33.72 94.27 32.60 94.22 111.84 
24 PLA 21.50 27.70 26.30 124.70 60.00 181.10 200.84 
32 PLA 11.40 30.90 26.60 143.00 34.30 246.00 240.75 
41 PLA 12.50 78.00 64.30 96.70 53.90 109.00 289.75 
66 PLA 22.50 74.50 56.10 123.10 79.60 100.30 199,74 
67 PLA 16.30 55.50 41.80 66.40 105.10 141.30 164.84 
70 PLA 9.70 41.20 31.80 105.90 70.50 135.50 119.84 
71 PLA 10.70 26.60 41.50 116.60 71.20 99.00 188.65 
76 PLA 19.25 77.79 45.74 97.20 65.00 101.21 178.74 
84 PLA 29.42 93.04 45.70 94.70 75.50 145.69 240.74 
89 PLA 17.03 56.14 42.40 107.59 67.23 139.90 220.74 
21 WP 17.00 32.30 37.10 118.30 145.60 135.40 272.74 
28 WP 12.20 37.50 54.90 95.30 148.70 185.00 165.84 
44 WP 6.70 40.50 36.50 85.60 112.00 135.40 167.47 
45 WP 5.10 47.80 34.80 82.90 103.00 161.20 237.70 
61 WP 19.70 43.80 39.10 95.20 137.50 202.70 177.85 
63 WP 9.80 36.90 25.10 105.00 138.50 76.30 190.47 
65 WP 20.10 45.60 46.00 86.00 144.90 87.90 228.77 
81 WP 20.12 84.98 46.78 112.03 86.70 136.61 272.64 
92 WP 26.57 110.44 59.27 86.96 85.70 183.33 190.74 
95 WP 30.06 92.26 49.56 108.51 122.40 179.82 277.74 
13 CP 17.30 66.20 93.80 106.20 43.00 122.20 116.64 
15 CP 10.50 43.10 77.20 78.00 31.20 144.90 187.64 
29 CP 17.10 29.60 17.40 83.10 38.00 145.40 190.74 
35 CP 10.90 31.10 27.00 103.70 27.90 232.60 200.57 
48 CP 17.40 48.50 56.50 140.20 165.70 106.10 250.75 
58 CP 17.70 62.90 64.10 129.90 70.30 110.00 197.76 
72 CP 22.70 47.00 44.40 100.10 97.80 125.50 177.00 
83 CP 36.16 102.47 54.48 117.10 62.10 162.22 276.64 
85 CP 25.17 90.44 51.56 94.46 87.20 186.96 188.84 
87 CP 28.80 100.18 56.09 133.20 63.50 170.65 190.74 
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APPENDIX J: RAW DATA FOR STUDY 3 
Study 3 Rat physical characteristics 
Rat # Group Food intake Total calorie Initial BW Final BW FHL muscle Adipose 
(g) (kcal) (g) (g) (mg) (g) 
1 SED 28.0 98.9 329 533 704 11.12 
2 SED 29.2 103.1 349 563 791 12.00 
12 SED 29.0 102.3 416 576 780 10.87 
16 SED 28.0 98.8 420 578 817 7.93 
31 SED 31.2 110.2 365 554 730 8.56 
34 SED 29.5 104.2 344 545 730 9.44 
37 SED 28.2 99.6 320 528 650 7.71 
3 PLA 27.8 98.0 407 544 881 5.15 
10 PLA 27.2 95.9 411 556 880 7.82 
13 PLA 28.2 99.7 415 572 860 13.10 
24 PLA 28.7 101.4 383 525 950 6.10 
27 PLA 27.5 96.9 380 497 830 6.12 
28 PLA 26.9 95.0 387 478 780 6.35 
36 PLA 26.7 94.3 341 464 780 7.06 
38 PLA 28.9 101.9 347 521 850 10.01 
4 WH 25.4 90.0 386 503 830 6.79 
6 WH 29.1 103.0 406 566 848 10.02 
11 WH 27.4 97.0 402 544 885 8.15 
14 WH 25.9 91.8 393 523 838 8.79 
22 WH 30.0 106.3 392 580 847 11.80 
26 WH 30.2 106.9 405 572 820 11.05 
32 WH 24.9 88.2 324 434 740 7.15 
39 WH 27.8 98.3 344 514 830 7.40 
5 CW 25.8 92.2 398 506 840 7.40 
7 CW 24.6 87.7 394 486 790 8.70 
15 CW 23.9 85.3 380 492 821 7.68 
25 CW 28.8 102.8 388 528 838 7.25 
30 CW 28.8 102.6 393 511 967 7.54 
33 CW 29.5 105.2 374 592 840 8.46 
35 CW 29.3 104.2 335 498 852 7.15 
40 CW 26.6 95.0 326 502 840 8.47         
 211 
  
Study 3 DEXA-week 0 
Rat # Group Fat % Lean mass % Fat mass (g) Lean mass (g) 
1 SED 35.1 64.9 112 207 
2 SED 33.5 66.5 113 223 
12 SED 34.5 65.5 127 241 
16 SED 35.3 64.7 129 236 
31 SED 39 61 125 196 
34 SED 37.3 62.7 112 188 
37 SED 35.4 64.6 98 179 
3 PLA 33.7 66.3 128 252 
10 PLA 40 60 148 222 
13 PLA 40.2 59.8 141 209 
24 PLA 31.5 68.5 112 244 
27 PLA 36.2 63.8 129 227 
28 PLA 36.1 63.9 129 229 
36 PLA 42.2 57.8 120 164 
38 PLA 38.5 61.5 109 174 
4 WH 36.8 63.2 135 231 
6 WH 38.5 61.5 140 225 
11 WH 35.4 64.6 124 226 
14 WH 34.6 65.4 120 226 
22 WH 36.2 63.8 134 236 
26 WH 34 66 122 238 
32 WH 35.2 64.8 115 211 
39 WH 38.4 61.6 108 173 
5 CW 36.5 63.5 138 240 
7 CW 36.1 63.9 134 238 
15 CW 36.3 63.7 123 215 
25 CW 38.8 61.2 140 220 
30 CW 33.9 66.1 124 242 
33 CW 37.6 62.4 118 197 
35 CW 36 64 108 192 
40 CW 37.9 62.1 104 171          
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Study 3 DEXA-week 4 
Rat # Group Fat % Lean mass % Fat mass (g) Lean mass (g) 
1 SED 43.4 56.6 187 244 
2 SED 38.7 61.3 172 272 
12 SED 42.1 57.9 218 299 
16 SED 43.8 56.2 218 280 
31 SED 49 51 231 240 
34 SED 40.9 59.1 188 271 
37 SED 40.7 59.3 176 256 
3 PLA 34.6 65.4 167 315 
10 PLA 41.4 58.6 204 288 
13 PLA 53.5 46.5 265 232 
24 PLA 38.4 61.6 172 275 
27 PLA 34.9 65.1 152 283 
28 PLA 43.7 56.3 183 236 
36 PLA 51.3 48.7 210 200 
38 PLA 50.9 49.1 222 215 
4 WH 39.6 60.4 177 270 
6 WH 44.8 55.2 220 271 
11 WH 40.8 59.2 194 284 
14 WH 44.8 55.2 202 249 
22 WH 46.5 53.5 226 259 
26 WH 44.7 55.3 215 266 
32 WH 42.7 57.3 164 220 
39 WH 45.2 54.8 197 239 
5 CW 43.9 56.1 199 255 
7 CW 41.4 58.6 179 254 
15 CW 44.1 55.9 190 240 
25 CW 42.2 57.8 187 256 
30 CW 40.8 59.2 182 264 
33 CW 46.8 53.2 235 267 
35 CW 46.8 53.2 201 228 
40 CW 45.8 54.2 183 216         
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Study 3 DEXA-week 8 
Rat # Group Fat % Lean mass % Fat mass (g) Lean mass (g) 
1 SED 46.4 53.6 234 270 
2 SED 43.1 56.9 231 305 
12 SED 44.9 55.1 250 307 
16 SED 44.8 55.2 247 304 
31 SED 48.1 51.9 260 281 
34 SED 39.9 60.1 211 319 
37 SED 34.5 65.5 176 334 
3 PLA 35.3 64.7 180 330 
10 PLA 45.7 54.3 245 291 
13 PLA 55 45 299 245 
24 PLA 39.2 60.8 200 311 
27 PLA 36.8 63.2 178 305 
28 PLA 41.8 58.2 189 263 
36 PLA 47.8 52.2 212 232 
38 PLA 47.4 52.6 234 259 
4 WH 38.6 61.4 251 294 
6 WH 47 53 184 284 
11 WH 44.5 55.5 234 292 
14 WH 45.6 54.4 233 278 
22 WH 45.6 54.4 255 304 
26 WH 51.7 48.3 281 263 
32 WH 38.4 61.6 157 253 
39 WH 44.4 55.6 216 270 
5 CW 41.3 58.7 207 287 
7 CW 45 55 202 253 
15 CW 45.3 54.7 213 258 
25 CW 44.5 55.5 222 277 
30 CW 42 58 208 287 
33 CW 47 53 266 300 
35 CW 43.3 56.7 205 269 
40 CW 46.3 53.7 226 256   
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Study 3 Maximal carrying capacity (g) 
Rat # Group 1 2 3 4 5 6 7 8 9 10 
3 PLA 485 545 605 635 665 725 785 845 905 935 
10 PLA 488 578 668 728 788 788 908 968 998 1028 
13 PLA 431 491 521 551 581 611 641 671 701 701 
24 PLA 467 557 587 677 737 797 797 827 827 827 
27 PLA 435 555 615 675 735 765 855 945 1005 1035 
28 PLA 501 561 621 681 681 711 771 801 831 921 
36 PLA 495 585 675 705 735 765 795 825 855 915 
38 PLA 500 530 680 800 830 890 890 920 980 1010 
4 WH 469 529 589 619 679 709 769 769 799 859 
6 WH 484 514 544 544 604 634 694 724 724 754 
11 WH 511 541 601 721 811 871 931 961 1051 1081 
14 WH 414 474 474 504 624 714 774 774 834 864 
22 WH 474 533 593 653 713 773 803 863 893 953 
26 WH 423 513 543 603 633 693 723 723 753 753 
32 WH 423 543 633 693 783 843 903 933 963 993 
39 WH 498 588 648 708 768 798 858 888 918 978 
5 CW 448 478 538 598 658 718 808 868 958 988 
7 CW 415 475 505 535 625 685 745 805 835 865 
15 CW 435 465 525 585 645 735 765 765 825 855 
25 CW 501 591 651 741 831 891 951 981 1041 1071 
30 CW 534 624 714 774 834 954 1014 1044 1074 1134 
33 CW 430 490 580 640 730 820 880 940 970 1000 
35 CW 461 551 581 701 821 881 911 971 1031 1091 
40 CW 424 484 544 694 724 784 814 904 934 964 
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Maximal carrying capacity (g) % increase % increase 
Rat # 11 12 13 14 15 16 17 18 19 20 
3 965 995 1085 1085 1115 1145 1235 1235 1295 1325 273 
10 1028 1028 1058 1058 1088 1088 1118 1178 1208 1298 266 
13 731 761 791 881 971 971 1001 1031 1061 1091 253 
24 887 947 1007 1067 1157 1187 1217 1247 1247 1247 267 
27 1065 1125 1155 1215 1245 1275 1275 1335 1365 1395 321 
28 981 1011 1071 1141 1201 1231 1291 1291 1291 1291 258 
36 945 945 975 1035 1095 1095 1125 1155 1155 1185 239 
38 1070 1170 1230 1290 1290 1320 1350 1380 1380 1410 282 
4 919 919 949 1009 1039 1099 1159 1159 1189 1219 260 
6 784 814 844 874 934 1024 1054 1084 1114 1174 243 
11 1141 1171 1231 1261 1321 1351 1351 1411 1441 1471 288 
14 954 1014 1044 1104 1164 1194 1224 1254 1284 1314 317 
22 1043 1073 1133 1163 1223 1253 1283 1313 1343 1343 283 
26 783 813 843 903 933 933 963 963 993 993 235 
32 1053 1113 1143 1203 1233 1263 1293 1293 1293 1323 313 
39 1008 1068 1128 1188 1218 1218 1218 1248 1248 1248 251 
5 1018 1048 1138 1138 1168 1228 1258 1258 1258 1288 288 
7 955 985 1015 1075 1105 1135 1135 1165 1165 1195 288 
15 915 1005 1035 1095 1155 1215 1245 1245 1275 1275 293 
25 1101 1176 1236 1326 1356 1386 1416 1446 1446 1476 295 
30 1224 1284 1344 1374 1434 1464 1524 1614 1674 1704 319 
33 1060 1120 1180 1210 1270 1330 1360 1360 1390 1390 323 
35 1151 1221 1341 1371 1400 1400 1470 1470 1470 1500 325 
40 1024 1054 1114 1144 1174 1204 1234 1264 1264 1294 305 
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Study 3 Muscle morphological results 
Rat # Group Fiber CSA Muscle length Muscle CSA # of Nuclei Myonuclear domain 
(µm2) (cm) (mm2) (per fiber) (µm2/nucleus) 
1 SED 1553.27 3.5 59.9 1.61 952.80 
2 SED 1526.78 3.3 71.4 1.56 1021.52 
12 SED 1718.67 3.3 70.4 1.35 1220.42 
16 SED 2456.83 3.3 73.8 1.47 1530.72 
31 SED 2373.10 3.1 70.2 1.40 1890.46 
34 SED 2228.79 3.2 68.0 1.24 2076.47 
37 SED 2371.95 3.2 60.5 1.17 1978.12 
3 PLA 3423.42 3.2 82.0 1.42 2517.34 
10 PLA 2736.32 3.1 84.6 1.61 1711.32 
13 PLA 3531.20 3.2 80.1 1.87 1806.18 
24 PLA 3278.41 3.2 88.5 1.69 1787.10 
27 PLA 3034.44 3.1 79.8 1.78 1529.08 
28 PLA 1894.70 3.1 75.0 1.21 1709.97 
36 PLA 2374.20 3.1 75.0 1.39 1742.25 
38 PLA 3317.99 3.1 81.7 1.46 2123.67 
4 WH 2408.35 3.4 72.7 1.92 1315.47 
6 WH 4217.08 3.1 81.5 1.77 2215.13 
11 WH 2260.02 3.3 79.9 1.46 1649.38 
14 WH 3234.37 3.2 78.0 1.56 2173.37 
22 WH 3612.27 3.2 78.9 1.83 2102.05 
26 WH 2817.49 3.3 74.0 1.52 1825.42 
32 WH 1728.17 3.2 68.9 1.14 1364.42 
39 WH 3563.22 3.1 79.8 1.54 2315.19 
5 CW 3819.27 3.1 80.7 1.78 2173.05 
7 CW 2735.92 3.1 75.9 1.56 1784.34 
15 CW 4104.90 3.2 76.5 1.77 2354.06 
25 CW 2362.83 3 78.3 1.32 1626.76 
30 CW 2513.45 3.1 93.0 1.51 1863.93 
33 CW 2395.04 3.2 78.2 1.38 1790.91 
35 CW 2703.99 3.2 79.3 1.48 1729.04 
40 CW 3286.53 3.1 80.7 1.36 2284.58      
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Study 3 Total and myofibrillar proteins 
Rat # Group Total protein concentration Total protein Myofibrillar concentration Myofibrillar protein 
(mg/g) (mg/muscle) (mg/g) (mg/muscle) 
1 SED 169.87 119.59 73.37 51.65 
2 SED 167.29 132.33 78.08 61.76 
12 SED 169.08 131.88 61.98 48.34 
16 SED 204.03 166.69 84.95 69.40 
31 SED 185.75 135.60 92.59 67.59 
34 SED 196.74 143.62 74.59 54.45 
37 SED 167.35 108.78 80.12 52.08 
3 PLA 203.06 178.90 83.84 73.86 
10 PLA 170.78 150.29 76.04 66.91 
13 PLA 154.83 133.16 71.53 61.52 
24 PLA 176.01 167.20 70.63 67.10 
27 PLA 211.64 175.66 91.97 76.34 
28 PLA 186.05 145.12 96.94 75.61 
36 PLA 197.91 154.37 74.46 58.08 
38 PLA 181.80 154.53 81.18 69.01 
4 WH 170.29 141.34 68.88 57.17 
6 WH 176.38 149.57 78.79 66.81 
11 WH 195.10 172.66 64.73 57.28 
14 WH 195.49 163.82 91.73 76.87 
22 WH 162.68 137.79 99.13 83.96 
26 WH 193.15 158.38 85.82 70.37 
32 WH 153.93 113.91 84.60 62.60 
39 WH 211.27 175.36 83.40 69.22 
5 CW 164.36 138.06 86.76 72.88 
7 CW 203.82 161.02 83.13 65.68 
15 CW 171.90 141.13 110.37 90.62 
25 CW 182.05 152.56 82.93 69.49 
30 CW 256.07 247.62 90.69 87.70 
33 CW 185.57 155.04 99.28 83.40 
35 CW 174.97 149.07 81.67 69.58 
40 CW 187.36 157.38 87.02 73.10       
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Study 3 Western blot results  (% of standard) 
Rat # Group IGF-1 Myostatin Pax 7 Myo D Myogenin α-tubulin 
1 SED 91.40 36.92 35.88 31.82 34.75 128.50 
2 SED 65.00 18.20 34.10 24.50 20.20 137.00 
12 SED 89.00 45.20 40.40 58.40 40.40 122.70 
16 SED 69.50 91.80 89.10 64.50 77.00 97.20 
31 SED 93.40 19.40 17.60 17.70 22.90 134.60 
34 SED 105.20 22.70 17.00 9.30 24.80 110.50 
37 SED 59.80 24.20 17.10 16.50 23.20 119.10 
3 PLA 77.90 46.40 61.00 60.20 47.40 122.70 
10 PLA 92.90 29.60 38.40 42.00 37.50 118.10 
13 PLA 99.80 39.90 32.20 46.10 35.00 115.80 
24 PLA 105.10 34.10 34.70 20.90 41.70 116.80 
27 PLA 98.80 23.40 20.60 16.30 40.00 144.70 
28 PLA 97.10 34.60 26.40 22.30 40.20 110.60 
36 PLA 43.10 27.20 25.30 20.00 24.80 113.70 
38 PLA 97.00 30.50 13.10 11.30 39.50 128.80 
4 WH 83.20 72.80 104.00 74.20 57.40 131.60 
6 WH 95.00 19.70 13.20 16.90 22.70 109.30 
11 WH 86.10 57.90 39.50 45.10 41.70 138.20 
14 WH 97.90 40.10 42.50 23.80 56.60 123.80 
22 WH 92.80 16.80 21.70 15.40 33.90 121.20 
26 WH 88.10 32.90 26.50 22.00 39.00 103.00 
32 WH 100.30 26.30 17.40 17.00 31.60 135.10 
39 WH 100.80 55.10 47.30 40.80 92.10 143.50 
5 CW 95.00 56.90 74.30 54.70 41.60 132.60 
7 CW 107.70 17.20 21.80 32.60 24.70 100.70 
15 CW 92.00 66.40 67.50 55.40 72.30 138.90 
25 CW 124.30 20.70 30.00 14.90 28.00 121.20 
30 CW 135.20 32.20 32.40 17.70 52.30 141.90 
33 CW 80.60 22.10 21.80 20.00 25.20 159.30 
35 CW 71.40 48.20 25.90 17.50 59.50 100.40 
40 CW 122.00 41.00 20.50 15.50 50.40 100.60       
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study 3 Plasma corticosterone (ng/ml) 
Rat # Group week 0 week 4 week 8 
1 SED 88.37 144.87 37.30 
2 SED 77.96 65.32 42.59 
12 SED 13.29 3.01 39.26 
16 SED 53.07 31.51 23.50 
31 SED 72.33 22.38 77.20 
34 SED 26.36 13.62 121.10 
37 SED 4.08 41.32 60.36 
3 PLA 40.45 0.64 68.78 
10 PLA 23.44 3.88 237.98 
13 PLA 2.62 43.65 8.35 
24 PLA 10.41 85.82 127.92 
27 PLA 32.29 30.01 79.76 
28 PLA 14.00 59.54 154.15 
36 PLA 55.19 19.62 109.21 
38 PLA 26.21 56.34 62.05 
4 WH 8.99 1.66 28.39 
6 WH 8.92 2.28 82.09 
11 WH 33.91 13.07 7.70 
14 WH 27.10 33.09 12.86 
22 WH 81.00 40.90 63.49 
26 WH 18.32 32.46 56.73 
32 WH 15.00 111.49 154.15 
39 WH 23.97 79.53 165.15 
5 CW 6.36 6.79 4.36 
7 CW 60.67 0.34 6.55 
15 CW 5.60 64.01 15.14 
25 CW 4.05 106.97 55.28 
30 CW 5.29 29.05 105.51 
33 CW 86.99 18.96 99.16 
35 CW 61.20 69.29 149.96 
40 CW 2.81 76.83 116.20    
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